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“Bayesians address the question everyone is interested in by using assumptions no-one
believes, while frequentists use impeccable logic to deal with an issue of no interest to
anyone. ”
Louis Lyons
Abstract
Physiological systems are well recognised to be nonlinear, stochastic and complex. In
situations when only one time series of a single variable is available, exacting useful
information from the dynamic data is crucial to facilitate personalised clinical decisions
and deepen the understanding of the underlying mechanisms. This thesis is focused
on establishing and validating data-driven models, that incorporate nonlinearity and
stochasticity into the model developing framework, to describe a single measurement
time series in the field of biomedical engineering. The tasks of model selection and pa-
rameter estimation are performed by applying the variational Bayesian method, which
has shown great potential as a deterministic alternative to Markov Chain Monte Carlo
sampling methods. The free energy, a maximised lower bound of the model evidence, is
considered as the main model selection criterion, which penalises the complexity of the
model. Several other model selection criteria, alongside the free energy criterion, have
been utilised according to the specific requirements of each application. The method-
ology has been employed to two biomedical applications. For the first application, a
nonlinear stochastic second order model has been developed to describe the blood glu-
cose response to food intake for people with and without Diabetes Mellitus (DM). It was
found that the glucose dynamics for the people with DM show a higher degree of non-
linearity and a different range of parameter values compared with people without DM.
The developed model shows clinical potential of classifying individuals into these two
groups, monitoring the effectiveness of the diabetes management, and identifying people
with pre-diabetes conditions. For the second application, a linear third order model
has been established for the first time to describe post-transplant antibody dynamics
after high-risk kidney transplantation. The model was found to have different ranges of
parameter values between people with and without acute antibody-mediated rejection
(AMR) episodes. The findings may facilitate the formation of an accurate pre-transplant
risk profile which predicts AMR and allows the clinician to intervene at a much earlier
stage, and therefore improve the outcomes of high-risk kidney transplantation.
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Chapter 1
Introduction
1.1 Overview
Extracting useful information from limited clinical data has always been one of the
main focuses of biomedical research. Clinicians need to make decisions – sometimes
life-changing ones – for individual cases based on the available data, which can often be
sparse and noisy [1]. Clinical data can broadly be split into two categories: one type
characterises the static properties such as age, gender, etc., and the other type char-
acterises the dynamic properties of how the physiological system evolves. Whilst the
first type of data is usually statistically analysed through data-mining techniques, the
second type is often limited to monitoring purposes after certain clinical interventions or
treatments. However, the dynamic response of the physiological system after a clinical
intervention or treatment carries essential information about possible clinical outcomes,
and therefore should be extracted and analysed to help the clinicians provide improved
prevention and screening, diagnosis, prognosis, and/or predictions of response to treat-
ment or clinical intervention [2–4]. Various mathematical models have been established
to describe, interpret, or predict the dynamic behaviours in clinical data [5–7] to obtain
two essential pieces of information: 1) the common patterns shown by different groups of
patients and 2) the distinctive features that only belong to an individual. However, when
knowledge of the underlying physiological system is limited, it is not straightforward to
establish a model that is capable of classifying and recognising patterns in clinical data.
1
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There are two fundamental approaches to developing a mathematical model for describ-
ing the dynamics of physiological systems [8], with the purpose of obtaining control of
the physiological system to external stimuli. The first approach is based on the under-
standing of the physiological processes that generate the measured data, which are often
referred to as physiological or mechanistic models. Depending on the purpose of the
model, this approach can be used to establish models at the molecular, cellular, tissue
or organ scale with parameters that have direct physiological interpretations [9]. The
process can be time-consuming, may be even impossible in practice, since it requires
knowledge at a detailed level about the system’s structure and all its parameters. The
second approach is focused on describing the measurement data without taking into
account explicit knowledge of the physiological processes underneath, which are often
referred to as data-driven models. In this case, the system’s internal structure is con-
sidered as a black box and the only available information about the system is given by
its measured inputs and outputs, and the model structure needs to be flexible enough
to capture the variations in the data [10]. Data-driven modelling is best implemented
when it can be based on the use of inexpensive accessible measurement data to produce
parsimonious models [11, 12]. Choice between these two approaches depends on the aim
of the research, the level of the understanding of the system, and the availability of the
data. The mechanistic approach is better for gaining insight into the working princi-
ple of a system, but when the underlying system is not well-understood, establishing a
data-driven model may help determine critical characteristics that can provide valuable
information for later establishing the mechanistic models [13].
There are several difficulties regarding establishing the first type of model for physiolog-
ical systems. 1) The most challenging part is to formulate the extraordinary complexity
of a physiological system that is the culmination of millions of years of evolution. A sys-
tem is defined as complex when the interactions between the components of the system
generate properties that cannot be reduced to its subunits [14]. In physiological systems,
new properties have been created as a consequence of the entwined feedback loops that
keep humans within the narrow bounds needed for survival [9]. For example, it may be
possible for the human body to survive the removal of certain parts by a spontaneous
self reorganisation of the system, such as the reshaping of the nervous system following a
severe injury, known as brain plasticity. However, a highly intertwined system structure
makes it difficult to understand the complex underlying mechanisms. The complexity of
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physiological system is handled in nature through multiple feedback mechanisms. This
also presents a challenge to system identification due to intrinsic couplings between the
variables and strong limitations to the exogenous excitation. 2) It is a formidable task
to identify all the parameters in physiological models [15]. Any physiological model that
is even approximately realistic will have a large number of parameters [16]. Researchers
commonly try to determine the values of these parameters given only one measurement
time series, such as the concentration of a certain type of blood cell, the electrical activ-
ity of the heart over a period of time (also known as electrocardiography), the human
breath rate or the heart rate time series, etc. [17, 18]. In many cases, it is impossible
to estimate these parameters, even with perfect data, due to lack of structural identi-
fiability. In cases where the parameter can be estimated in theory, it can still remain
statistically challenging, especially in the case where the number of the observation data
points in the time series and the number of the parameters are comparable [16]. When
certain physiologically based variables in the model are inaccessible, it might be possible
to identify these variables in animals where more invasive studies can be conducted [19].
However the translation between human and animal parameters is not as simple as linear
scaling [20]. 3) Another important problem is the limited data available for personalised
modelling. In clinical applications, individualised models are required for personalised
patient care, but many physiological models use a single set of parameters representing
the ‘average person’ [16]. However, reliable data acquired through minimally invasive
techniques for each patient still remain scarce [21]. 4) The lack of a generalised accept-
able model for different physiological processes is another issue, since the nature and
structure of underlying processes varies significantly from system to system [22].
The second category - data driven dynamic modelling - does not require a complete
understanding of the underlying physiological system and therefore does not have the
difficulties that are associated with the physiologically based models . Data-driven mod-
els can be categorised into parametric and non-parametric models. A parametric model
describes the system using a limited number of characteristic quantities – the parameters
of the model – while a non-parametric model determines the model structure directly
from the measurements. The term non-parametric does not imply that the model lacks
parameters. Instead, it means that the number and the nature of the parameters are
flexible and not fixed in advance, leading to less structural interpretability compared
to parametric models. However, within parametric models, the information about the
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system is captured by a relatively small number of parameters, compared with non-
parametric models. Therefore, the physical insights and concentration of information
per parameter is more substantial for parametric models than for non-parametric models
[10]. This thesis will focus on parametric models, which seek quantitative descriptions of
physiological systems based on input-output information derived from the experimental
data. They are mathematical descriptions of data, with only implicit correspondence to
the underlying physiology. Non-parametric models, such as Volterra models [23], will
not be considered in this thesis. Within the data-driven modelling paradigm, one of
the most common approaches is autoregressive models. An autoregressive (AR) model
describes the output of a time-varying process by a linear combination of its past values
and certain stochastic terms representing noise. The advantage of AR models is that the
future output can be easily predicted by only considering the previous values. However,
most AR models have no structural interpretation; the identification and estimation of
the parameters can also be seriously distorted by measurement outliers.
Data-driven models based on differential equations are often overlooked due to the diffi-
culties of selecting the appropriate form to account for the nonlinearity and stochasticity
of the system. Furthermore, the parameter estimation of nonlinear continuous-time mod-
els is not a trivial task, and can be computationally involved due to the calculation of
time-derivatives or integrals of sophisticated nonlinear functions. However, differential
equation based models have the following inherent advantages: 1) the estimated model
is defined by a unique set of parameters that are not dependent on the sampling interval,
which allows extrapolation to explore and predict in the region that is not included in
the data. 2) It can handle irregularity in the sampled data better than the difference
models [24]. 3) A differential equation can be approximated by a difference equation
with a higher order, and therefore, a model based on differential equations allows a
more parsimonious representation compared to difference models [25]. 4) Differential
equations can easily accommodate certain prior information into the model by specific
initial conditions. 5) The most fundamental reason for using differential equations is
that the behaviour of physiological systems constantly evolves with time. The under-
lying physiological process is continuous by nature (without considering molecular or
smaller scales), even though the measurement time series are discrete [26]. Therefore,
modelling the continuous process by a differential model is more appropriate than a
difference model.
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One fundamental property of a physiological system is its nonlinearity. It is often pos-
sible to use linear models to approximate nonlinear systems, which is an attractive idea
because linear models are well established and easy to interpret. It requires much less
effort to build linear models compared with nonlinear models. However, linear equations
can only lead to exponentially decaying/growing or (damped) periodically oscillating so-
lutions. For linear modelling, all irregular behaviour of the system has to be attributed
to some random external input to the system [17]. However, input is not the only source
of the irregularities in a system’s output: a small intervention in a nonlinear system,
such as a disturbance in the initial conditions can have unexpected outcomes which can-
not be simply explained by linear models [14]. A linear approximation to a nonlinear
system is only valid for a given input range. On the other hand, nonlinear modelling is
less straightforward and far less well understood than its linear counterpart. There is
no general nonlinear parametric model framework in the system identification literature
[10]. Recognising the nonlinear behaviour and formulating the nonlinear differential
equation involves a series of trial-and-error processes with a wide range of nonlinear
forms to select from, especially when the measured time series are corrupted with noise.
This thesis presents methodology for identification of the structure of the nonlinear
mathematical models from the available measured input-output data for several impor-
tant medical applications, and analysis of both linear and nonlinear behaviours of the
transient responses of corresponding dynamic physiological systems.
Another important property of a physiological system is its stochasticity. The state of
the stochastic system can only be predicted probabilistically, whereas the outcome from
a deterministic system can be reproduced as long as the input stays the same [27]. The
uncertainty in the model originates from the action of a very large number of factors or
‘degrees of freedom’. Stochasticity can be introduced from external stochastic distur-
bance, such as environmental influences, to intrinsic regulatory responses towards the
disturbance [28], but it is not realistic to model such high-dimensional dynamics. Thus,
deterministic models disregard the stochastic aspects of physiological systems. Stochas-
tic models couple their deterministic equations to ‘noise’ which mimics the perpetual
action of many unconsidered variables in the system. Noise is an essential part of the
physiological system that should not be neglected. A small amount of noise can have
an important role in physiological systems (e.g., [29–31]). For example, the normal hu-
man heartbeat fluctuates in a complex stochastic manner [32]; the heartbeat time series
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from patients with high risk of sudden death showed reduced stochastic property. By
accounting for the intrinsic unpredictability of the system, a stochastic model provides
a more realistic view of the underlying process. The sources of uncertainty are usually
formulated in stochastic models as two types of noise. The first type corresponds to
the uncertainties in the observations, which is modelled as the measurement noise. The
second is the imperfection of the model, which is modelled as the system noise [33].
Measurement noise usually only has a blurring effect on the observation, and does not
influence the evolution of the system. However, when the system noise interacts with
the dynamic variables in nonlinear systems, it can lead to effects such as transitions
between the stable states. Since it can dramatically modify the deterministic dynamics,
the system noise should not be neglected during the modelling procedure, especially in
the case of nonlinear systems. Stochastic models come at a price as they are more com-
putationally demanding than deterministic models, and considerably more difficult to
fit to experimental data [34]. The latest advances in statistical inference methods make
building such stochastic nonlinear models feasible [35, 36], and such stochastic systems
are the subject of our investigations.
As stated above, relevant data that reveal the dynamics of the underlying system, espe-
cially in physiological systems, can be limited. A reliable method is needed to extract the
maximal information from the limited data to provide two essential pieces of informa-
tion: 1) the estimates for model parameter values; 2) how well the model describes the
data. The process of estimating the parameter values in the model is usually referred to
as inference and the evaluation of the model is usually referred to as model selection. In
certain fields of engineering, such as electronic engineering, mechanical engineering and
systems engineering, the interactions between the input and output data have been well
studied since more powerful computing and electronic equipment has made measure-
ment collection easy and affordable. In the biomedical field, however, model selection
and parameter estimation remain challenging considering the limited input-output re-
lationships that can be observed in physiological systems. When the measurements are
disturbed by noise, the distinguishability between different models is reduced, leading to
an uncertainty in the final selection of the model. Therefore, it is paramount to choose
an appropriate method of model development to best exploit limited clinical data.
The techniques for model selection and parameter estimation can be divided into two
major categories: the ‘classical’ or frequentist methods and the probabilistic or Bayesian
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methods [37, 38]. These two categories of methods have several philosophical differences.
First, the frequentist methods calculate the probability of obtaining the measurement
time series assuming that the model is true, whereas the Bayesian methods calculate
the probability of the model being true given the time series. Take the comparison of
two nested models, where one model is the reduced model of the other, as an example.
The most common technique in frequentist methods is hypothesis testing based on the
p-values. Treating the reduced model as the ‘null’ hypothesis, the obtained p-value
represents the probability of obtaining the measurements assuming the null model is
true. The test is an all-or-nothing proposition for rejecting the null hypothesis, without
providing any information about the other model [39]. The Bayesian approach, on the
other hand, calculates the probability of either model being true based on the data. It
provides a more realistic view [40] since we are more interested to know if the model
is more probable rather than if the data are more probable. Second, the frequentist
method makes a point estimate of the parameter and compares models based on the
exact parameter values inferred; whereas the Bayesian inference method expresses the
parameters as probability distributions, and the uncertainties in the parameter values
are accounted for during the model comparison [41]. As the model is stochastic with the
purpose of capturing the uncertainty of the system, a probabilistic inference method fits
better with such a purpose [42]. Furthermore, in Bayesian statistics, a prior belief of the
parameter distribution is quantified by a probability distribution, and this belief gets
updated based on the likelihood of observing the data. Finally the posterior belief of the
parameter distribution takes into account the prior information and the support from
the data [42]. In the classical methods, there is no such option of including preliminary
information about the data. Therefore, based on the above properties and keeping in
mind the complexity and stochasticity of the underlying biomedical systems, Bayesian
methods will be considered for model selection and parameter identification.
Probabilistic models can be computationally difficult to implement, especially when a
large number of parameters need to be estimated and the distributions of the parameters
are not in standard forms (or intractable); there are two ways of addressing this issue.
The first is to use stochastic sampling methods such as Markov Chain Monte Carlo
(MCMC) and Sequential Monte Carlo (SMC) to sample from the unknown distribu-
tion. Thanks to the development of these stochastic sampling methods that are capable
of simulating high-dimensional distributions of parameters, the Bayesian approach has
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gained popularity in parameter inference ever since the 1990s [42, 43]. However, standard
MCMC algorithms such as the Metropolis-Hastings algorithm [44] and the Gibbs algo-
rithm [45] cannot provide a quantitative measure for model comparison between model
candidates, and therefore, an additional step for model selection is required. In addition,
SMC, MCMC, and related sampling methods require large computational power, which
is undesirable. The second way is to approximate the intractable distribution rather
than sampling from it, and one of the methods that has been well developed in statis-
tical physics is called the Variational Bayesian (VB) method. The VB method breaks
down the task of inferring all the parameters into manageable subsets and learns the
value of parameters by iteratively optimising one subset whilst keeping the rest fixed
[41]. With no need of stochastic sampling, the VB method provides measures of uncer-
tainty for any point estimates for the parameters with relatively low computational cost.
This method has been exploited in parameter inference for graphical models amongst
the machine learning community, however, there have been relatively few studies from
other potential fields such as biomedical research [42]. Stochastic sampling methods
such as MCMC might still remain the dominant method in the field of Bayesian infer-
ence, but the purpose of this thesis is to show that the VB method can be successfully
applied to biological system identification and can yield robust dynamic models capable
of capturing essential properties of such biomedical systems from limited data.
1.2 Aim and objectives
The aim of this thesis is to develop and validate nonlinear stochastic data-driven models
that describe the transient responses of the underlying physiological systems through
one-dimensional clinical measurement time series. This thesis investigates two clinical
applications by applying the Variational Bayesian method to identify and select the
model with the appropriate degree of complexity, based on the availability and the
precision of the measurement data for each application.
In the first application, the aim is to construct a generalised data-driven model of tran-
sient glucose responses to the food intake of subjects with and without diabetes that
takes into account the complexity, nonlinearity and stochasticity of the underlying glu-
cose regulatory system. The novelty of this model lies in its concise and parsimonious
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form adjusted to each food intake, whilst still retaining an ability to generalise over glu-
cose response behaviours seen in different individuals. Maintaining glycaemic stability
is one of the primary goals in diabetes management for people with or in progression
towards diabetes. For people that are prone to glucose variability, a model that can
accurately describe the glucose responses to each food intake can help to monitor and
improve their control over diabetes, leading to a healthier life. For diabetic patients
who need insulin injections or medications before each food intake, the model facilitates
an informed estimation of the insulin and medication needed, tailored to each meal at
specific time of the day.
In the second application, the aim is to build an individualised data-driven model for
the first time to describe the post-transplant antibody dynamics after high risk kidney
transplantation. The understanding of post-transplant antibody behaviours is still in
its early stages and the mechanisms controlling the antibody dynamics are not well
understood. Seizing the opportunity opened up by the recently developed technique
of measuring the antibody levels, a novel mathematical model is constructed in this
thesis to extract information from the limited sparse data and to provide insights with
regard to better controlling the antibody response in the early post-transplant stage. The
establishment of the data-driven model can also provide information about the structure
of the physiological system, and therefore lay the foundation for future physiologically
based models.
The objectives of the thesis are listed as follows:
1) Identify the dynamic features in the transient response of the underlying physiological
system from a single measurement time series. Construct model candidates with
different levels of complexity that can describe the identified dynamic features.
2) Apply the variational Bayesian method to infer the parameters of the model candi-
dates and select the best model with the appropriate degrees of complexity in terms
of nonlinearity and stochasticity. Develop appropriate model selection criteria for
both applications.
3) Perform structural identifiability and parameter sensitivity analysis to assess the
reproducibility and robustness of the model.
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4) Gain clinical insights from the selected models and the inferred parameters, with the
aim of improving patient management and treatment in both applications.
1.3 Overview of the thesis structure
The structure of the thesis is as follows: Chapter 1 gives the background information
about modelling physiological systems. It outlines the aim and objectives of this thesis.
Chapter 2 describes the main methodology of model specification, parameter estima-
tion, model selection, structural identifiability, and parameter sensitivity. Chapter 3
focuses on the modelling of post-prandial glucose dynamics, and Chapter 4 focuses on
the modelling of post-transplant antibody dynamics. Both chapters apply the methods
described in Chapter 2. The novelty, the main discoveries, and the future directions of
this research are presented in Chapter 5.
Chapter 2
Methodology
This chapter describes the underlying methodology for model specification, parameter
estimation, model selection, structural identifiability, and parameter sensitivity. It in-
troduces the Variational Bayesian (VB) method which is adapted for the applications
given in Chapters 3 and 4. This chapter is divided into eight sections. Section 2.1
describes the procedure for specifying the form of the models in this thesis. Section 2.2
discusses commonly used parameter inference and model selection methods. Section 2.3
gives details of the VB method for parameter estimation. Section 2.4 provides a com-
parison between several model selection criteria and introduces the free energy criterion.
Section 2.5 discusses the effect of the choice of the prior distributions on the parameters
of the model. Sections 2.6 and 2.7 present several techniques that are used for parameter
identifiability and sensitivity analyses respectively.
2.1 Model specification
Model development in data-driven modelling usually focuses on parameter estimation
and model selection [46–48]; whereas relatively little attention is given to the other cru-
cial part of the modelling procedure – specifying the appropriate form of the model that
is capable of adequately describing the observed data is paramount. In the previous
chapter, the advantages of using differential equations, while accounting for nonlineari-
ties and stochasticities in describing dynamic clinical data, were established. The next
11
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step is to formulate the model using differential equations and incorporate the nonlinear
and stochastic features into the model.
2.1.1 Model formulation using ordinary differential equations (ODE)
A dynamical system is described by three components: the state space variables, time,
and the law of evolution in time. The state space variables are physical variables of the
dynamical system that contain all the information needed for evolution of the states.
Each state space variable corresponds to the coordinate axes of the state space. When
assembled as a vector, the state variables form the state vector, and each possible state
of the system corresponds to one point within the state space. The second component of
a dynamical system, time, can be treated as a discrete or continuous variable. Empirical
measurements are taken at discrete time points – typically at sequential integer values,
and the time interval between two sequential integers is the time ‘unit’. Continuous
time, in contrast, is typically applied to variables that are related to time by functions.
The third component of the dynamical system, the law of evolution, is a rule that
transforms one point in the state space, representing the state of the system ‘now’, into
another point, representing the state of the system one time unit ‘later’. The state of
the system starts at certain initial conditions, evolves with or without external inputs,
and generates outputs. As described in Chapter 1, the two biomedical processes that
have been investigated for this thesis have a common feature: only one measurement
time series, denoted as y (y = {y1, y2, . . . , yT } where yT is the last measurement at time
t = T ), is available, and only one external input, denoted as u (u = {u1, u2, . . . , uT ′}
where uT ′ is the last input at time t = T
′, note that T ′ does not necessarily equal T ), is
given to the system. Therefore, the theoretical description is restricted to single input
single output systems (SISO).
A dynamic model can be written in two forms: the input-output form and the state-space
form. Both forms essentially carry the same information about the system dynamics,
but are applied in different situations [49]. The ‘input-output’ dynamic equation relating
the input u (the input at time t is denoted as ut) to the output of the system y (the
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measurement at time t is denoted as y) is as follows:
dnxt
dtn
+
n−1∑
i=1
fi(xt,θi)
dixt
dti
+ f0(xt,θ0) = ut (2.1a)
yt = g(xt,φ) (2.1b)
In this thesis letters in bold font represent vectors. The equation (2.1a) is the dynamic
equation of nth order, and (2.1b) is the measurement equation. The equation (2.1a) can
also be written in state-space form where the evolution of each state variable is described
by a first-order differential equation, where xt =

xt
x˙t
...
x
(n−1)
t
 is the state vector at time t.
A set of n initial conditions must be known in order to solve the equations for a given
input u. fi (i = 0, 1, . . . , n−1) and g are the functions of the dynamic and measurement
equations respectively, and they can be linear or nonlinear. θi (i = 0, 1, . . . , n − 1) are
the vectors of parameters in (2.1a) and φ is the vector of parameters in (2.1b). In this
thesis, fi and gi are assumed to be smooth and continuously differentiable to guarantee
the existence and uniqueness of the solution based on the Picard–Lindelo¨f theorem [50].
To describe a variety of dynamic responses to the inputs u, a generic form of the dynamic
equation is needed, i.e. the functional forms of fi (i = 0, 1, . . . , n− 1) need to be deter-
mined. As discussed in Chapter 1, a linear form is easy to implement and linear systems
are well understood, but a dynamic equation with linear fi can only describe limited
behaviours of the time series. Nonlinear forms, on the other hand, can be chosen from a
huge variety of functions, such as polynomial, logarithmic, trigonometric functions etc.
Among these forms, polynomial forms, such as Taylor series, have a wide range of nonlin-
ear solutions, and are computationally easy to differentiate and integrate which simplify
the procedure for parameter estimation. For the applications given in Chapters 3 and 4,
exponential decay features can be identified by visual examination of the measurement
time series. Such features agree with the characteristics given by the solutions of the
differential equation with the fi in polynomial forms. In addition, the linear form of a
polynomial function is a special case of its nonlinear form (where the polynomial terms
with orders larger than one are zeros), both linear and nonlinear behaviours in the time
series from different subjects can be unified using a generalised dynamic equation by
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using a polynomial form. Therefore, the polynomial form is selected for fi as a starting
point to explore the nonlinear behaviours in the data.
The next task is to identify the polynomial terms to capture the key dynamic patterns
expressed in the given data. Linear differential equations are considered first. If the
fitting of a model to data is unsatisfactory, higher order polynomial terms will be added
to the fi. As the order of the polynomial terms increases, more varieties of the dynamic
patterns can be expressed by the equation; however, a high order fi may lead to over-
fitting, and a large number of parameters may cause identifiability issues. The optimal
number of the polynomial terms is that at which the benefit gained from increasing the
order compensates for the risks associated with increased model complexity. The details
of the choice of the functional forms for the two biomedical applications are further
explained and justified in Chapters 3 and 4.
2.1.2 Model formulation using stochastic differential equations (SDE)
A system may have one or more sources of noise coupled in one or more ways, and the
literature on the different ways that noise can be incorporated in the model – additively
or multiplicatively – is abundant [51]. As stated in Chapter 1, noise can be categorised
into system noise and measurement noise. System noise disturbs the states, influencing
how the system evolves; while measurement noise is introduced into the system when the
states are being measured, and therefore does not perturb the evolution of the dynamical
system. The analysis of either form of noise is always coupled with the system states
because neither the measurement noise nor the system noise is measurable independently.
With system and measurement noise considered separately, the ODE in (2.1a) can be
written as a Stochastic Differential Equation (SDE) in the form of a Langevin equation
[52], and the input-output model in (2.1a) and (2.1b) can be written as the system
equation and the measurement equation as follows:

dnxt
dtn +
∑n−1
i=1 fi(xt,θi)
dixt
dti
+ f0(xt,θ0) = ut + ηt
yt = xt + εt
(2.2)
where ηt corresponds to the system noise, εt corresponds to the measurement noise.
Additive noise does not depend on the states of the system, and therefore takes a sim-
pler form than multiplicative noise which depends on the states of the system. With
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no preliminary information about the noise available and to reduce model complexity,
additive noise is selected for the applications considered in this thesis. Both of the noise
terms ηt and εt are modelled as Additive White Gaussian Noise (AWGN) [51], which is
a standard noise model to mimic the effect of many random processes. ‘White’ indicates
that the noise has no correlation in time, i.e. the noise has no memory. ‘Gaussian’ indi-
cates that the noise intensity is normally distributed: ηt ∼ N (0, Iη), εt ∼ N (0, Iε). The
mean values of both noise terms are zero. Iη and Iε are the intensities of the system
and measurement noise respectively. They are equivalent to the variances, σ2η and σ
2
ε ,
of the corresponding noise. The precisions of the system and measurement noise, which
are the inverse of the variances, are denoted as αη = 1/σ
2
η and αε = 1/σ
2
ε . The noise
precisions αη and αε, considered as the parameters of the stochastic part of the model,
together with the deterministic system parameters, are aimed to be inferred from the
noisy measurement time series using the inference method described in Section 2.3.
2.2 Model selection and parameter estimation
In Section 2.1, a model structure based on SDEs with polynomial functions was selected,
which leads to multiple model candidates which differ in the number of polynomial
terms. The task of choosing the best model among these candidates is referred to as
model selection in this thesis. Determining the specific values of model parameters that
describe the data is referred to as parameter estimation or inference.
In classical statistical methods, the parameters of each model need to be estimated
before model selection. The model parameters are usually estimated by minimising a
cost function which measures a ‘goodness of fit’ (GOF) for a model. GOF is evaluated
by analysing the differences between observed values and the values expected under the
model in question. The differences are referred to as ‘residuals’. The most widely used
method is to minimise a cost function of the sum of the squared residuals, named least
squares (LS) estimation [53]. Except for constructing a cost function, there are other
ways to measure GOF, among which the most popular way is the maximum likelihood
(ML) method [54]. The ML method looks for the optimised parameters by maximising
the likelihood of obtaining the measurement time series y given the parameters θ of
the model M , (the likelihood is denoted by P (y|θ,M)). Both LS and ML estimation
optimises the GOF for each model; however, a model with a better GOF value (a smaller
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cost or a higher likelihood) does not guarantee a ‘better’ model. With a sufficiently
complex model, parameters can be found to fit the observed data with a high level of
precision, but the model might have been ‘overfitted’ to the data by erroneously fitting
the noise as well. Overfitted models tend to be sensitive towards small fluctuations in
the measurements, which can lead to spurious predictions. Therefore, a penalty term
for model complexity is often introduced to the cost or the likelihood function (such as
the AIC and BIC criteria described in Section 2.4 in detail), along with cross-validating
techniques [55], to check for model overfitting. The choice of this penalty term is essential
for the model selection task. A penalty term that is too large can result in choosing
an underfitted model. Underfitted models often fail to reproduce important features in
the experimental data, which introduce approximation errors into the model — known
as bias. A model is considered underfitted if there are serial correlations between the
residuals [56]. The model with appropriate order and structure needs to seek a balance
between overfitting and underfitting.
Compared with these classical approaches, Bayesian approaches have emerged as a more
effective and informative alternative in the tasks of parameter estimation and model
selection where the tasks can be done simultaneously without the need to choose an
appropriate penalty term. Bayesian approaches interpret ‘probability’ as a quantity that
represents a state of knowledge instead of a frequency of a certain event happening [57],
and the states of knowledge get updated when more information is given, known as the
Bayes’ rule introduced by Cournot (1843). Applying Bayes’ rule to model selection, a
preference over several models p(M) before accounting for any data is defined as the
prior. Given the data y, the conditional probability p(M |y) of the model M being true
is defined as the posterior distribution, and can be described in mathematical terms as
follows:
p(M |y) = P (y|M)× p(M)
P (y)
(2.3)
where p(·) represents a probability density function (normalised function which inte-
grates to one) and P (·) represents a likelihood function which is not necessarily nor-
malised.
The model with the largest p(M |y) among the model candidates is considered the most
probable model. When there is no prior preference for any model, p(M |y) is determined
by the likelihood function P (y|M), defined as the marginal likelihood. To calculate
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P (y|M), the parameters of the model need to be estimated. In the next two sec-
tions, three parameter estimation methods — maximum likelihood (classical method),
maximum-a-posteriori (a bridge between the classical and the full Bayes’ method), and
the full Bayes’ methods — are presented.
2.2.1 Maximum Likelihood and Maximum-a-Posteriori
As suggested by the name of the method, Maximum Likelihood (ML) looks for the most
probable parameter values θˆML by maximising the likelihood function P (y|θ,M), which
is the likelihood of obtaining y given the parameter θ and the model M , as follows:
θˆML = arg max
θ
P (y|θ,M) (2.4)
The ML parameter estimation method is widely used due to its simplicity. However,
under some circumstances, estimating the most probable parameter only based on data
can be misleading. For example, assume model M includes a parameter which repre-
sents the probability of having an earthquake in city A with no previous record of an
earthquake. The most probable value of the parameter is zero based on the record,
which would underestimate the risk of the earthquake, especially if it is known that the
city is located right on top of a tectonic plate boundary. Such information – known
before taking the data into account – is the prior for the parameter. The method that
incorporates the prior information into the ML method is the Maximum-a-Posteriori
(MAP) method, which can be formulated as follows:
θˆMAP = arg max
θ
p(θ|M)P (y|θ,M) (2.5)
where p(θ|M) is the prior of the parameters given the model, and P (y|θ,M), the same
as the term in (2.4), is the likelihood of obtaining y given the parameter θ and the
model M .
The MAP method, just like the ML method, only estimates the mode of the posterior
distribution of the parameters. In situations where the confidence level of the estimated
parameter is of interest, both the ML and MAP methods are not sufficient and the full
Bayes’ method is needed.
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2.2.2 Full Bayes’ method
The full Bayes’ method provides the probability distribution of the parameters instead
of point estimations of the parameters. Given the prior distribution of the parameters,
p(θ|M), the posterior distribution of the parameters can be obtained by normalising the
right hand side of (2.5):
p(θ|y,M) = p(θ|M)P (y|θ,M)
P (y|M) (2.6)
The prior distribution p(θ|M) can have a big influence on the posterior distribution
p(θ|y,M) (discussed in detail in Section 2.5). The posterior distribution of the parame-
ters p(θ|y,M) is obtained by updating the prior belief p(θ|M) based on data y; therefore,
it contains information from both the prior p(θ|M) and the likelihood of obtaining the
data given the parameters for a given model P (y|θ,M).
The denominator of (2.6) — the marginal likelihood P (y|M) — can be obtained by
integrating over the parameter space as follows:
P (y|M) =
∫
P (y, θ|M)dθ =
∫
P (y|θ,M)p(θ|M)dθ = 〈P (y|θ,M)〉p(θ|M) (2.7)
where 〈·〉p denotes the expectation with respect to the probability density function
p(θ|M) in the subscript. As the marginal likelihood is the normalisation constant of
the posterior distribution of the parameters, it is obtained as a by-product of the pa-
rameter distribution estimation. As stated in the last paragraph in Section 2.2, the
model with the largest value of marginal likelihood is chosen to be the most probable
model; therefore, the task of model selection is achieved simultaneously with the task of
parameter estimation by using the full Bayes’ method.
An important principle for model selection is called the principle of parsimony, which
states a preference for the simplest possible model that fits the data [48]. The marginal
likelihood value intrinsically obeys this principle, because it accounts for the model
complexity regarding the dimension of the parameter space by integrating the likelihood
function P (y|θ,M) over the parameter space. Intuitively, a more complex model with a
larger number of parameters can describe more varieties of data compared to a simpler
model. However, in situations where both models describe the data equally well, the
simpler model is preferable, because the combination of the parameters that gives the
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best fit for the simpler model is more likely to occur in a low-dimensional parameter
space than in a high-dimensional parameter space. For example, if a model with two
parameters can fit the data equally well compared with a model with four parameters, the
chance of the two-parameter model being true is larger than the four-parameter model.
Such a penalty for having a higher dimensional parameter space in a complex model
is reflected mathematically by the integration of the likelihood function over parameter
space. Therefore, using the marginal likelihood value as a model selection criterion does
not require a specific penalty term for model complexity.
However, for most models, it is analytically difficult to perform the integration to calcu-
late the marginal likelihood P (y|M). The dimension of the parameter space can be high
and the marginal likelihood can be difficult to express in a simple mathematical form.
Therefore, the choice of the mathematical form for the posterior distribution is often
limited or approximated to the normal distribution for computational convenience.
In recent years, iterative simulation methods have been developed to draw samples
of the parameter values from general distributions [45]. These sampling methods are
numerical techniques to obtain the posterior distribution of the parameters (p(θ|y,M)
in (2.6). When the posterior distribution is analytically difficult to calculate, the idea
of these iterative sampling methods is to draw a set of samples θ(i) (where i represent
ith sample of θ, i = 1, 2, . . . , N) independently from a sequence of distributions that
converge, as iterations continue, to the desired target posterior distribution of p(θ|y,M),
known as Monte Carlo integration. The reliability of the estimation from the Monte
Carlo methods increases with the increased number of samples. The problem is that
generating independent samples θ(i) can be difficult. When direct sampling is difficult,
a Markov chain sequence of random samples can be drawn instead, which is defined by
giving an initial distribution for θ(0), and the transition probability for θ(i) given the
value for θ(i−1) [58]:
θ(i+1) ∼ p(θ(i+1)|θ(i)), i = 1, 2, . . . (2.8)
The sample θ(i+1) only depends on the previous sample θ(i). Different Markov Chain
Monte Carlo (MCMC) algorithms [44, 45] have a different way of determining whether
a proposed new sample should be accepted. When a new sample θ(i+1) is accepted, the
next proposed sample will be based on this new sample; when a new sample is rejected,
the next proposed sample will be still based on the old sample. As i→∞, the Markov
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chain converges to its target distribution p(θ|y,M). Introduced by Metropolis (1953)
and widely popularised in the 1990s, MCMC remains one of the most important tools
for Bayesian inference due to its flexibility in sampling from general distributions, and
different MCMC algorithms have been developed to optimise the sampling procedures
for different problems [45]. However, being iterative sampling methods, MCMC methods
also have their shortcomings:
1) the samples from the exact solution are obtained at significant computational ex-
pense;
2) even though in theory the probability distribution will converge as i tends to infinity,
in practice, it is not easy to decide how many samples are enough to be sure that
the posterior distribution has converged;
3) standard MCMC algorithms such as the Metropolis-Hastings algorithm [44] and
Gibbs algorithm [45] avoid calculating the marginal likelihood by choosing an ac-
ceptance ratio that can cancel out this term, and obtain the posterior distribution
of the parameters without knowing the marginal likelihood. Since the model selec-
tion task requires comparison among the marginal likelihood values of competing
models, standard MCMC algorithms cannot perform this task.
Therefore, standard MCMC algorithms such as Metropolis-Hastings algorithm and Gibbs
algorithmare used for parameter estimation only. To obtain the marginal likelihood,
more advanced MCMC algorithms (such as Population MCMC and thermodynamic
integration [48, 59]) are required, which can be more computationally demanding.
Sequential Monte Carlo (SMC) methods [60] belong to another class of sampling meth-
ods that compute the posterior distribution of the parameters. Instead of constructing a
Markov chain of samples from the posterior distribution like MCMC, SMC methods con-
struct a sequence of distributions where the initial distribution is a simple distribution
from which it is easy to sample and the final distribution is the posterior distribution.
The intermediate distributions are required to be similar to each other, with the later
distribution usually sampled from the previous distribution by using Important Sam-
pling methods [61]. Importance sampling methods sample from a distribution that is
different from the target distribution and compensate by weighting the samples so that
the weighed samples would form a distribution that is closer to the target. Compared
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to MCMC, SMC is better at handling multimodal distributions; however, as a sampling
method, it has a similar problem to MCMC in terms of being computationally expen-
sive. This is mainly because many intermediate distributions are need to obtain the
final distribution [62].
As opposed to the sampling methods, approximate (deterministic) methods, such as
the expectation maximisation method [63] or expectation propagation method [64], do
not need samples from the posterior probability distribution of the parameters. One of
these methods is the variational Bayesian (VB) method, which has been proposed [65]
to approximate the marginal likelihood. In the VB method, the marginal likelihood is
often referred to as the model evidence. Being a deterministic method, the computa-
tional expense of the VB method is significantly less than the MCMC methods. MCMC
methods take samples from the true posterior distribution of the parameters, and there-
fore with infinite sample sizes, the true posterior distribution can be obtained. The
issue with MCMC methods is knowing a sufficient sample size in order that the sampled
distribution is close enough to the true distribution. The VB method, on the other
hand, approximates the true distribution using statistical distributions in the exponen-
tial family. Therefore, the issue with the VB approach is knowing the distance between
the approximated posterior distribution and the true distribution. In this thesis, our
main focus is to investigate applications of the VB method.
2.3 Variational Bayesian scheme
This section explains the key methodology involved in the VB algorithms, and modifica-
tions that were made to adapt the methodology to the applications of Chapters 3 and 4.
As the model evidence is the key quantity that is used to compare different models in the
task of model selection, this section emphasises how the VB method approximates the
model evidence P (y|M). Since approximated distributions are required in this method,
a measure of the distance between two distributions, known as the Kullback–Leibler di-
vergence (K-L divergence), is introduced first, and then to minimise this distance, the
concept of free energy is introduced in the following sections.
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2.3.1 Kullback–Leibler divergence and free energy
Biological systems adapt to the changing environment by constraining themselves via
feedback mechanisms to remain at certain states that require a minimal level of energy
[66]. To maintain a low energy consumption, a system should have a high probability of
staying in states requiring low energy, and a low probability of staying in states requiring
higher energy. In information theory, the amount of information each state contains is
measured by a quantity termed ‘self-information’ [67]. Self-information, denoted by S,
can be defined as the negative log-probability of an outcome state x:
S = − log p(x) (2.9)
If an outcome state rarely happens, e.g, a coin standing on its edge, the ‘self-information’
quantity will be large. A system’s average amount of information, defined as the Shannon
entropy (referred to as ‘entropy’ for short in this thesis) [68], H, can be defined as follows:
H = −〈log p(x)〉p = −
∫
p(x) log p(x)dx (2.10)
where 〈log p(x)〉p represents the expectation of log p(x) with respect to the probability
density function p(x). A low entropy means that the system is easy to predict on average.
To calculate the system’s entropy, a strict mathematical representation is required to
describe the probability density p(x) of the states x. p(x) is usually complex (intractable)
and cannot be captured by a closed-form statistical distribution. Therefore, a tractable
distribution q(x) is constructed to approximate p(x). The information loss introduced
by the approximation, denoted as KL[P‖Q], can be calculated as follows:
KL[P‖Q] =
∫
p(x) log
p(x)
q(x)
dx (2.11)
KL[P‖Q], known as the Kullback-Leibler divergence (K-L divergence), represents the
‘distance’ between the probability distributions from q(x) to p(x). It is a directed mea-
sure, which means that KL[P‖Q] is not equal to KL[Q‖P ]. According to the Gibbs’
inequality [69], the K-L divergence is always non-negative. A smaller value in KL[P‖Q]
indicates a better approximation of p(x). To achieve the closest approximation, the
K-L divergence needs to be minimised by determining the optimal configuration of the
parameters of q(x) using an inference method, and minimising KL[P‖Q] or KL[Q‖P ]
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can result in different optimised parameters. KL[P‖Q], where q(x) is the denominator
of the log within the integrand, allocates a higher weight to the region where q(x) is
near zero but p(x) is not. Thus minimising KL[P‖Q] leads to q(x) covering as much of
the region that p(x) covers as possible. On the contrary, minimising KL[Q‖P ] leads to
q(x) avoiding regions where p(x) is small [70]. Therefore, the parameter inference meth-
ods using KL[Q‖P ] (such as the VB method) tend to find a q(x) that approximates a
mode of p(x); whereas the parameter inference methods using KL[P‖Q] (such as the
expectation propagation method [64]) tend to find a q(x) that approximates the mean
of p(x). In the case of approximating the model evidence P (y|M), the distribution is
often multi-modal due to high dimensional parameter space, with most of the poste-
rior mass concentrated in several small regions of the parameter space, such as the two
peaks of P as shown in Fig. 2.1. When such multi-modal distributions are approximated
based on minimising KL[Q‖P ], one of these modes q1(x) will be found, depending on
the prior distribution; on the other hand, when KL[P‖Q] is minimised, the resulting
approximation q2(x) tends to average across all the modes, but at the mean value, the
probability density might be low. The mode of the parameter probability density is of
interest in this thesis; the ‘closeness’ between two probability distributions is therefore
defined as KL[Q‖P ]. To avoid the problem of using KL[Q‖P ] – only one mode of the
posterior distribution can be found even if the true posterior distribution is multi-modal
– different values of the priors are set up to explore the parameter space.
Figure 2.1: Approximation of the parameter distribution of P based on two K-L
divergence measures; q1(x) is based on KL[Q‖P ] and q2(x) is based on KL[P‖Q].
This method has been applied to approximate the probability distribution of system
states x in both applications considered in this thesis in the following manner. As-
sume x can be observed through a series of measurements y. Similar to (2.11), the
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KL[Q‖P ] divergence between the approximated distribution q(x) and the true distri-
bution p(x|y,M), given observations y and the model M , can be written as follows:
KL[Q‖P ] =
∫
q(x) log
q(x)
p(x|y,M)dx = −
∫
q(x) log
p(x|y,M)
q(x)
dx (2.12)
Then the conditional distribution p(x|y,M) is replaced with a joint distribution p(x,y|M)
and the model evidence p(y|M) [41]:
p(x|y,M) = p(x,y|M)
p(y|M) (2.13)
So the KL(Q||P ) can be separated into two parts:
KL[Q‖P ] = log p(y|M)−
∫
q(x) log
p(x,y|M)
q(x)
dx (2.14)
The first term of the right side of (2.14) is the self-information of y, which is also the
logarithm of the model evidence and therefore known as the log-evidence of the model,
representing the log-probability of obtaining the measurements given the model. When
there is no prior preference over different models, the model with the highest log-evidence
is the best model.
The second term of the right side of (2.14) is defined as the ‘variational free energy’ F
(free energy for short in this thesis):
F =
∫
q(x) log
p(x,y|M)
q(x)
dx (2.15)
Since the K-L divergence is non-negative [70], the value of the free energy is always
smaller than or equal to the log-evidence. As the log-evidence is not a function of q(x),
looking for a probability distribution q(x) that minimises KL[Q‖P ] is equivalent to
looking for q(x) that maximises the free energy. If the free energy is equal to the log-
evidence, the K-L divergence reaches zero, meaning that there is no discrepancy between
the true posterior distribution and the approximated distribution.
Note that the ‘free energy’ in the thesis is not the same concept as the free energy used
in thermodynamics. In this thesis, the free energy value can be negative as it is the lower
bound of the log-evidence. To reach as close as possible to the log-evidence, the value
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of the free energy is maximised using an iterative algorithm explained in Section 2.3.2,
and to understand the composition of the free energy better, an example is provided in
Section 2.3.4.
2.3.2 Parameter and state estimation
In Bayesian approaches, all unknown quantities are treated as random variables, and rep-
resented by probability distributions. Therefore the parameters are treated as variables
which do not change over time in the VB method. The maximisation of the free energy
F in (2.15) can be achieved by optimising the distributions of the parameters θ and
the system states x. Therefore, the optimisation procedure depends on the assumptions
regarding the parameters and the states, i.e. whether the parameters have a standard
form of distribution (such as a normal distribution), are independent of each other or
are interacting with each other, and whether the states are measurable. From (2.12),
the posterior distributions of the states are approximated by q(x). Assuming that θ is
the parameter vector for the system, the log-evidence in (2.14) can be approximated as
follows:
log p(y|M) ≥
∫
q(x,θ) log
p(x,θ,y|M)
q(x,θ)
dxdθ
= 〈log p(x,θ,y|M)〉q(x,θ) − 〈log q(x,θ)〉q(x,θ)
= E +H
= F(q(x,θ))
(2.16)
where 〈·〉q denotes expectation with respect to the probability distribution q. The free
energy F comprises an energy term E = 〈log p(x,θ,y|M)〉q(x,θ) and an entropy termH =
−〈log q(x,θ)〉q(x,θ) as shown in (2.16). q(x,θ) is an approximation of the distribution
p(x,θ|y,M). Driving q(x,θ) closer towards p(x,θ|y,M) by optimising the parameters
of the distribution q(x,θ) can push the value of F towards the log-evidence log p(y|M).
As introduced in Section 2.1.2, the precision of the system and measurement noise in
(2.2), αη and αε (inverses of the noise intensities), are the stochastic parameters of the
model. Instead of treating the precisions of both types of noise as fixed values, they
are modelled as Gamma-distributed variables with shape hyperparameters — aη and aε
and rate hyperparameters — bη and bε. When the parameters of the model (αη and
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αε) are further parameterised, aη, aε, bη and bε are referred to as hyperparameters, and
the model is referred to as a hierarchical model. Hierarchical models allow the prior
distributions of certain parameters to be expressed as a probability distribution instead
of a fixed value, and therefore one more hierarchy is added in the inference procedure of
the noise in (2.2) to avoid giving priors to the noise precision that are too assertive. The
prior values assigned to the hyperparameters are known as hyperpriors. Even though
the hyperpriors are still specified as fixed values, the estimation of the parameters is less
sensitive to a misspecification in a hyperprior than in a prior.
There are five components that need to be inferred from the data y, and they can be
denoted as a set of components (including the parameters and the states):
Θ = {αη, αε,θ,x0,x1:T } (2.17)
αη and αε are the stochastic parameters representing the precisions of system and mea-
surement noise respectively; θ is the deterministic parameter vector; x0 is the vector of
initial states; x1:T is the vector of the states: x1:T=(x1:T , x˙1:T , . . . , x
(n−1)
1:T )
ᵀ (the number
in the parenthesis represents the order of the derivative) where each element in the vec-
tor represents the whole of the state trajectory. The main idea of the VB algorithm is to
iteratively optimise the components of Θ: optimising one component while keeping the
other four components fixed. To proceed to perform the iteration, the components are
assumed to be conditionally independent for the given measurement data [41]. There-
fore, individual component distributions q(Θi) can be used to approximate the combined
distribution of all the components q(Θ), and this is known as the mean-field approxi-
mation. This treatment has been applied in the VB method to approximate the mixed
posterior distribution of q(Θ):
q(Θ) =
∏
i
q(Θi) = q(αη)q(αε)q(θ)q(x0)q(x1:T ) (2.18)
2.3.3 Iterative updating rule for hyperparameters, parameters and the
states
Using the mean-field approximation, all components can be iteratively updated as illus-
trated in Fig. 2.2. At each iteration step, the probability distribution of one component,
q(Θi) (qi for short), is optimised to maximise the free energy F , when the probability
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distribution of the other components q\i (the sign ‘\’ means ‘excluding’, i.e. all other
probability distributions of Θ, except the ith component, are considered) are fixed. The
cycle of the iterations continues until all the posterior distributions of the components
are optimised and the free energy is maximised. Local convergence of the procedure to
an optimal posterior distribution has been proved analytically [71].
Figure 2.2: One iteration cycle of the VB algorithm. In each step, the probability
distribution of the ith component qi (i = 1, 2, 3, 4, 5) is optimised to maximise the free
energy F while keeping the probability distributions of the other components fixed. The
lower bound of the log-evidence, i.e. the free energy, is guaranteed to increase (or stay
unchanged) during each step. The mark ∗ indicates that the probability distribution
has been updated.
Computationally, to update the probability distribution of each component, variational
calculus is applied. Variational calculus is a method to find a function (in this case
q(Θi) ={q(αη), q(αε), q(θ), q(x0), q(x1:T )}, where each component approximates the
probability densities of p(αη|y,M), p(αε|y,M), p(θ|y,M), p(x0|y,M), p(x1:T |y,M)
respectively), that maximises a functional (in this case F(q(αη, αε,θ,x0,x1:T )).
By equating the derivative of the free energy F with respect to the probability distri-
bution of one component q(Θi) to zero, q(Θi) can be obtained in the following form:
q(Θi) = arg max
q(Θi)
F ⇒ dF
dq(Θi)
= 0 (2.19)
where q(Θi), denoted as qi for short, is the probability density function of the ith
component of Θ, and q\i (without i) are the probability density functions of the other
four components.
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Then log(qi) can be obtained in the following form (its derivation can be found in [35]):
log(qi) =
1
Zi
∫
log p(αη, αε,θ,x0,x1:T ,y|M)q\i
∏
\i
dΘ\i
=
1
Zi
〈log p(αη, αε,θ,x0,x1:T ,y|M)〉q\i
(2.20)
where Zi is a normalisation constant ensuring that qi is a probability density function
which integrates to one over the entire space. The VB algorithm iteratively optimises
the components from i = 1 to 5 until F is maximised. In (2.20), the terms inside the
angle bracket represent the log-joint distribution of the measurements y and all the
components given in the model, log p(αη, αε,θ,x0,x1:T ,y|M). In practice, however, not
all the components are required to update qi. Thus, (2.20) can be further simplified
according to Fig. 2.3 in the following way. Take the update of q(αε) as an example.
The measurements y, defined as the ‘children’ of αε, are under direct influence. The
measurements y are also influenced by another ‘parent’ x1:T . The ‘child’ y, and its
‘parent’ x1:T are defined as the ‘Markov blanket’ of αε [72]. Therefore, the updating
rule for q(αε) can be simplified by only considering the components that are under the
Markov blanket of αε as follows:
log(q2) = log(q(αε)) =
1
Z2
〈log p(αε,x1:T ,y|M)〉q(x1:T ) (2.21)
The function 〈log p(αε,x1:T ,y|M)〉q(x1:T ) is defined as the ‘variational energy’ for αε,
and is denoted as Iq2 (the index ‘2’ refers to the second component of the vector Θ).
xtxt-1
yt
θ, η 

x0
ut
t=2, ..., T
Figure 2.3: Illustration of the model M . yt is the measurement point at time t, and
xt is the state vector of the system at time t. θ is the parameter vector of the system
equation (2.2). αη is the precision of the system noise and αε is the precision of the
measurement noise, ut is the input of the system at time t.
The VB iterative updating rule for the first two components (stochastic parameters αη
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and αε) is different from the other three components which are presented later in this
section. As explained in Section 2.3.2, αη and αε are further parameterised by the hy-
perparameters aη, bη, aε and bε. Therefore, αη and αε are updated through updating
the hyperparameters. Using the probability distribution of the parameters θ, the ini-
tial condition x0 and the states x1:T estimated from the previous iteration cycle, the
approximate posterior distribution probability of the noise precision can be obtained by
using (2.20) directly, e.g. without further approximation of (2.20). Take the updating
rule of q(αε) as an example. From (2.21), the joint probability function p(αε,x1:T ,y|M)
can be further factorised into p(αε|M), p(y|αε,x1:T ,M), and p(x1:T |M), out of which
the first two terms are kept to optimise the variational energy of q(αε). The first term
p(αε|M) is the prior of the measurement noise precision, which is modelled as a Gamma
distribution. The second term, p(y|αε,x1:T ,M), is the conditional likelihood function
(conditioned on the states x1:T ), which is modelled as a Gaussian distribution. Inte-
grating the conditional likelihood function p(y|αε,x1:T ,M) with respect to the normally
distributed q(x1:T ) gives the likelihood function for αε, p(y|αε,M), which is normally
distributed. The Gamma prior is conjugated to the Gaussian likelihood (‘conjugate’
indicates that the mathematical form of the posterior stays the same as the prior dis-
tribution after it has been updated by the likelihood function), resulting in a Gamma
distributed posterior distribution q(α).
For the other three components (the parameters θ, the initial state x0 and the states
x1:T ), the procedure is more complicated and requires further approximation of the
variational energy. The variational energy for the parameter θ, denoted as Iq3 , is shown
below:
log q(θ) =
1
Z3
Iq3 = 〈log p(αη,θ,x0,x1:T ,y|M)〉q(αη),q(x0),q(x1:T ) (2.22)
Factorising the joint probability term p(αη,θ,x0,x1:T ,y|M), three terms depend on θ
(p(θ|M), p(x1:T |αη,θ,x0,M), and p(y|αη,θ,x0,x1:T |M)) and therefore are kept to op-
timise q(θ). The first item p(θ|M) is modelled as a Gaussian distribution. Integrating
the multiplication of the other two terms p(x1:T |αη,θ,x0,M)p(y|αη,θ,x0,x1:T |M) with
respect to the probability distributions q(αη), q(x0), and q(x1:T ) gives a Gamma dis-
tributed likelihood for θ. A Gaussian prior does not conjugate with a Gamma likelihood
function, and therefore an approximation of the likelihood function p(y|θ,M) is needed
to update q(θ). The updating rule for each of these three components (the parameters
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θ, the initial state x0 and the states x1:T ) needs such an approximation, known as the
‘VB-Laplace’ approximation.
A VB-Laplace approximation is the Laplace approximation in the VB context. The
original Laplace approximation of the probability distribution q(Θ) is to match its first
two moments (mean and variance) with a Gaussian distribution. The first two moments
of Θ is a vector of means for each component of Θ and the covariance matrix. Assume
the mode of the probability distribution of q(Θ) is at Θ∗. The Taylor-expansion of the
logarithm of q(Θ) around the mode Θ∗ gives the following:
log q(Θ) = log q(Θ∗)− 1
2
(Θ−Θ∗)ᵀH (Θ−Θ∗) + . . . (2.23)
where H is called the ‘Hessian matrix’ of q(Θ), and it is defined as the matrix of the
second-order partial derivatives of q(Θ):
H =
∂2 log q(Θ)
∂Θ2
(2.24)
The Laplace approximation works well when the actual distribution of q(Θ) is close to a
normal distribution. However, when the mode is not near the majority of the probability
mass, the Gaussian approximation around its mode is far from representative of the
posterior distribution.
In the VB context, such problems can be avoided by iteratively tuning the mode and
the covariance matrix of an individual component of Θ until an optimal distribution qi
is achieved. This iterative optimisation of each component is allowed due to the mean-
field approximation. With the VB-Laplace approximation for each component (the
parameters θ, the initial state x0 and the states x1:T , a numerical method, the Gauss-
Newton method, can be applied to iteratively approach the optimised vector of means
and the covariance matrix of q∗i (i = 3, 4, 5) that maximise the respective variational
energy (Iq3 , Iq4 and Iq5). A sequence of the vector of the mean values and the covariance
matrix of qi (i = 3, 4, 5) is obtained starting from the values from the last iteration cycle,
and converging towards the optimised values q∗i . Unlike Newton’s method, the Gauss-
Newton method does not require the second derivative of the variational energy, i.e. the
Hessian matrix of the variational energy is approximated. Therefore, it simplifies the
computation compared with Newton’s method, but only works with mild nonlinearity in
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the variational energy due to the approximation of the Hessian matrix. The maximised
variational energies of the third component θ and the fourth component x0 can therefore
be obtained to update the approximated posterior distribution functions of these two
components. [72].
The VB-Laplace updating rule for the final component (the states x1:T ) is the most
complicated procedure among all the components. It is intuitive to calculate the ap-
proximate posterior probability of the states x1:T simultaneously; however, the optimi-
sation calculation involved exponentially increases with the number of states, which is
undesirable when T is large. Therefore, instead of approximating the distribution of all
the states simultaneously, a sequential propagation is used to evaluate q(xt) point by
point from t = 1 to t = T using the extended Kalman-Rauch smoother algorithm [73].
This algorithm contains two passes that propagate the first and second order moments
of the approximate posterior density of q(xt). The first pass – the forward pass – is to
compute the current state q(xτ ) given the previous and the current observations y1:τ .
The second pass – the backward pass – is to incorporate the future observations into up-
dating the posterior distribution on the current time step obtained by the forward pass.
The details involved in these two steps are shown in [72] and in Chapter 5 of [41]. The
VB-Laplace Kalman-Rauch algorithm applied to obtain the updating rule for the states
is different from the traditional extended Kalman filter because it accounts for the un-
certainties in the parameters Θ, which improves the performance when the VB-Laplace
Kalman-Rauch algorithm deals with nonlinear systems with unknown parameters [72].
2.3.4 Free energy decomposition
As shown in Fig. 2.2, the iterative optimisation for the probability distributions of each
component qi ensures that the value of F is monotonically increasing towards the model
log-evidence until it converges, i.e. the difference between the free energy and the log-
evidence – the K-L divergence – is minimised. The maximised free energy value F can
then be compared between different models to select the best model. The approximations
of the posterior distributions of the hyperparameters, the parameters, the initial states
and the states influence the value of the free energy F , and therefore a closer look at
the calculation of the free energy can provide more insights into how the estimation of
each component influences the free energy value.
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A simple example model is considered in this section to help understand the calculation
of the free energy. Two unknown components, the parameter θ and the measurement
noise precision α, are considered in this example:
z = θt+ ε (2.25)
where z = (z1, z2, . . . , zN )
ᵀ, t = (t1, t2, . . . , tN )ᵀ, and ε corresponds to the measurement
noise, which is modelled as a Gaussian distribution: ε ∼ N (0, α−1). The prior of the
parameter θ is modelled as a Gaussian distribution: θ ∼ N (µ0, σ20), and the prior of the
noise precision α is modelled as a Gamma distribution α ∼ Ga(a0, b0), where a0 and
b0 are the prior shape and rate hyperparameters for the noise precision. The posterior
distribution of the parameter θ and the hyperparameters a and b are estimated through
the iteration steps described in Section 2.3.3. At the nth iteration, the parameter θ and
the hyperparameters (a and b) are denoted with the index n. According to (2.16), the
free energy F(q(α, θ), z) can be decomposed as the energy term E and the entropy term
H as follows:
F(q(α, θ),y) = E +H
=〈log p(z, θ, α|M)〉q(θ,α) − 〈log q(θ, α)〉q(θ,α)
=〈log p(α|M)〉q(α) + 〈log p(θ|M)〉q(θ) + 〈log p(z|θ, α,M)〉q(θ,α)
− 〈log q(α)〉q(α) − 〈log q(θ)〉q(θ)
= 〈log Ga(α|a0, b0)〉q(α)︸ ︷︷ ︸
(a)
+ 〈logN (θ|µ0, σ20)〉q(θ)︸ ︷︷ ︸
(b)
+ 〈logN (z|θt, α−1)〉q(θ,α)︸ ︷︷ ︸
(c)
−〈log Ga(α|an, bn)〉q(α)︸ ︷︷ ︸
(d)
−〈logN (θ|µn, σ2n)〉q(θ)︸ ︷︷ ︸
(e)
(2.26)
The mean field approximation has been applied in (2.26) to factorise the energy term
and the entropy term into three and two components respectively: (a), (b), and (c)
comprise the energy term, and (d) and (e) constitute the entropy term. (2.26) can be
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further expanded as follows:
(a) : a0 log b0 − log Γ(a0) + (a0 − 1)(ψ(an)− log bn)− b0an
bn
(b) : − 1
2
log 2pi − log σ0 − 1
2σ20
(µn − µ0)2
(c) : − N
2
log 2pi +
N
2
(ψ(an)− log bn)− an
2bn
zTz +
an
bn
µnt
Tz − an
2bn
(µ2n + σ
2
n)t
T t
(d) : −
(
log bn − log Γ(an) + (an − 1)ψ(an)− an
)
(e) : −
(
1
2
log 2pi − log σn − 1
2
)
(2.27)
where Γ(·) is the gamma function, and ψ(·) is the digamma function, which is defined
as ψ(·) = Γ′(·)/Γ(·). The detailed derivation is as follows:
(a): The noise precision α follows a Gamma distribution with hyperparameters a0 and b0:
α ∼ Ga(a0, b0). The Gamma distribution can be expanded as α = b
a0
0
Γ(a0)
αa0−1e−b0α. As
the posterior mean of the noise precision αpost = an/bn, so 〈α〉q(α) = an/bn. Therefore,
the log-probability of α with respect of q(α, θ) can be obtained as:
〈log Ga(α|a0, b0)〉q(θ,α) = a0 log b0 − log Γ(a0) + (a0 − 1)〈logα〉q(α) − b0〈α〉q(α)
= a0 log b0 − log Γ(a0) + (a0 − 1)(ψ(an)− log bn)− b0an
bn
(2.28)
(b): The parameter θ follows a normal distribution with mean µ0 and standard deviation
σ0, and the updated mean of the parameter is µn, and therefore, the log-probability of
θ with respect of q(α, θ) can be obtained as:
〈logN (θ|µ0, σ20)〉q(θ,α) = −
1
2
log 2pi − log σ0 − 1
2σ20
(〈θ〉q(θ) − µ0)2
= −1
2
log 2pi − log σ0 − 1
2σ20
(µn − µ0)2
(2.29)
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(c): The log-probability log p(y|θ, α,M) with respect of q(α, θ) can be obtained as:
〈logN (z|θt, α−1)〉q(θ,α)
= − N
2
log 2pi +
N
2
〈logα〉q(α) −
an
2bn
(zTz − 2〈θ〉q(θ)tTz + 〈θ2〉q(θ)tT t)
= − N
2
log 2pi +
N
2
(ψ(an)− log bn)− an
2bn
zTz +
an
bn
µnt
Tz − an
2bn
(µ2n + σ
2
n)t
T t
(2.30)
(d): The Shannon entropy of α is obtained as follows:
− 〈log q(α)〉q(α) = − log bn + log Γ(an) + (1− an)ψ(an) + an (2.31)
(e): The Shannon entropy of θ is obtained as follows:
− 〈log q(θ)〉q(θ) =
1
2
log 2pi + log σn +
1
2
(2.32)
The free energy criterion seeks a balance between the accuracy and the complexity of
the model [74], and can be expressed as:
F(M) = Accuracy(M)− Complexity(M) (2.33)
In this example, term (c) in (2.27) accounts for the accuracy of the model and the sum
−∑ ((a) + (b) + (d) + (e)) is the term penalising the model complexity. The analysis
of the accuracy and complexity terms of the free energy is not straightforward because
a change in one estimated parameter can have an impact on several terms.
For the accuracy term (c) in (2.27), the mean and the variance of the parameter prior
distribution, µ and σ0, and the hyperpriors a0 and b0 of the noise precision do not
influence the accuracy term. The accuracy term is only determined by the posterior
distributions of the parameters and the posterior values of the hyperparameters. The
accuracy term (c) equals
N
2
log
αn
2pi
− αn
2
(z − θt)ᵀ(z − θt) (2.34)
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A higher residue (z− θt)ᵀ(z− θt) from the model corresponds to a smaller value of the
accuracy term (2.34). When the posterior noise precision αn = an/bn is less than 2pi,
the accuracy term is less than zero, which may lead to a negative free energy value.
The complexity term is more difficult to analyse. Here we focus on the influence of
increasing the dimension of the parameter space on the complexity term, assuming that
the hyperparameters are fixed. The complexity term can therefore be written as follows:
Complexity(M) =
1
2
σ−20 (µn − µ0)2 + log
σ0
σn
+ C (2.35)
where C includes all the terms that do not contain information about the parameters θ.
With the increased number of parameters, the variances in (2.35) become vectors:
Complexity(M) =
1
2
(µn − µ0)ᵀΣ−10 (µn − µ0) +
1
2
log
|Σ0|
|Σn| + C (2.36)
where Σ0 is the prior of the covariance matrix of the parameter vector θ. The subindices
‘0’ and ‘n’ indicate the prior and the posterior of the covariance matrix respectively. The
symbol | · | represents the determinant of the matrix. The increased complexity due to a
higher dimension of the parameter space manifests mainly in the following three ways:
1) Assuming the prior variances for each parameter are the same, a higher dimension
of the parameter space leads to more terms in the expression 12(µn−µ0)ᵀΣ−1(µn−
µ0), and, therefore, to a higher value of this expression.
2) The ratio of the determinants of the prior to posterior covariance matrices, |Σ0||Σn| ,
also known as the Occam factor [48], increases. The determinants of the covari-
ance matrices correspond to the volume spanned by their eigenvectors in parameter
space [75]. An increased number of parameters would enable the model to fit more
diverse patterns of data, resulting in a more ‘flexible’ model [76]. On the other
hand, to represent certain data, the parameters need to be specified in a narrower
region for a model with more parameters. When the number of parameters in-
creases, the relative posterior volume |Σn| with respect to the prior volume |Σ0|
in parameter space decreases. A narrower region in the posterior distribution of
the parameters indicates a more brittle model, and this is the penalty for a more
accurate fitting.
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3) A higher correlation between the posterior distributions of the parameters (covari-
ance matrix) increases complexity. Considering a model with two parameters, the
determinant of the posterior covariance matrix for the parameters θ1 and θ2 is
given as follows [75]:
|Σn| = (1− r2)σ2θ1σ2θ2 (2.37)
where r is the posterior correlation between the parameters θ1 and θ2; σθ1 and σθ2
are the posterior standard deviations of the two parameters. A higher correlation
between the two parameters indicates a smaller value of |Σn|, implying a larger
complexity penalty term. When the correlation between the parameters is high, the
parameters cannot be estimated accurately, causing higher posterior variances of
both parameters (σθ1 and σθ2), which offsets the higher complexity penalty caused
by the higher correlation. In that situation, the additional parameter might not
cause a decrease in the free energy value, and an over complicated model may be
falsely selected [75]. Therefore, when the posterior variances of the parameters
are high, the free energy criterion tends to choose an over complicated model; and
when the posterior correlations between the parameters are high, the free energy
criterion biases towards a simpler model.
In this simple example, the calculation of the free energy involves five interactive terms,
each of which is influenced by the priors and posteriors of the parameter and/or the
noise precision. In the applications shown in Chapters 3 and 4, the calculation of the
free energy involves more terms and is more complicated. In this thesis, all of the
calculation is dealt with by the variational Bayesian toolbox [77], the use of which is
illustrated in Section 2.8.
Before the parameters are estimated, identifiability analysis (introduced in Section 2.6)
is required to check if individual parameters can be uniquely determined given the model
and model observation. After obtaining the estimated parameter distributions, param-
eter sensitivity analysis (introduced in Section 2.7) needs to be applied, especially when
the posterior variances for the parameters are high, to check how sensitively the system
would respond to a small change in the parameters. Also, because of the highly inter-
active nature among different terms of the free energy, effects caused by unsatisfactory
estimation may not be reflected in the final value of the free energy when different terms
offset each other. Therefore, other model selection criteria are also considered, together
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with the free energy criterion, to choose the most appropriate model for the biomedical
applications in later chapters.
2.4 The criteria for model selection
As introduced in Section 2.2, a good model selection criterion selects a model that
describes the data adequately without overfitting it. The VB method uses the lower
bound of the model evidence as in Fig. 2.2, i.e. the maximised value of the free energy,
to select the best model candidates. Compared with other model selection criteria in the
literature such as the Akaike Information Criterion (AIC) and the Bayesian Information
Criterion (BIC) [47, 78], the free energy criterion assigns a heavy penalisation term due
to the integration over the whole parameter space, which gives a bias towards over-
simplified models. As shown in the previous section, the calculation of the free energy is
complicated and influenced by all of the priors and the posteriors of the parameters and
the states. In cases where the free energy is sensitive to the change in priors, trusting the
free energy value blindly can be problematic. Therefore, in practice, instead of treating
the free energy criterion as a definite rule, other criteria, alongside the free energy, should
be considered to gain quantitative information about how well the models fit the data,
especially when the ‘goodness-of-fit’ for the measurements between the models is close
[76]. When conflicts between the criteria occur, which is not unusual, it depends on the
modeller to decide which criteria to use and which results to trust.
The Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC)
are two commonly used model selection criteria, and both are simplified versions of
the free energy criteria (or K-L divergence). Akaike introduced the K-L divergence (see
Section 2.3.1) as a fundamental basis for model selection, and started advocating the AIC
in the mid-70s. The AIC is based on the idea of minimising the K-L divergence between
the true probability distribution p(y) and the approximated probability distribution
q(y|M) of the measurements y as follows (refer to (2.11)):
KL[P‖Q] = 〈log p(y)〉p(y) − 〈log q(y|M)〉p(y) (2.38)
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The model-dependent part of the K-L divergence KL[P‖Q] is the second term:
KLr = 〈log q(y|M)〉p(y) (2.39)
which is known as the relative K-L divergence. Assuming the distribution q(y|M) is
parameterised by θ, the relative K-L divergence can be written as follows:
KLr = 〈log q(y|θ,M)〉p(y) (2.40)
Unlike the free energy criterion, the AIC only considers the most probable value of the
parameters θ. The problem is that the parameters are unknown and the expectation
with respect to p(y) in (2.40) cannot be evaluated since p(y) is unknown. Using the
same measurement data y to estimate the parameters and then integrating log q(y|θ,M)
with respect to the probability distribution of y would have the bias of using the same
data y twice. To avoid this problem, it is assumed that the most probable parameter θˆ
can be obtained by applying the ML estimation from a fictitious data vector x with the
same length and the same probability distribution as y but independent from y. Then
the following equation can be considered as the approximation for log q(y|M):
log q(y|M) = 〈log q(y|θˆx,M)〉p(x) (2.41)
The fictitious data x are created to estimate the parameters, and the dependence of the
fictitious data x can be eliminated via the expectation operation 〈·〉p(x) in (2.41). A
second-order Taylor expansion of log p(y|θˆx) around θˆy, log p(y|θˆx) can be obtained as
follows:
log q(y|θˆx,M) = log p(y|θˆy,M) + 1
2
(θˆx − θˆy)H (θˆy)(θˆx − θˆy) (2.42)
where H (θˆy) is the Hessian matrix evaluated at θˆy. θˆx and θˆy are the ML estimates
of the parameters for the data x and y respectively. Using the fact that x and y have
the same distribution and have the same length, KLr – which defines the AIC – can be
obtained by inserting (2.42) into (2.39) as follows (a formal derivation can be found in
[79]):
AIC = KLr =
〈
〈log q(y|θˆx,M)〉p(x)
〉
p(y)
= log(p(y|θˆy,M))− k
(2.43)
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where k is the number of the parameters in the model.
A simple example will be presented to demonstrate how the AIC can be calculated. In
this example, assuming the measurements yt are conditionally independent of each other
given the model and the parameter vector θ, the marginal likelihood P (y|θ,M) can be
factorised into T separate terms:
P (y|M,θ) =
T∏
t=1
P (yt|M,θ) (2.44)
Assuming that the measurement noise is Gaussian distributed with zero mean and vari-
ance σ2ε , (2.44) can be further decomposed as follows:
P (y|M,θ) =
T∏
t=1
1√
2piσ2ε
exp(− 1
2σ2ε
(yt − yˆt)2)) (2.45)
where yˆt is the estimation of the value of yt based on the estimated parameters θˆ. Taking
the natural logarithm of both sides of (2.45) yields:
logP (y|M,θ) = −T
2
log(2piσ2ε)−
1
2
T∑
t=1
(
yt − yˆt
σε
)2
(2.46)
The logarithm of the marginal likelihood, logP (y|M,θ), often called the log-likelihood,
is used instead of the likelihood itself to simplify the calculation (using summation
instead of multiplication). The maximum value of P (y|M,θ) can be achieved when the
parameter mean and variance satisfy the following conditions (the ML estimation):
∂ logP (y|M,θ)
∂θ
= 0 (2.47)
and
∂ logP (y|M,θ)
∂σε
= 0⇒ σ2ε =
1
T
T∑
t=1
(yt − yˆt)2 (2.48)
Substituting the estimated variance in (2.46), the log-likelihood function can be calcu-
lated as follows:
logP (y|M,θ) = −T
2
log
(
yt − yˆt
σε
)2
+ C (2.49)
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where C is a constant independent of the model. Substituting the log-likelihood function
in (2.43) by (2.49), the AIC can be calculated as follows:
AIC = −T
2
log
(
yt − yˆt
σε
)2
− k + C (2.50)
where
(
yt−yˆt
σε
)2
is defined as the residual sum of squares (RSS).
The AIC has been reported to perform poorly for small numbers of data points, which
motivated the inclusion of a correction term as follows [79]:
AICc = AIC− k(k + 1)
N − k − 1 (2.51)
where N is the number of data points and k is the dimension of the parameter space.
The AICc, known as the ‘corrected AIC’, penalises parameters more than AIC does and
the two criteria become approximately equal for N > k2. Both the AIC and AICc have
a tendency to select an overfitted model from the competing model candidates, which
originates from overfitting the fictitious sample x to estimate the parameter vector θˆx.
However, the data generating mechanisms in practice are often more complicated than
any proposed model candidates, especially when the data are sparse. In these cases, the
AIC or the AICc may perform better compared with the free energy criterion due to
the tendency of the AIC or the AICc to select an overfitted model. Both the AIC and
AICc have been found useful in many applications reported in the literature [47].
The Bayesian Information Criterion (BIC) is an extension of the AIC. The expectation
with respect to the probability distribution of θˆx, 〈log q(y|θˆx,M)〉p(θˆx), rather than the
probability distribution of x, 〈log q(y|θˆx,M)〉p(x), is used to estimate the log-evidence
log q(y|M). Viewing the estimated parameter vector p(θˆx) as the prior for the parame-
ter, model evidence q(y|M) can be obtained as follows:
q(y|M) =
∫
q(y|θˆx,M)q(θˆx|M)dθˆx (2.52)
An approximation of the integral can be obtained under two assumptions: 1) the prob-
ability distribution of the parameter is flat around the estimated value θˆx; 2) the prob-
ability of the parameter is independent of the length of the data. Expanding q(y|θˆx)
around θˆy using a second-order Taylor series, KLr can be estimated as follows (the
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formal derivation can be found in [79]):
KLr ≈ log q(y|θˆy,M) + log q(θˆy) + k
2
log 2pi︸ ︷︷ ︸
does not scale with N
−k
2
logN (2.53)
As the sample size N tends to infinity, the terms that do not scale with the number of
data points N can be neglected, yielding the BIC:
BIC = log q(y|θˆ,M)− k
2
logN (2.54)
The BIC does not need the prior to quantify the model evidence q(y|M) because the
prior term does not scale with the number of data points as stated by assumption 2)
in the last paragraph. When the number of data points N is greater than 15, the
complexity term of the BIC, k2 logN , is larger than the complexity term of the AIC, k,
and as a result the BIC has less probability of overfitting the data. Since it neglects
the terms that do not scale with the number of data points, the complexity term is
smaller than the complexity term in the free energy criterion. Therefore, the BIC is less
strict towards model complexity compared with the free energy criterion, but stricter
compared with the AIC.
Depending on the chosen criterion (AIC or BIC), a higher value of the AIC or the
BIC indicates a better model. The difference in either the AIC or the BIC between
two models is assessed using the Bayes factor [80]. Advocated by Jeffreys in 1961, the
Bayes factor aims at providing a Bayesian equivalent to hypothesis testing in classical
statistics. When two models are compared, the probability of one model M1 being true
over the probability of another model M2 being true can be obtained as follows:
p(M1|y)
p(M2|y) =
p(M1)
p(M2)
p(y|M1)
p(y|M2) (2.55)
The prior probabilities of the two models are considered equal, i.e. p(M1) = p(M2), and
therefore the Bayes factor in favour of M1 over M2 is defined as follows:
B1,2 =
p(y|M1)
p(y|M2) (2.56)
Kass and Raftery [80] suggested interpreting the Bayes factor in the natural logarithm
scale as in Table 2.1:
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Table 2.1: Bayes factor compared between models M1 and M2
log(B1,2) B1,2 Evidence against M2
0 ∼ 2 1 ∼ 3 Not significant
2 ∼ 6 3 ∼ 20 Positive
6 ∼ 10 20 ∼ 150 Strong
> 10 > 150 Very strong
Bayes’ rule works for the AIC, BIC, and the free energy criterion: the differences in the
AIC values, the BIC values and the free energy values are equivalent to a log-Bayes factor
log(B1,2) in Table 2.1. If the AIC is chosen to be the model selection criterion, then
AIC(M1) − AIC(M2) > 3 (3 is a conventional choice based on [81] and [80]) indicates
that M1 outperforms M2. If the BIC is chosen to be the model selection criterion, then
BIC(M1)−BIC(M2) > 3 indicates that M1 outperforms M2. If the free energy criterion
is chosen, then F(M1)−F(M2) > 3 indicates that M1 outperforms M2.
Compared with the free energy criterion, both the AIC and BIC are more widely used
due to their simplicity. They do not take the uncertainty about parameters into consid-
eration, i.e. the value of the AIC or the BIC is only based on the estimated parameter
values from the ML method. The uncertainty of the parameters is underestimated in
both methods, and therefore overfitted models are more likely to be chosen using ei-
ther of these two criteria [80], which has been shown by [82] and [83]. The free energy
criterion, on the other hand, provides a model comparison taking the uncertainty of
the parameters into account. It is worth noting that a higher free energy value does
not guarantee higher model evidence because the gap between the free energy and the
model evidence can be different for each model candidate. As shown in Chapter 4 in
[41], the gap – the K-L divergence – is found to be positively correlated with the number
of parameters, which means that the estimation of the model evidence becomes more
pessimistic as the model complexity increases, rendering the VB methods to suffer from
a tendency to select a model that underfits the data. Therefore, in later applications
in Chapter 3 and Chapter 4, several criteria are considered together to select the best
model, with the purpose of minimising the limitations of each criterion.
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2.5 Priors and hyperpriors
As stated in Section 2.3.2, the VB method treats all unknown quantities as random
variables, and if certain prior knowledge or information about these random variables
(including hyperparameters, the parameters, the initial state or the states of the sys-
tem) is known before accounting for the data, it should be taken into consideration.
Mathematically, this information is encapsulated as the prior, p(θ|M), that is one factor
of the numerator in (2.3) shown in Section 2.2.1. The essence of Bayesian inference is
to incorporate the prior information into the information extracted from the data [84],
and obtain the posterior combining both. The prior provides the opportunity for the
modeller to express belief regarding the variable of interest, and should be treated with
caution.
There are two categories of priors: informative priors and uninformative priors. In-
formative priors are usually chosen based on known information about the variable of
interest. An inference without priors could lead to unreliable results, especially when
the available data set is small. For example, if a coin was tossed three times and each
time landed heads, the data by themselves would suggest a zero probability of obtaining
tails, which contradicts common sense. Including an informative prior in the form of a
normal distribution with a mean value of 0.5 would provide a more realistic predictive
outcome of the experiment. Another type of informative prior can be originated from
previously available data. If a model is updated when more data become available, then
the posterior distribution of the parameters inferred from the previous data may be used
as the prior distribution of the parameters for the data obtained later.
The second category is uninformative or weakly informative priors. Common weak pri-
ors include flat priors, priors with large variances, Jeffreys priors, etc [85]. A flat prior,
i.e. the unknown parameter is uniformly-distributed from negative infinity to positive
infinity, is often chosen to be the first attempt at an uninformative prior. However, such
a prior is improper (does not integrate to one), and might lead to an improper poste-
rior which invalidates the model [86]. An improper prior would also be problematic for
calculating the model evidence since the model evidence is the conditional likelihood,
P (y|θ,M), integrated over the prior distribution p(θ|M) as shown in (2.7). Therefore,
weakly informative priors, or ‘vague’ priors, rather than uninformative priors, are pre-
ferred in practice, and in this thesis, weakly informative pirors, such as priors with large
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variances as well as Jefferys priors, are chosen for all of the variables of interest Θ as in
(2.17).
One choice of a weak prior is to assign a normal distribution with a large variance, such
as θ ∼ N (0, 104) [84]. In both clinical applications in Chapter 3 and Chapter 4, the
priors for the parameter vectors θ, the states x1:T and the initial states x0 are set to be
normally distributed with zero means and large variances of order 104 (larger variances
in the priors have been tried to see if it makes a difference in the posterior distributions,
and 104 is regarded as large for the two applications mentioned).
Another choice of a weak prior is a Jeffreys prior. The idea of a Jeffreys prior originated
from the attempt to solve one of the problems of the uniform prior — a uniform dis-
tribution for a random variable does not imply a uniform distribution for a function of
the random variable, i.e. an uninformative prior for the random variable becomes infor-
mative after re-parameterisation. For example, assume a uniform prior distribution for
the parameter ρ which describes the probability of raining tomorrow. The probability of
raining tomorrow and the day after tomorrow is ϑ = ρ2, and therefore ϑ ∼ 1
2
√
ϑ
, which
is not uniformly distributed any more. A Jeffreys prior was proposed so that the prior
distribution can be invariant to such re-parameterisation [87]. It is based on the princi-
ple of maximising the K-L divergence between the prior and the posterior distribution
[88]. A Jeffreys prior of parameter ρ is defined as follows:
p(ρ) ∼ FI(ρ)1/2 (2.57)
where FI is the ‘Fisher information matrix’ [89], defined as the expectation of the second
derivative of the log-likelihood function with respect to the probability distribution of
ρ, or the second moment of the log-likelihood function:
FI(ρ) = −〈d
2 log p(y|ρ,M)
dρ2
〉p(ρ) (2.58)
The Fisher information matrix measures the curvature of the log-likelihood function.
Since high curvature represents large changes in the likelihood when the value of the
parameter changes, a Jeffreys prior gives more weight to those parameter values ensuring
that maximised information can be obtained from the influence of the data [84, 90].
Applying (2.58) to obtain a Jeffreys prior for the precision parameter α in the example
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shown in (2.26):
p(α) ∼ α−1 (2.59)
Given (2.59), it can be easily proved that the natural logarithm of α is uniformly dis-
tributed. Applying a change of variable β logα yields:
∫
p(β)dβ =
∫
p(α)
dα
dβ
dβ =
∫
1
C
e−βeβdβ = 1 (2.60)
where C is the normalisation constant. As β follows a uniform distribution implying the
prior does not favour any one scale over another, after Jeffreys prior for α is therefore
weakly informative.
In this thesis, the priors for the noise precision parameters, αη and αε shown in Section
2.1.2, have been set to approximate Jeffreys priors by choosing the hyperparameters that
define the Gamma distributed noise precisions. Using the hyperparameters to specify the
noise provides a more objective prior by estimating the noise precision as a probability
distribution instead of a number. Even though the hyperpriors of the hyperparameters,
a0 and b0, are required to describe the distribution of the noise precision, it is less
arbitrary than specifying a number as the prior of the noise precision using subjective
information [85]. Consider measurement noise as an example. The measurement noise
is a vector ε = (ε1, ε2, . . . , εN )
ᵀ, t = 1, 2, . . . , N , and εt at time t is the difference
between the measured values yt and the estimated values yˆt: εt = yt − yˆt. The value
of the noise precision α is drawn from the Gamma distribution Ga(a, b) and then the
measurement noise εt is drawn from the Gaussian distribution N (0, α−1). The joint
probability p(ε, α|M) can be decomposed as p(ε, α|M) ∝ p(ε|α,M)p(α|M), and further
expanded as the multiplication of Gaussian distributions and a Gamma distribution:
p(ε, α|M) =
N∏
t=1
√
α√
2pi
exp
(
−ε
2
tα
2
)
ba00
Γ(a0)
exp (−b0α)α(a0−1) (2.61)
Grouping similar terms together, (2.61) can be written as:
p(ε, α|M) ∝ αa0+N2 −1 exp
(
−α
(
b0 +
1
2
N∑
i=1
ε2t
))
. (2.62)
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which is in the form of a Gamma distribution, so p(ε|M) can be obtained by integrating
α out in (2.62) as follows:
p(ε|M) ∝
(
b0 +
1
2
N∑
i=1
ε2t
)−(a0+N2 )
. (2.63)
Dividing the joint distribution p(ε, α|M) of (2.62) by the distribution for the measure-
ment noise p(ε), the posterior conditional distribution of p(α|ε,M) can be obtained as
follows:
p(α|ε,M) ∝ αa0+N2 −1
(
b0 +
1
2
N∑
i=1
ε2t
)a0+N2
exp
(
−α
(
b0 +
1
2
N∑
i=1
ε2t
))
. (2.64)
As seen from (2.64), the posterior conditional distribution p(α|ε,M) is in the form of a
Gamma distribution with its shape and rate parameters (a0 +
N
2 , b0 +
1
2
∑N
t=1 ε
2
t ). This
means that the posterior conditional distribution depends on the hyperpriors a0 and
b0, the sample size N and the squared sum of the differences between the observations
and the estimations. The prior mean of α is a0/b0 and the prior variance is a0/b
2
0.
Therefore, if the values of a0 and b0 are small compared with the sample size N , the prior
carries little information about α, and the posterior hyperparameters are approximately
(N2 ,
1
2
∑N
t=1 ε
2
t ). The posterior mean of the noise precision is proportional to the inverse
of α, i.e. N2 /
1
2
∑N
i=1 ε
2
t = α
−1, which coincides with the Jeffreys prior as shown in (2.59).
To conclude, when the hyperpriors (a0 and b0) of the Gamma distribution are negligible
compared to the number of the data points N , the Gamma distribution for the noise
precision is approximately a Jeffreys prior as in (2.59). Therefore, Ga(0.001, 0.001) or
Ga(0.01, 0.01) or Ga(1, 1) are the common choices for the prior distribution of the noise
precision [85]. However, when a0 or b0 are set too close to zero, it can lead to an improper
posterior density: as Ga(0, 0) is an improper prior and leads to an improper posterior,
an approximation to the improper prior would also approximate its improper posterior,
leading to an unstable inference [91]. As illustrated by [85], when the inferred variance
α−1 is close to zero, the inference result becomes sensitive to a0 and b0 in (2.64). For the
applications in Chapter 3 and Chapter 4, different hyperpriors, such as Ga(0.001, 0.001),
Ga(0.01, 0.01), and Ga(1, 1), have been used and compared.
There are different techniques to implement the hyperparameters’ inference. In many
empirical Bayesian methods, the hyperparameters are optimised before a regular Bayesian
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inference is conducted with the estimated hyperparameters to infer the states and the
parameters of the model. The drawback of these methods is that the same data are
used twice, leading to data overfitting. The VB method includes the optimisation of the
hyperparameters in the iterative algorithms and therefore successfully avoids this major
drawback of empirical Bayesian methods.
Regarding the functional form of the priors, the VB method works better when the
priors and the posteriors belong to the same probability family. If the posterior distri-
bution is in the same family as the prior distribution, the prior is called a conjugate prior
for the likelihood function. Because the posterior distribution is a standard statistical
distribution, a conjugate pair of the prior and the likelihood distribution enables us to
compute the posterior density analytically without the trouble of the integration oper-
ation to calculate the normalisation constant in the denominator (as shown in (2.6)).
In this thesis, two conjugate pairs have been used: a Gaussian distributed prior and
a Gaussian-distributed likelihood function are a conjugate pair; a Gamma-distributed
prior and a Gaussian-distributed likelihood function are also a conjugate pair. Using
conjugate pairs makes the mathematical calculation much easier, but at the same time
limits the applications of the model. From the previous example, the prior of the noise
precision p(α|M) and the posterior p(α|ε,M) are both in the form of a Gamma distri-
bution, and the likelihood function p(ε|α,M) is in the form of a Gaussian distribution.
Considering many likelihood functions are Gaussian distributed or at least belong to the
exponential family, which is the case in the considered applications in this thesis, the
requirement for the conjugation prior can be satisfied by many models, making the VB
method a good inference choice for those cases. When the distributions of the parame-
ters do not conjugate with the likelihood function, approximation of the distributions is
required, which would introduce bias towards the inference results.
2.6 Structural identifiability
In biomedical systems modelling, perturbations through some forms of inputs, for ex-
ample an injection or infusion of drug, are often applied to the physiological system
of interest; measurement data can then be obtained as the output of the system. The
system structure is an unknown black box and its parameters are learned through this
input-output relationship. Before estimating the system parameters, it is necessary to
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make sure that the parameters can be uniquely identified with respect to a particular
input-output structure, and this is referred to as structural identifiability analysis [92].
Theoretical structural identifiability tests are based on two assumptions: 1) the structure
of the model is appropriate; 2) there are no measurement errors. For the deterministic
form of the model in (2.2), the generic parameter vector θ is defined to be structurally
locally identifiable if there exists a neighbourhood of vectors around θ, N (θ), such that
if θ¯ ∈ N (θ) and for every input u and t > 0, y(t,θ) = y(t, θ¯), then θ = θ¯. If N (θ) is
the whole parameter space, the previous statement still holds true, then θ is structural
globally identifiable.
A number of techniques are available for performing the structural identifiability analysis
of a linear model, but only the most common method, the Laplace transform approach,
is applied here. The following is a summarisation from a review article [93]. Consider a
general n-dimensional linear model in state-space form given by
x˙t = Axt +But
yt = Cxt
(2.65)
where x is the n × 1 state vector, y is the m × 1 output vector and u is the r × 1
input vector; A is the n× n state matrix, B is the n× r input matrix, C is the m× n
output matrix. The initial conditions are assumed to be zero here, x0 = 0 (non-zero
initial conditions will be considered in Chapter 4). Taking the Laplace transforms of the
system (2.65) gives:
sX(s) = AX(s) +BU(s)
Y (s) = CX(s)
(2.66)
where X(s), U(s) and Y (s) are the Laplace transform of the state, input and output
vectors, respectively. Rearranging and combining these equations gives:
Y (s) = C(sIn −A)−1BU(s) (2.67)
where C(sIn − A)−1B is the transfer function matrix. Measurements taken for the
transfer function are assumed known so that the coefficients of the powers of s in the
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numerators and denominators of the measured outputs can be assumed to be uniquely
determined by the input-output relationship.
For example, for a two-state linear system:
x¨t + θ1x˙t + θ2xt = Fut (2.68)
with observation
yt = xt (2.69)
and initial conditions
x0 = 0
x˙0 = 0
(2.70)
the Laplace transform of (2.68) is given by
(s2 + θ1s+ θ2)X(s) = FU(s) (2.71)
The Laplace transform of the observations is of the form:
Y (s) =
F
s2 + θ1s+ θ2
U(s) (2.72)
where F , θ1 and θ2 are assumed to be known [93]. Therefore, θ1, θ2 and F are uniquely
identifiable.
The identifiability analysis for a nonlinear system is generally more complicated than
for linear systems, especially when the number of the parameters is large. By locally lin-
earising nonlinear systems, local identifiability can be evaluated since this only requires
the parameter to be unique in small neighbourhoods of the parameter space [94]. One
of the widely accepted methods to check the identifiability of a nonlinear system is the
Taylor series approach [93, 95, 96]. The idea is to evaluate the measurements y and their
successive time derivatives y(i) at a particular time, usually t = 0, using a Taylor series.
For the deterministic system considered in (2.1a) and (2.1b) with exact measurements,
i.e. yt = xt, the observed measurements y can be expanded as a Taylor series around
t = 0 as follows:
yt = y0 + ty˙0 +
t2
2!
y¨0 + · · ·+ t
i
i!
y
(i)
0 + . . . (2.73)
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The coefficients of the Taylor series y
(i)
0 are theoretically measurable and y
(i)
0 is a function
of the system parameters θ. Therefore, the identifiability problem reduces to determin-
ing the possible solutions of the parameter vector θ that generates the infinite list of
coefficients y
(i)
0 (i = 0, 1, 2, . . . ). Margaria et al. [97] provides an upper bound on the
number of coefficients that need to be considered with all polynomial transfer coeffi-
cients, which is n + r, where r is the number of parameters. If only one solution of
the parameter vector exists, the parameters are uniquely identifiable. If the number of
solutions is countable, the parameters are locally identifiable. If the number of solu-
tions is uncountable, the parameters are unidentifiable [96]. To illustrate this method, a
two-state deterministic system is considered with the states at time zero x0 impulsively
perturbed. The impulsive input can be expressed as initial conditions at t = 0 and the
system in (2.1a) can be written as follows:
x¨t = −(θk2x2t + θk1xt + θk0)x˙t − θ1xt (2.74)
with known initial conditions:
x0 = 0 (2.75a)
x˙0 = F (2.75b)
Substituting the initial conditions into (2.74),
x¨0 = −(θk2x20 + θk1x0 + θk0)x˙0 − θ1x0 = −θk0F (2.76)
the third derivative of the state x at time 0 can be obtained by differentiating (2.74),
x
(3)
0 = −(2θk2x0x˙0 + θk1 x˙0)x˙0 − (θk2x20 + θk1x0 + θk0)x¨0 − θ1x˙0
= −F (θ1 − θ2k0 + Fθk1)
(2.77)
Higher derivatives at t = 0 can be obtained by continually differentiating (2.77). As-
suming another parameter vector
θ¯ =

θ¯k0
θ¯k1
θ¯k2
θ¯1
 (2.78)
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can generate the same output (and the same derivatives of any order of the output) as
θ. By comparing the derivative terms calculated using the parameter vector θ¯ and θ,
(2.76) yields:
− θk0F = −θ¯k0F (2.79)
Since F is the known initial condition which is non-zero, (2.79) implies that θk0 = θ¯k0 .
Equation (2.77) yields:
− F (θ1 − θ2k0 + Fθk1) = −F (θ¯1 − θ¯2k0 + F θ¯k1) (2.80)
Three more equations can be obtained by equating higher order derivatives of x at t = 0
(including x
(4)
0 , x
(5)
0 , and x
(6)
0 , here n+ r = 6, and hence these terms are needed) using
the parameter vectors θ¯ and θ in the same manner. These three equations, together
with (2.79) and (2.80), can be solved through symbolic calculation by the Mathematica
software [98], and the following unique solution is obtained:
θk0 = θ¯k0 θk1 = θ¯k1 θk2 = θ¯k2 θ1 = θ¯1 (2.81)
Therefore, the illustrative nonlinear model is proved to be uniquely identifiable.
These aforementioned structural identifiability analyses provide a theoretical basis for
deterministic linear system as well as nonlinear system and can be performed without
any actual experimental observations. In biomedical applications, the uncertainty in
the model and the measurement noise are often large. This means that even if the
parameters are theoretically identifiable, fitting a model to data may still not yield
unique and optimal parameter estimates, especially when the measurements are sparse
and do not have enough constraining power over the parameters [99]. Unidentifiability
causes no real difficulties [100, 101] for Bayesian approaches by assigning different priors
in the parameter space to check for the uniqueness of the parameter estimates. When
the parameters are not uniquely identifiable, the mapping from the distribution of the
parameters to the marginalised likelihood function is not one-to-one, and the model
evidence is multi-modal. In these situations, it is necessary to select different priors in
the parameter space and check if these different priors yield the same posteriors.
The noise in stochastic nonlinear models plays an important role in identifying the
deterministic parameters in the inference process. Meaningful parameter estimation can
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only be obtained with a sufficiently small amount of noise in the measurements [102].
The noise intensity can be used as an indicator of how well the parameters describe the
data. In this thesis, the main purpose is to build data-driven models to describe clinical
data; taking account of the noise makes the model more realistic, and the description of
the data more accurate. However, the main interest in both applications remains at the
deterministic level which reveals the relationship between the inputs and outputs of the
system, and may help predict clinical outcomes.
The theoretical parameter identifiability analysis is performed for the nonlinear deter-
ministic system in Chapter 3 and the linear deterministic systems in Chapter 3 and
Chapter 4. Different prior settings for the hyperpriors and priors are also performed to
check the system identifiability for both applications.
2.7 Parameter sensitivity analysis
After the unknown parameters have been estimated for the given the model, the next
step is to assess the sensitivity of these parameters. Parameter sensitivity analysis is
performed to investigate the effect of change in a parameter value on the overall sys-
tem. It provides critical information on the relationship between parameters and system
outputs. With parameter sensitivity analysis, it can be assessed whether the system is
robust enough to operate reliably when its parameters vary within their expected ranges.
A small variation in a highly sensitive parameter may introduce fragility into the system
[103]. On the other hand, if the clinical outcome of interest is sensitive to one or sev-
eral parameters in the system, the parameter may serve as an indicator of the clinical
outcome. There are two categories of sensitivity analysis techniques: local sensitivity
analysis and global sensitivity analysis [104].
One of the simplest local sensitivity analysis methods is one-at-a-time analysis. The
parameter sensitivity can be measured by repeatedly varying the parameter of interest
while holding the other parameters fixed. The sensitivity of a parameter θi can be
reflected by the change in the system output towards the percentage change in that
parameter [103]. It is easy to measure the change in the system outcome when the
output is one single value; however, the output in our applications is a time series.
Therefore, a function of the output W is defined to quantify the change in the output
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time series, and δW is the change in W caused by the change in the parameter δθi.
Typically W are: the sum of the squared differences between the output produced by a
reference parameter and the perturbed system output [105], the area under the curve of
the output [106], the amplitude and period of oscillation [107], etc. In this thesis, since
root mean square is one of the most widely used measures of model goodness-of-fit, W
is defined as the root mean square difference between the measurements and the output
produced by the deterministic parameters with a small perturbation in θi:
W = RMSE =
√√√√ 1
N
T∑
t=1
(y˜t − yt)2 (2.82)
where yt is the measurement value at time t, y˜t is generated using the mean values of
the deterministic parameters, denoted as µθi , with a small perturbation. A reference
W (0) can be obtained when the mean values of the deterministic parameters are used
without perturbation. To test the sensitivity of the parameter θi, 1000 samples of
θi are drawn from a uniform distribution from 0.99µθi to 1.01µθi , each sample θ˜
(j)
i
(j = 1, 2, . . . , 1000), along with other parameters θ\i, are used to generate a deterministic
time series that deviates from the time series generated by θ. The change of percentage
in W compared with the reference value W (0) for each time series is then divided by the
change of percentage in θi accordingly. The sensitivity of the parameter θi, denoted as
the sensitivity index SIθi , is therefore defined as follows:
SIθi =
1
1000
1000∑
j=1
δW (j)/W (0)
δθ
(j)
i /µθi
(2.83)
The sensitivity index does not have a unit, since it represents a ratio of change in
an output to a change in a parameter. This is a local sensitivity analysis, because it
only considers the sensitivity of the parameters around a certain chosen point of the
parameter space. For the VB method in this thesis, all the inferred parameters follow
a normal distribution, therefore, a small value in the RMSE between the measurement
points and the output generated by the mean values of the parameters, cannot guarantee
small RMSE values generated with parameter values within a small neighbourhood of
the mean values. To guarantee the robustness of the model with the inferred parameter
values with a level of uncertainties, it is important to check the absolute value of the
RMSE and the sensitivity index.
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The other group of sensitivity analysis techniques not only considers the individual pa-
rameter sensitivity, but also assesses the combined variability resulting from considering
all parameters simultaneously. Random samples of parameters in the whole parameter
space, instead of one parameter, are generated based on the inferred posterior distribu-
tions. The change in the output towards the change in the parameter can be used to
assess the parameter sensitivity in a ‘global’ sense. In this way, the obtained parameter
sensitivity is dependent on the interactions and influences of all of the parameters. The
drawback of global sensitivity analysis is the high computational cost.
In this thesis, one-at-a-time analysis is performed to assess the sensitivity of model
parameters in Chapter 3 and Chapter 4.
2.8 Illustrative example of the use of the VB toolbox
In this section, an example is given to show how the VB method works given a single
measurement time series, and how different priors and hyperpriors influence the free
energy. A VB toolbox [77], initially developed for neuroimaging data, is applied to
perform the inference. The toolbox was designed to provide a flexible platform to deal
with nonlinear dynamic models in continuous time. It is capable of performing efficient
and robust parameter estimation, and providing quantitative diagnostics of model fitting.
This section presents the parameter inference and model selection procedure for a toy
model based on second order SDEs. A time series was generated using the toy model
and the strategy of obtaining the parameters and selecting the best model has been
investigated. This strategy is then applied to real data in later chapters.
The toy model was chosen in the form of (2.2). The VB method was then applied to
infer the model parameters and choose the best model from several model candidates.
Tests were performed to see whether the program can select the right structure and infer
the parameters successfully.
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2.8.1 The toy model
The toy model is linear and is based on (2.2), in which n = 2, f1 = θ1x˙t, f0 = θ2xt + θ3,
ut = 0: 
x¨t + θ1x˙t + θ2xt + θ3 = ηt
yt = xt + εt
(2.84)
with the initial condition: x0=
x0
x˙0

In (2.84), ηt corresponds to the system noise and εt represents the measurement noise,
both of which are modelled as AWGN noise: ηt ∼ N(0, α−11 ) and εt ∼ N(0, α−12 ); α1 is
the precision of the dynamic noise and α2 is the precision of the measurement noise. The
toolbox is capable of accounting for either measurement noise only or for both system
and measurement noise, with two sets of inference results accordingly. To differentiate
these two sets of inference results, in this thesis, the model with measurement noise
only is referred to as the deterministic model, and the model with both forms of noise
is referred to as the stochastic model.
The system equation of (2.84) can be written in state-space form as:
(
xt
x˙t
)′
=
 0 1
−θ2 − θ3/xt −θ1
(xt
x˙t
)
+
(
0
1
)
ηt (2.85)
Denote xt =
xt
x˙t
 as the state vector, a set of variables representing the configuration
of the system. The system reaches its steady state when xsteady =
−θ3/θ2
0
 . A time
series y consisting of 100 time points with the time interval of ∆t = 1 (Fig. 2.4) was
simulated using the parameter values listed in the second column of Table 2.2. In the
simulated time series, both noise intensities, α−11 and α
−1
2 , were set to be 0.01, which
was relatively small compared with the peak height around 350.
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Figure 2.4: Simulated time series from the toy model.
Table 2.2: Summary of the parameter settings for the time series simulated by the
toy model
Parameter Values for simulation Prior
θ

0.1
0.02
−5
 N


0
0
0
 ,

104 0 0
0 104 0
0 0 104


α1 100 Ga(0.001, 0.001)
α2 100 Ga(0.001, 0.001)
x0
(
5
10
)
N
((
x0
x˙0
)
,
(
104 0
0 104
))
With the simulated time series, parameter inference was performed using the VB toolbox
and the inferred parameters were compared with the parameter values used for simu-
lation. Note that this simulated time series has a relatively large measurement noise
precision, which is 100. When the simulated measurement noise precision decreases, the
uncertainty of the inferred parameters and hyperparameters may increase.
2.8.2 The choice of priors
This section is devoted to illustrating how the priors/hyperpriors for the parameter-
s/hyperparameters were selected for the toy model. The VB method has been applied
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with different prior settings to infer the parameters and the hyperparameters of the
simulated time series. The following prior information was required: the priors for the
deterministic parameters, the hyperpriors for the stochastic parameters, and the priors
for the initial conditions. To compare the inference results between the deterministic
model and the stochastic model, all the priors for the deterministic model, except for
the system noise hyperpriors, were set the same as for the stochastic model. All these
priors can influence the inferred posterior distributions of the parameters and the value
of the free energy, as shown in Section 2.3.4. As a larger free energy value indicates
a better model, the priors/hyperpriors of the parameters/hyperparameters set by the
modeller are important for model comparison. The influence of prior over posterior can
be viewed in two ways. On the negative side, the dependence of free energy on priors
requires exploration over the parameter space to achieve the optimal free energy for each
model candidate. On the positive side, a better knowledge of the parameter range can
constrain the parameter space that needs to be explored. Therefore, thorough explo-
ration is only needed for some typical time series, and the selected prior can be applied
to similar time series.
To illustrate the importance of prior settings, they were initially set as the values shown
in Table 2.2. To quantify the influence of the priors over the value of free energy, various
prior settings have been explored to provide an insight into how to select the priors
wisely for different parameters.
2.8.2.1 Initial default setting of priors and hyperpriors
As discussed in Section 2.5, weakly informative priors were initially set for all of the
parameters to make sure that the prior would not overpower the data. For the deter-
ministic parameters modelled as Gaussian distributions, a typical weak prior was set
with zero mean and relatively large variances as shown in the third column of Table
2.2. The variances, set to be 104, allowed the algorithm to search over a relatively wide
region for the optimal posterior distributions for the parameters. Both noise precisions,
α1 and α2, were modelled by gamma distributions: αi ∼ Ga(ai, bi) (i = 1, 2). Both hy-
perparameters ai and bi (i=1,2) were set to 0.001, which is a typical weakly informative
prior (see detail in Section 2.5).
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The free energy value for the stochastic model, denoted as Fs, is −248, and the free
energy value for the deterministic model, denoted as Fd, is −1059. The free energy is
the lower bound of the log-evidence of the model, logP (y|M). The higher free energy for
the stochastic model indicates that the stochastic model is more probable. The inferred
posterior distribution of the parameters follows a normal distribution as θ ∼ N (θˆ,Σθˆ),
where θˆ is the vector of the posterior mean values of the parameters and Σθˆ is the
posterior covariance matrix of the parameters:
θˆ =

0.104
0.022
−5.53
 Σθˆ =

7.98× 10−5 5.63× 10−6 −0.0016
5.63× 10−6 1.35× 10−6 −3.39× 10−4
−0.0016 −3.39× 10−4 0.09
 (2.86)
The posterior hyperparameters for the system noise, aˆ1 and bˆ1, and the posterior hyper-
parameters for the measurement noise, aˆ2 and bˆ2, are as follows:
aˆ1 = 100, bˆ1 = 41, aˆ2 = 100, bˆ2 = 38. (2.87)
The inferred posterior distribution of the initial condition follows a normal distribution
as x0 ∼ N (xˆ0,Σxˆ0),where xˆ0 is the vector of the means of the initial condition and Σxˆ0
is the covariance matrix of the initial condition:
xˆ0 =
7.38
6.24
 Σxˆ0 =
 0.88 −0.48
−0.48 0.49
 (2.88)
Compared with the parameter values used for the simulation as seen in Table 2.2, the
estimation errors (difference between the mean of the posterior and the true value) for the
parameters θi (i=1, 2, 3) are 0.004, 0.002 and -0.53 receptively. The correlation between
the parameters is shown in Fig. 2.5, from which it can be seen that the correlation
between θ2 and θ3 is high (Fig. 2.5). The relative higher estimation errors in θ2 and θ3
(around 10%) compared with the estimation error in θ1 (4%) can be explained by the
high correlations in the covariance matrix between θ2 and θ3 (see the caption of Fig. 2.5),
which causes difficulties in identifying the parameters individually as explained in Section
2.3.4. The mean precisions of the posterior system noise and measurement noise are
aˆ1
bˆ1
= 2.44 and aˆ2
bˆ2
= 2.63, both of which greatly underestimate the real precision of 100.
This underestimation is caused by poor selection of the priors and the hyperpriors. Based
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on the hyperpriors, the prior mean for the both noise intensities is 1. The posterior mean
for both noise intensities has increased to larger than 2 in light of the data. However,
the influence from the prior over the posterior is not negligible, and this causes the
underestimation of both noise intensity.
By exploring different settings for the prior/hyperpriors of the parameters/hyperparam-
eters, the estimation errors of the parameters/hyperparameters can be further decreased
and the free energy value can be further increased, implying that the gap between the
free energy and the log-evidence for the model can be further decreased.
Figure 2.5: The correlations between the parameters θ1, θ2, θ3 and the initial condi-
tions x0, x˙0. The correlation between θ2 and θ3 is 0.97, between θ1 and θ2 is 0.54, and
between θ1 and θ3 is 0.60.
2.8.2.2 Select the mean vector of the prior distribution for the parameters
To see if the inferred posterior distributions of the parameters remain unchanged with
different mean vectors of the prior distributions for the parameters, the prior means of
each parameter ranging from −30 to 30 have been used to obtain the posteriors.
First, with the priors of θ1 and θ2 fixed, the prior mean of θ3 was changed ranging from
−30 to 30 with an increment of 1. The free energy values and the posterior mean θˆ3 of
θ3 are shown in Fig. 2.6. When the prior values are around zero, the change of the free
energy is dramatic. The deviation from the true value of θ when the prior mean is zero
might be caused by multi-modality in the model evidence. Therefore, the prior mean
should be chosen outside of the range from −1 to 1.
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Figure 2.6: Free energy and posterior means of θ3 using different prior means of θ3.
Second, with the priors of θ1 and θ3 fixed, the prior mean of θ2 was changed from
−30 to 30, and the corresponding inferred posterior mean θˆ2 is shown in Fig. 2.7. It
shows that changing the prior mean of θ2 can cause dramatic changes in the free energy
and the posterior mean. From the bottom figure in Fig. 2.7, the posterior mean θˆ2
increases when the prior mean increases except when the prior was set between −3 and
3. But compared with the top figure in Fig. 2.7, the free energy dramatically changes
in that region, and the prior setting that generates the highest value of free energy is
when θ2 = 0. The possible explanation is that the parameter θ2 might only be locally
identifiable, and with a prior that is far away from its true value, the posterior mean will
be determined by the prior mean. The sensitivity of the free energy to the prior mean
near the true value of the mean makes it necessary to explore different prior means for
θ2 to select the appropriate parameter prior.
Finally, the priors of θ2 and θ3 were fixed, and the prior mean θˆ1 was changed from −30
to 30 as shown in Fig. 2.8. When the prior mean is larger than 27, which is far from the
true value of 0.1, the posterior mean θˆ1 settles at around 0.2. However, from the much
smaller value of the free energy, the inferred value is not optimal. From the magnified
box shown in Fig. 2.8, different prior means with a smaller step of 0.1 between −1 and
1 were used. The posterior mean θˆ1 is not as sensitive to the prior as θ2 and θ3, but a
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Figure 2.7: Free energy and posterior means of θ2 using different prior mean values
of θ2
small change in the prior mean can still cause a big difference in the free energy values.
It is clear that the change of prior means of the three parameters have different levels
of influence over the posterior means and the free energy values. In fact, the degree
of influence of the prior mean of the parameters also depends on the number of the
measurement data points. As explained in Section 2.5, the posterior distribution of the
parameters is dependent on both the priors and the data, which means more weight
would be put on the priors when there are less measurement data. Thus, to make sure
the inferred posterior is robust with respect to different prior settings, different prior
means of the parameters should be considered by covering a reasonable area in the
parameter space in order to find the ‘true’ value of the parameters as indicated by the
free energy.
2.8.2.3 Select the variances of prior distributions for the parameters
The posteriors of the parameters are influenced not only by the mean value of the prior
distributions, but also by the variances of the prior distributions. In this toy model, the
covariance matrix of the prior distributions for θ1, θ2 and θ3 are set to be 10
4I3 (I3 is the
3× 3 identity matrix). The large variance allows a wide range of parameter values to be
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Figure 2.8: Free energy and posterior means of θ1 using different prior means of θ1
explored in parameter space, and also expresses the uncertainty on the parameter values
before the data are observed. If certain information of the parameter value is known,
then the variance of the parameter can be set to a narrower range to incorporate the
known information, which may lead to a smaller variance in the posterior distribution,
and improve the estimation of the parameters. To explore the influence of the variances
of the parameter prior distributions for the parameters, the variances of the priors 10jI3
were changed from j = −2 to j = 8. The free energy for different settings is shown in Fig.
2.9. To quantify the estimation errors for all three parameters, the Root Mean Square
Error (RMSE) between the real values and the estimated mean values (θˆi, i = 1, 2, 3) is
calculated as follows:
RMSEΣ =
√
(θ1 − θˆ1)2 + (θ2 − θˆ2)2 + (θ3 − θˆ3)2
3
(2.89)
As shown on the bottom graph in Fig. 2.9, when the covariance matrix of the prior
distribution is set to 10 I3, i.e. j = 1, the estimation errors of the parameters are the
smallest with RMSEΣ of 0.019 and free energy of −230. From Fig. 2.9, when the variance
of the prior distribution is set too small (j < 0), the area in the parameter space that can
be explored is highly limited, and therefore, the free energy F settles at a suboptimal
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value. When the variance of the prior distribution are increased from j = −2 to j = 0,
the estimation error of the parameters between the posterior mean and the true value
decreases, and remains low when the variances of the priors are further increased from
j = 0 to j = 8.
Figure 2.9: Free energy F and RMSEΣ with the variance of the prior distribution for
all three parameters 10jI3 changing from j = −2 to j = 8.
For this example, it is clear that when the variances of the parameters are larger than
10, the accuracy of the parameter inference stays the same and the slight difference in
free energy is only caused by the different priors. Therefore, the priors for the variances
of the parameter shows robustness when large prior settings for the variances are chosen
(> 10), and the posterior distributions of the parameters do not rely on the prior variance
for the parameters. To conclude, it is better to set a larger variance as a weak prior in
real applications.
2.8.2.4 Select the hyperpriors for the hyperparameters
The precisions of both forms of noise are modelled by Gamma distributions: f(αi) ∼
Ga(ai, bi) where ai is the shape parameter and bi is the rate parameter. Correspondingly,
the probability density function is as follows:
f(αi) =
baii
Γ(ai)
αai−1i e
−biαi (2.90)
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An illustrative graph is shown in Fig. 2.10 with different values of ai and bi where ai/bi
is the mean of the distribution, and ai/b
2
i is the variance.
Figure 2.10: Probability density distribution of the precision of the noise
Let us consider how the hyperpriors ai and bi in both types of noise (system noise and
measurement noise) influence the posterior distribution of the parameters. As explained
in Section 2.5, setting all the hyperparameters (a1, a2, b1, b2) to 0.001 can provide weakly
informative hyperpriors for the precision of both forms of noise. Different combinations
of the hyperprior setting have been used to study the influence of the hyperpriors over the
estimation error for the noise intensity and the value of the free energy. The estimation
error for both forms of noise intensity can be calculated as follows:
RMSEα =
√
( aˆ1
bˆ1
− 100)2 + ( aˆ2
bˆ2
− 100)2
2
(2.91)
First, fix the hyperpriors for the system noise, a1 and b1, to 0.001, and consider the
influence of the hyperpriors of the measurement noise over the free energy value and
the posterior distributions of both forms of noise intensity. Varying the values of a2 and
b2 results in different values of free energy as shown in Fig. 2.11 (a). It is clear from
the figure that the free energy values along the diagonal lines (parallel to the indicated
line) are close. The free energy values are maximised along the indicated diagonal line
log(a2) = log(b2) + 2, where the prior mean is a2/b2 = 100. This means that the prior
mean of the measurement noise intensity has a non-negligible influence over the free
energy values. The RMSE between the estimated mean of the noise precision and the
true noise precision was calculated according to (2.91). The logarithm of the RMSEα
(log RMSEα) for different combinations of the shape (a2) and rate (b2) hyperparameters
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Figure 2.11: (a)The value of free energy and (b) RMSEα for different combinations
of the shape a2 and rate b2 hyperpriors for the measurement noise. Note that the figure
is shown in log-scale (with a base of 10). All the free energy values F in this graph are
negative, so the logarithm of the free energy is calculated by − lg(|F|).
of the measurement noise is shown in Fig. 2.11 (b). These results agree with the free
energy results shown in Fig. 2.11 (a): when the prior mean of the measurement noise
precision a2/b2 is set to 100, F is maximised and RMSEα is minimised. Along the
indicated diagonal line in both Fig. 2.11 (a) and Fig. 2.11 (b), the variance of the prior
distribution for the measurement noise precision, a2/b
2
2, decreases when log(b2) increases.
To make sure that the variance of the prior distribution of the noise intensity is large
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enough, the variance of the prior distribution of the noise intensity should be at least 102,
which means that b2 should be no larger than 1. When b2 is set to 1, and a2 is 10
2, the
posterior estimations for the hyperparameters are: aˆ1 = 100.001, bˆ1 = 5.31, aˆ2 = 200,
bˆ2 = 2.22, and the free energy is −21, which is the largest value. It is worth noticing that
the posterior mean of the system noise precision aˆ1/bˆ1 = 19, and the posterior mean of
the measurement noise precision is aˆ2/bˆ2 = 90. Both estimated precisions are smaller
than the real precisions of 100, with the measurement noise precision closer to the real
value. The underestimated noise precision indicates that the VB method tends to be
conservative in terms of noise precision inference.
Second, fixing the hyperpriors for the measurement noise, a2 and b2, to 0.001, and
consider the influence of the hyperpriors of the system noise over the free energy value
and the posterior distribution of both forms of noise intensity. Varying the value of a1
and b1 from 10
−4 to 105 (order 10 incremental) results in different values of the free
energy F as shown in Fig. 2.12 (a) and the RMSEα as shown in Fig. 2.12 (b). Note that
varying the value of a1 and b1 from 10
−4 to 105 has covered a huge range of possible
noise intensities from 10−9 to 109, which is considered sufficiently wide. Similar to the
mean of the prior distribution of the measurement noise intensity, the mean of the prior
distribution of the system noise, a1/b1, also influences the value of F and the RMSEα. It
is worth noticing the high free energy values on the top left corner of Fig. 2.12 (a). Take
a1 = 10 and b1 = 10
−4 for example, the free energy value, F = 473, and is large. This
indicates that the probability of the model being true with the inferred parameters is
high. However, from Fig. 2.12 (b), the RMSEα with hyperpriors a1 = 10
−4 and b1 = 101
is as high as 7.8× 105, indicating an inaccurate inference. The contradictory result of a
high free energy and a high RMSEα is caused by the bad choice of the hyperpriors of the
system noise with a mean value of a1/b1 = 10
−5 and a variance of a1/b2i = 10
−6. With
such a strong informative hyperprior, the posterior hyperparameters aˆ1 = 110, bˆ1 = 10
−4
are completely dominated by the prior distribution. The artificial high confidence level
of the small system noise precision boosts up and dominates the value of the free energy.
Therefore, the mean of the prior a1/b1 is held at 100 indicated by the straight line shown
in Fig. 2.12 (a). Finally, a1 = 100 and b1 = 1 are selected based on the free energy value
of 2. It is the largest among all of the combinations of the hyperparameters except for
the top left corner where the free energy values do not reflect the goodness of fit. The
posterior hyperparameter values are aˆ1 = 200, bˆ1 = 1.54, aˆ2 = 100.001, bˆ2 = 10.30.
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Figure 2.12: (a)The value of free energy and (b) RMSEα for different combinations
of the shape a2 and rate b2 hyperpriors for the system noise. Note that the figure is
shown in log-scale (with a base of 10).
The posterior mean of the system noise is aˆ1/bˆ1 = 130, which is overestimated and the
posterior mean of the measurement noise is aˆ1/bˆ1 = 9.71, which is underestimated.
The optimal free energies of the second step (fixing the hyperpriors for the measurement
noise) are higher than for the first step (fixing the hyperpriors for the system noise).
Therefore, the hyperpriors are finally chosen as: a1 = 100, b1 = 1, a2 = b2 = 0.001. The
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mean of the posterior distribution for the parameters θ and the covariance matrix Σθˆ
are as follows:
θˆ =

0.099
0.020
−5.03
 Σθˆ =

1.53× 10−6 1.13× 10−7 −3.11× 10−5
1.13× 10−7 2.60× 10−8 −6.58× 10−6
−3.11× 10−5 −6.58× 10−6 0.0017
 (2.92)
The posterior hyperparameters for the system and measurement noise are as follows:
aˆ1 = 200 bˆ1 = 1.54 aˆ2 = 100.001 bˆ2 = 10.30 (2.93)
Compared with the posterior distributions of the parameters obtained using well-selected
priors with the posterior result shown with (2.86) and (2.87) obtained using the default
priors, every inferred parameter is closer to its real value as shown in Table 2.2. There-
fore, it can be concluded that selecting the priors and hyperpriors would improve the
performance of the algorithm.
It is worth noticing that the improvement of the inference is reflected not only by the
improved mean values of the parameters, but also the smaller variances of the parameter
posterior distributions and a smaller error of the estimation for both forms of noise
intensity. The free energy, increased from −284 to 2, proves to be a good indicator of
selecting priors and hyperpriors, except when the prior variances are set too narrow.
When the VB method is applied in practice and the real values of the parameters are
unknown, not only a high free energy value, but also a small estimated variance of the
parameter distributions, and a high estimated noise precision indicate a good choice of
the priors and hyperpriors for the parameters and hyperparameters.
2.9 Chapter summary
The methodology that is later applied in Chapters 3 and 4 has been presented in this
chapter. The model framework based on differential equations has been presented in
Section 2.1, and this framework is going to be used for model development for two
medical applications in Sections 3.3.1 and 4.3. The VB method has been described in
detail in this chapter, and its advantages and disadvantages compared to other sampling
methods such as MCMC and SMC have also been discussed. Free energy calculated
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using the VB method serves as a model selection criterion, and it has been compared
to other criteria such as the AIC and BIC. It has been stressed that the VB method,
as a full Bayes approach, provides a probabilistic view towards every unknown variable
including the parameters, the hyperparameters, the initial conditions and the states,
and the calculation of free energy takes the uncertainties of these unknown variables
into consideration. The VB method will serve as the main tool to select the best model
structure and learn the parameter values in applications presented in Sections 3.3.2
and 4.3.2. The choices of priors and hyperpriors for parameters and hyperparameters
have been discussed and their influence over the posteriors has been highlighted in the
provided example. The specific choice of priors will be further investigated in Sections
3.4.1 and 4.3.2.
The format and the quality of the data collected in the two clinical applications are
different. Both sets of measurement data consist of one single time series. The measure-
ment data collected for the first application are sampled with equal spacing without any
missing data. The measurement data collected for the second application are irregularly
sampled, and the data are relatively sparse. However, the VB method is successfully
employed to select the best model that describes the data for both applications, demon-
strating the flexibility and capability of the method.
Chapter 3
Post-prandial glucose dynamics
With an ever increasing population with Diabetes Mellitus (DM), scientists have been
endeavouring to establish and develop various mathematical models to describe or pre-
dict in human glucose dynamics. This chapter presents a data-driven model that has
been developed using the VB method for model selection and parameter inference. In-
spired by a linear deterministic model built by Wu [108] based on data from one DM
patient, a stochastic model with a second order nonlinear differential equation has been
developed to describe the response of blood glucose concentration to food intake using
continuous glucose monitoring data for people with and without DM. The number and
values of the system parameters were defined by iterative optimisation of the free energy
as introduced in Chapter 2. A comprehensive analysis demonstrated that deterministic
system parameters belong to different ranges for DM and non-DM profiles. Implica-
tions for clinical practice are discussed. This is the first study introducing a continuous
data-driven nonlinear stochastic model capable of describing blood glucose dynamics for
people with and without DM. This work has been published in [109, 110]. The structure
of the chapter is as follows. Section 3.1 gives a background introduction to DM and the
glucose regulatory system, and discusses the models available in the literature. Section
3.2 provides details on the data available for the analysis. Section 3.3 presents the pro-
cess of the model formulation and development, and explains the VB method that has
been adapted to this application. Detailed analysis of system parameters and compari-
son of the parameters between the groups of people with and without DM are discussed
in Section 3.4 together with clinically related interpretations. Section 3.5 summarises
the results.
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3.1 Introduction
Diabetes Mellitus (DM), commonly referred to as diabetes, poses an alarming threat
in modern public health with rising trends and severity in recent years. According to
an International Diabetes Federation report [111], an estimated 387 million people have
DM worldwide, and the number is expected to rise to 592 million by 2035. DM is a
group of diseases characterised by high blood glucose (known as hypergycemia) levels
that result from defects in the body’s ability to produce and/or use insulin. The chronic
hyperglycemia of DM can lead to various microvascular and macrovascular complica-
tions, including blindness, limb loss, ischemic heart disease and end-stage renal disease
[112]. The majority of the DM cases fall into two categories, both of which result from
complex interactions between the genes and the environment, but the pathophysiology
and the treatments are different.
Type 1 diabetes (T1D), which accounts for 5 – 10 % of the diabetes population, usually
starts in childhood and adolescence. It is caused by the inability of the β cells in the
pancreas to produce insulin. Therefore, T1D patients need to be treated with insulin
injection or insulin pumps to control hyperglycemia. Poor judgement of the amount of
the insulin injected can result in serious hypoglycamia (low blood glucose) which may
lead to brain damage, coma and even death [113].
Type 2 diabetes (T2D), which accounts for 90 – 95 % of the diabetes population, is
caused by a combination of tissue resistance to insulin and an inadequate compensatory
insulin secretion. T2D occurs more frequently with increasing age, and is highly related
with a sedentary modern lifestyle with excess caloric intake. Various oral anti-diabetic
drugs [114] that reduce insulin resistance or increase insulin sensitivity, as well as insulin,
are used for treatments. Lifestyle changes, such as limitation of energy intake, regular
exercise, and weight reduction, have also proved beneficial to control [115, 116] and even
reverse the progression of the disease [117]. T2D has long been considered as a chronic
progressive condition and has several different stages [118]. It may stay undetected for a
long period of time without clinical symptoms when the underlying disease is developing
and causing damage in β cells.
When the glucose level is higher than normal, but not yet high enough to be classified as
T2D, it is usually referred to as pre-DM. Without intervention, people with pre-DM have
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a higher risk of progressing to T2D; thus there is an urgent need for improved diagnostic
methods that are capable of detecting symptoms at early stages of the disease. For people
with DM or in the process of progressing into DM, it is crucial to achieve the goal of
maintaining glycaemic stability during daily life, which requires a deep understanding of
which and how different factors (food intake, exercise, mental stress, etc.) influence the
glucose variations [119].
This chapter is focused on one important factor – food intake – that influences glucose
variations in daily lives. Each food intake is considered as one event that serves as
an external excitation force to the glucose regulatory system. The glucose excursions
afterwards reflect the transient response of the system to such excitation, and eventually
the glucose concentration settles back to the baseline, which represents the steady state
of the system.
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Figure 3.1: Simple illustration of the glucose - insulin feedback system.
A wide variety of hormones take part in glucose regulation including insulin, glucagon,
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epinephrine, cortisol and growth hormone. Among them, the main regulator is insulin.
As indicated by the dark blue arrows in Fig. 3.1, when the glucose perturbation occurs
(after a meal), β cells in the pancreas secrete more insulin in response to the excessive
glucose and the increased insulin promotes the glucose utilisation in various tissues and
inhibits the hepatic glucose production to bring the blood glucose effectively down to the
pre-perturbation level. Note that the blood in the human body normally only contains
less than 6 g of glucose, which approximately corresponds to three cubes of sugar [120].
Since the blood is not a large reservoir of glucose, the large amount of glucose intake
is added to the blood gradually by the digestive tract and the liver, and removed by
the cells of the body for hours. Like all physiological systems (stated in Chapter 1),
the underlying process of the glucose regulatory system is nonlinear, stochastic, and
complex, all of which make an external control over the glucose concentration difficult.
Various mathematical models have been developed to describe glucose variations using
physiologically-oriented models or data-driven approaches. The physiological modelling
is mainly based on compartmental modelling, as it approximates a complex system by
a number of interconnected subsystems named compartments. Compartmental models
have been used to study the dynamic flow of chemicals such as nutrients, hormones,
drugs and radioisotopes between different organs of the human body. In these cases, a
‘compartment’ is defined as an amount of a chemical that acts kinetically in a homoge-
neous way; if the chemicals in the same physiological space behave differently in their
kinetics, they are considered to belong to different compartments [121]. The flows of
chemicals between the compartments follow physical rules, which can be expressed as
mathematical ordinary differential equations [121].
The first simple linear two-compartment model [122, 123] aimed at describing the blood
glucose regulatory system during a glucose tolerance test, which monitored glucose con-
centration variations for more than three hours after a large dose of glucose intake
[124]. Following this publication, the slightly more complex ‘minimal model’ [125]
gained wide popularity and still remains the most popular choice for diagnostic pur-
poses [126]. The minimal model separates the effect of insulin on glucose utilisation into
two compartments: the glucose-dependent insulin compartment, and the postulated
glucose-independent insulin compartment. The parameters of the minimal model (in-
sulin sensitivity and glucose effectiveness) have been shown to have clinical importance
and can be estimated from intravenous glucose tolerance test data [127] using nonlinear
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least squares methods [128] or Bayesian techniques [129]. More complex models with
more compartments [130] based on the minimal model [131–135] have been developed
to capture the complexity of the underlying physiology (production, distribution, and
degradation of glucose and insulin) by compartments, each of which associates with sev-
eral differential equations. For example, Watson has built a three compartment model
using a proportional-integral-derivative controller [134]. With a specially designed triple-
tracer experiment, a ‘Maximal Model’ (MM) was proposed [135] including 12 differential
equations and 35 parameters.
For all these compartmental models, the parameters, which have direct physiological
interpretations, need to be obtained or inferred from measurements. Identifying these
parameters is difficult, sometimes impossible, because the data collection for certain vari-
ables may be too expensive or unethical in practice. For example, all compartmental
models require readily available time series for blood glucose and insulin concentrations
[112]. While the glucose concentration time series are relatively easy to obtain, attain-
ing enough insulin concentrations for an individual requires invasive and costly blood
tests. In practice, clinicians and patients observe the glucose variations to improve DM
management. Therefore, mathematical models that only require the glucose time series
are in urgent need to give information about the underlying glucose regulatory system
for the patient.
Data-driven models are capable of exploiting the information hidden in the data without
detailed knowledge of the underlying physiological processes [136]. Modern continuous
glucose monitoring (CGM) devices [137] – developed for the purpose of improving glucose
self-monitoring management and avoiding dangerous hypoglycemic episodes – are able
to obtain hundreds of data points collected at short time intervals, and have become
particularly valuable for data-driven modelling. Many data-driven methods have been
developed including artificial neural network models [120, 138], Volterra models [139]
and others [112, 119]. Among them, one of the most popular data-driven methods is
based on difference equations - autoregressive (AR) models. Sparacino et al. [140]
suggested a first-order autoregressive model with time-varying parameters, and Gani
[141] proposed an AR model of order 30 with fixed coefficients. AR models represent
the random process of glucose concentration as a linear combination of past values and
external inputs. However, to reflect the complex underlying process, a small number of
AR model coefficients is not sufficient to capture the temporal variations of the time
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series [142]; but an AR model with a large number of coefficients suffers from overfitting
the data by mistakenly treating the noise as a feature in the time series.
On the other hand, differential equation based data-driven models have also been ex-
plored and showed promising results [108, 131, 143]. Ordinary differential equations
(ODE) permit a more parsimonious presentation of data compared with a high order
difference equation. Wu [108] modelled the blood glucose excursions after food intake
by a second order linear differential equation based on CGM data from one T2D pa-
tient. Khovanova et al. [144] demonstrated that such linear systems can successfully
describe some postprandial (after food intake) glucose excursions in subjects without
DM, whereas strong nonlinear responses were evident for many DM profiles. It is con-
cluded that the blood glucose variation in the diabetes profile is greater in amplitude and
smoother, with retention of inter-dependence between neighbouring values in a profile.
Even though the form of the nonlinearity is not explored, the importance of including
nonlinear terms in the modelling equations is highlighted in the paper [144].
Another factor characterising glucose dynamics is the presence of a strong stochastic
component [56, 131]. As stated in Chapter 1, physiological systems are intrinsically
stochastic, which can be incorporated in the form of system noise into the model. System
noise accounts for model misspecification, and can be added to an ODE system as
a stochastic term to form ‘stochastic differential equations’ (SDE). By using models
based on SDEs, the effects of model uncertainties can be decoupled from the effects
of measurement noise. From the parameter estimation point of view, using a SDE
instead of an ODE can decrease serially correlated residuals, high values of which are
an indicator of model structure misspecification. However, SDE models have not been
given the requisite attention in the vast literature on glucose regulation models.
It is worth noting that the solutions of ordinary differential equations can be presented
in polynomial form. One may argue that polynomial fitting is more straightforward
compared with ODE based models. However, an ODE based model has the advantage
of structural interpretability compared to a model in a polynomial form. Even though
this data-driven approach does not provide direct physiological interpretation for the
model parameters, much information can be obtained from the inferred model structure
and parameter values such as the order of the system, the class of the dynamic system,
the inferred system and measurement noise intensity, and the natural frequency and
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damping coefficient in the linear model. Another choice would be to develop models
that are based on transfer functions. However, the main limitation of transfer functions
is that they can only be used for linear system [145]. It should be pointed out that despite
this limitation, transfer functions still remain a valuable tool for designing controllers for
nonlinear systems, mainly through constructing their linear approximations around an
equilibrium point of interest. However, models based on transfer functions cannot take
system noise into account, which contradicts the nature of the underlying physiological
system. On the other hand, an ODE based model has the flexibility of incorporate
nonlinearity and stochasticity into the model framework.
For people with or in progression towards DM, it is important to maintain glycaemic
stability during daily activities. A personalised model that accurately describes the
glucose dynamics can help to monitor and improve an individual’s control over DM
in their daily lives. Therefore, the aim of this research is to develop a data-driven
continuous-time model to describe the transient response of blood glucose dynamics to
each food intake. The model is in the form of SDEs with a minimal number of equations
and parameters, and accounts for nonlinearity and stochasticity of the underlying glucose
dynamics. The VB method described in Chapter 2 is applied to select the best model
structure among several model candidates and infer the deterministic and stochastic
model parameters. Other methods, such as least squares methods, that could not serve
the purpose of inferring the parameters and selecting the model based on stochastic
differential equations are therefore not considered in the chapter. Sampling methods,
such as Markov Chain Monte Carlo methods, are not the main focus of this research,
and the advantages and disadvantages of these methods compared with VB methods
have been discussed in detail in Section 2.2.2.
3.2 Data description
Glucose profiles from fifteen subjects, including five subjects without DM (control group),
four subjects with T1D and six subjects with T2D, were collected by our clinical col-
laborator from the University of Oxford, Dr. Tim A. Holt, and were available for the
study [144]. The recruitment ensured a diverse sample of ages and treatment regimens.
Baseline biographical data were obtained on age, sex, body mass index, type of DM,
treatment regimen, and recent HbA1c value which can be found in Table 3.1. The
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treatment regimen listed in Table 3.1 is assumed to be consistent throughout the whole
experimental period, and does not affect the modelling development in this study, be-
cause the main focus of this research is the dynamics of the glucose response following
food intake. Medtronic Minimed CGM devices were used to obtain blood glucose values
every 5 minutes over 72 hours, and one participant in the T1D group voluntarily (on
the independent advice of their clinician) kept the device on for more than 6 days. The
CGM devices use enzymatic sensors that are inserted subcutaneously in the abdomen to
measure the interstitial fluid glucose concentration. There are 3 – 12 minutes of time lag
between the interstitial fluid glucose concentration and the plasma glucose concentration
due to the diffusion of glucose across the capillary endothelial barrier [137]. Measurement
time series G(ti) are available for each subject, and comprise the glucose concentrations
(in mmol/L) at time points ti = ih, where h = 5 minutes is the sampling interval and
i = 1, 2, . . . , N (N is the number of measurement points). The measurements were taken
in ‘free living’ conditions, i.e. no restrictions were placed on the subjects’ daily activities
or food intake. The types of meals taken and the calorific intake are not available.
Several example time series are presented in Fig. 3.2. The dotted peaks in the time series
represent the postprandial blood glucose excursions. To avoid mistaking measurement
noise for genuine postprandial peaks, only distinguishable peaks with height more than
1.1 mmol/L during the daytime from 6 am to midnight were selected. The highest
peak value for the subjects in the control group is just below 8 mmol/L, whereas the
highest values for the T1D and T2D patients are greater than 15 mmol/L. Because the
CGM devices need calibration at the beginning of each experiment and all the subjects
started wearing the device during the evening time of the first day, the first peak for all
the participants is selected as the first peak of the second day, which can be seen in Fig.
3.2. Since there are no restrictions on the time and the number of meals (food intake),
the subjects have various numbers of distinguishable peaks corresponding to food intake
events (between five to fourteen peaks for each individual).
There was no detailed information about the time of the food intake. The glucose
concentration time series measured in the interstitial fluid by the CGM device was
known to have a lag behind the blood glucose concentration. Therefore, the beginnings
of the transient responses to each food intake needed to be determined by the modeller.
After the transient response, the glucose concentration settled to a steady state. It
was common in the fifteen time series that another external excitation (such as food
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Table 3.1: Biometric indices, treatment regimens, HbA1c values and corresponding
estimated average blood glucose levels of participants.
No. Age Sex BMI Diabetes Treatment HbA1c Glucose level
kg/m2 status regimen mmol/mol mmol/L
1 57 F 20.5 T1D Basal bolus 63 10.0
(glargine plus
aspart)
2 27 F 19.2 Control N/A N/A N/A
3 59 F 27.3 Control N/A N/A N/A
4 49 F 21.9 Control N/A N/A N/A
5 32 F 29.4 T1D Insulin pump 55 9.0
6 74 M 20.5 T2D Metformin, 61 9.7
gliclazide,
rosiglitazone
7 66 F 25.9 T1D Insulin pump 38 6.3
8 75 M 23.4 T2D Metformin 46 7.6
9 68 F 32.7 T1D Basal bolus 48 7.8
(glargine plus
aspart)
10 39 F 21.3 Control N/A N/A N/A
11 61 F 32.6 T2D Metformin 52 8.4
12 56 M 30.0 T2D Metformin 68 10.8
13 52 F 44.5 T2D Metformin, 89 13.8
glargine
14 22 F 19.6 Control N/A N/A N/A
15 63 F 27.0 T2D Newly diagnosed 42 7.0
intake, exercise, etc.) occurred before the glucose concentration had the chance to
settle. In these cases, the response to the first food intake was interrupted and the
steady state, which was the basal level Gb, remained unknown. The basal glucose level
usually demonstrates slow nonstationary dynamics [144]. Therefore, the basal level for
each individual peak was considered different. Compared with the baseline differences
from peak to peak, the baseline variations within the duration time of a single peak
could be neglected and the baselines were considered as constant during the transient
response to one food intake.
The shapes of the peaks exhibit different patterns, even for the same subject. The most
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Figure 3.2: Example subcutaneous glucose time series G of a participant from (a) the
control group (b) the T1D group (c) the T2D group. The solid grey curves represent
the measured glucose values and the dots are the values used for modelling of single
postprandial peaks. The solid and dashed vertical lines correspond to midnight (0
hours) and 6 am respectively. The first several hours of data in Day 1 (to the left from
the first solid vertical lines) were excluded from the modelling due to the adjustment
period of the CGM system. ‘B’ indicates breakfast, ‘S’ indicates snack, ‘L’ indicates
lunch, ‘D’ indicates dinner.
common patterns are as follows: 1) peaks with a clear and almost symmetrical rise and
fall, such as the first peak in Fig. 3.2 (c); 2) peaks with a steep rise followed by a slow
fall and then a rapid fall, such as four peaks marked with ‘∗’ in Fig. 3.2 (b); 3) peaks
with a distinguishable secondary peak indicated with ‘×’, or with multiple subpeaks
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indicated with ‘o’ in Fig. 3.2 (a) and (b). According to [146], the glucose variations
after food intake (and therefore the shape of the curves) can be influenced by different
macro-nutrients of the meal, the time of the meal, the gender of the subjects and the
diurnal cycling of hormones [146]. The peak shape variation is most likely due to erratic
gastric emptying. The appearance of glucose in plasma depends on the gastric emptying
rate. Liquids display exponential gastric emptying without an initial lag, while solids
show biphasic gastric emptying with a lag [147]. When there are multiple peaks existing
within a short period of time (within 3 hours), they may be caused by various emptying
rate for different meal compositions or a pulsation secretion of insulin for the same food
intake event, but can also be caused by two separate food intake events within a short
interval of time. The complex patterns and the varieties in peak dynamics, as well as
the lack of information on the precise food intake (including time, quantity and the
constitution of macro-nutrients) make the task of finding a universal model difficult.
Observing the time series in Fig. 3.2 can provide valuable information about the subjects’
food routines. For example, the peaks representing breakfasts for the subject in Fig.
3.2 (c) are similar suggesting the subject has a daily breakfast routine. The small peaks
between the breakfast and lunch in both days suggest that the subject also has a routine
of eating a snack before lunch. Other subjects, such as the time series shown in Fig. 3.2
(b), have less fixed meal times and more varieties of features in peaks that represent the
same meal in different days.
3.3 Model and Methods
3.3.1 Model formulation
Three important characteristics of the blood glucose response to food intake need to be
taken into account during model formulation. First, the glucose response is nonlinear
(as explained in Section 3.1). Second, stochasticity enters into the model in two forms:
1) as measurement noise from the CGM device, 2) as dynamic intrinsic noise account-
ing for model misspecification resulting from factors other than food intake, including
physical activity and emotional stress. For patients using insulin, inaccurate estimation
of the necessary dose is another factor influencing postprandial excursions. Third, the
endocrine system tends to maintain homoeostasis, and any deviations of blood glucose
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from the basal level decay rapidly and return to the pre-disturbed status. As described
in Section 3.2, the basal glucose level is different throughout the day and demonstrates
slow nonstationary dynamics [144]. In this study the basal level Gb of glucose is assumed
to be constant within one peak (usually several hours), but different from peak to peak.
Compared with the minimal model where fixed baselines are considered, a model with
a different basal level for different peaks gives a more realistic view of the slow variation
in the basal level, which might be caused by the circadian rhythm. The basal level is
chosen between the first data point when the transient response to the food intake starts,
and the last data point when the glucose concentration reaches its steady state. The
glucose concentration over the baseline Gb represents the system’s transient response to
food intake.
The generic model framework (2.2) constituting a system equation and a measurement
equation has been introduced in Section 2.1.1. To achieve a parsimonious description
of the postprandial excursions for all the peaks, a minimal order of the system and a
minimal number of parameters are required. Wu [108] has developed a model based on
a second order linear ODE that is capable of describing the postprandial blood glucose
excursions for one T2D subject. Inspired by this publication, an order of two is selected
as the system order. Therefore, the model proposed in Section 2.2 with an order or two
was selected to describe the transient glucose response to food intake for people with
and without DM namely:
x¨t + f1 (xt) x˙t + f0 (xt) = ut + ηt (3.1a)
yt = xt + εt (3.1b)
where (3.1a) is the system equation. The state vector of the system is (xt, x˙t)
ᵀ, ηt
corresponds to the dynamic noise, ut is the input function. Equation (3.1b) is the
measurement equation, yt is the measurement value at time t and εt corresponds to the
measurement noise. Two stochastic terms, the system noise ηt and the measurement
noise εt, were modelled as additive white Gaussian noise (refer to Section 2.1.2 for
definition) [148] with zero means and intensities of Iη and Iε respectively.
With no accurate information about how long each food intake lasts and how fast the
food absorbed through the digestion tract can be reflected in the rise of the blood glucose
level, the external excitation input ut to the system is simplified as a bolus injection of
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glucose at time zero. This means that the input function ut equals zero when t > 0, and
equals F when t = 0. Mathematically, such an input can be formulated as follows:
ut = Fδ(t) =

F if t = 0
0 if t 6= 0
(3.2)
where δ(t) is the Dirac delta function that is zero everywhere except at zero, with an
integral of one over the entire time line [149]. F is regarded as an unknown food impact
factor.
Functions f1 (xt) and f0 (xt) play an important role in the suggested model. Shown by
Khovanova et al. [144], nonlinearity needs to be introduced into the model to have the
capacity to describe the dynamic behaviours in all of the time series. As introduced in
Section 2.1.1, to describe a variety of dynamic responses to the external excitation force
(representing the food intake), the functions f1(xt) and f0(xt) in the system equation
need to be structurally flexible. Polynomial forms allow the description of a wide range
of nonlinear solutions, and can be adjusted to fit different dynamic features by increasing
the number of components and by varying their parameters. Therefore, f1(xt) and f0(xt)
are defined as follows:
f1 (xt) =
n∑
i=0
θkix
i
t, f0 (xt) =
m∑
j=1
θjx
j
t (3.3)
where θki and θj in (3.3) are system parameters.
A linear deterministic equation is a particular case of this model when n = 0, m =
1, f1 (xt) = θk0 (later referred to as θk in linear case for short), f0 (xt) = θ1xt and
the stochastic terms are zero: ηt = 0, εt = 0. The linear noise-free system has been
considered in [108] and was based on one T2D patient profile. The nonlinearity is
introduced into the system by including the higher order polynomial functions in (3.3).
3.3.2 Model selection and parameter inference
Model (3.1a – 3.1b) covers a variety of dynamic patterns depending on the order of the
polynomial functions f1 (xt) and f0 (xt) (later referred to as f1 and f0 for short). The
aim was to select the best – parsimonious but not over-simplified – model structure for
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each postprandial peak with the minimal number of parameters. To introduce sufficient
nonlinearity into the system without overcomplicating the model, combinations of f1
and f0 with different numbers of polynomial terms have been tried to fit the time series.
For example, three polynomial terms were used in both functions f1 and f0 for the first
model candidate M1 as listed in Table 3.2. The second model candidate M2 has three
terms in f1 and one linear term in f0. The third model candidate M3 has three terms
in f0 and one term in f1. All three models have been compared with each other and
with the linear model ML. The combinations described by models M1, M2, M3 and
ML are not exhaustive. Many combinations were disregarded before applying the model
selection and Bayesian inference method. For example, omitting the quadratic term of
f0 in model M3 would make the system highly symmetrical which would significantly
restrict the possible forms of the solutions. Similarly, omitting the cubic components
in f0 would lead to unstable solutions of the system, which can be proven analytically
[150]. Also, using four or more terms would over-complicate the structure of the system,
which is against the aim of searching for a parsimonious model.
Table 3.2: Four model candidates for fitting
Models f1 f0
M1 θk0 + θk1xt + θk2x
2
t θ1xt + θ2x
2
t + θ3x
3
t
M2 θk0 + θk1xt + θk2x
2
t θ1xt
M3 θk θ1xt + θ2x
2
t + θ3x
3
t
ML θk θ1xt
To decide which of the four models best describes the postprandial transient blood
glucose response and, at the same time, identify corresponding values of the deterministic
(θki , θj) and stochastic (Iη, Iε) parameters, an inference method that can incorporate
nonlinearity and stochasticity into the model framework was required. Both sampling
methods such as the Monte Carlo methods (refer to Section 2.2.2 for detail) or the VB
method can serve this purpose well. The benefit of using the VB method compared to the
Monte Carlo methods has been elaborated in Chapter 1 and Section 2.2.2, and therefore
the VB method was employed. The algorithm accounts for the stochastic nature of
the underlying glucose dynamics and also enables us to distinguish between these two
types of stochasticity: dynamic and measurement noise. The algorithm is flexible and
estimates the model parameters in the form of probability distributions rather than fixed
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values. The final result thereby includes information on uncertainties in the parameter
estimates. Specifically, the VB toolbox [77] was applied. The equations (3.1a) – (3.1b)
were incorporated into the framework of the VB algorithm. Free energy values F for
each model candidate M (where M is M1, M2, M3 or ML) were found, and the model
with the highest value of free energy (details in Section. 2.3.1), if it also satisfied other
criteria explained in Section 3.3.3, was selected.
As elaborated in Section 2.5 and Section 2.8.2, the choice of priors and hyperpriors is
important for the VB method since it influences the posterior parameter distributions.
Since there was no information about the parameter values in the model, weakly in-
formative priors were selected for all deterministic parameters. Since the deterministic
parameters were modelled as Gaussian distributions, a relatively large variance is im-
portant for the VB algorithms to search over a wide enough parameter space to look
for the optimal values of the parameters. The mean values of the priors for the sys-
tem parameters θk and θ1 were set to zero in accordance with Wu’s paper [108]. For
consistency, mean values of priors for extra deterministic parameters (θk1 , θk2 , θ2, θ3)
were also set to zero for models M1 – M3. All of the variances for the deterministic
parameters were set to be 104 as a default value. To make sure that this variance was
set sufficiently large, larger variances were used to see if the posterior distribution of the
parameters would change. The differences are negligible, and therefore variances were
selected as 104.
The prior of the food impact factor F was set to be normally distributed with a mean
value of yt2−yt1 , where yt1 and yt2 are the first and second time points of each peak, with
a variance of 104. The noise precisions αε and αη, which are inversely proportional to
the noise intensities Iε and Iη, were modelled by Gamma distributions with both shape
a and rate b parameters set to 0.001 as the default hyperpriors, which was justified in
Section 2.5. As illustrated in the examples shown in Section 2.8.2, the inference result
can be sensitive to the choice of the prior and hyperpriors, and therefore different prior
and hyperprior combinations for the different models were trialled to optimise the free
energy for each model candidate. The models that are finally selected are proven locally
identifiable (see details in Sections 3.4.2).
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3.3.3 Model selection criteria
Four models (ML, M1, M2 and M3) were compared to achieve the most satisfactory
fitting. To select the best model, the following two criteria were considered:
1. Decay ratio. Since the glucose dynamics are tightly regulated by the endocrine system,
it is a stable process with limited decaying oscillations except for patients in a critical
condition or T1D patients who have to maintain the blood glucose concentrations with
insulin injections. Thus, any blood glucose excursion after food intake should relax to
a steady state demonstrating the dynamics of an over-damped system. In the available
time series the transient response corresponding to one food intake is often superimposed
by the response of another food intake within a short interval, and such overlapping
responses cause problems of observing and identifying some important dynamic features,
such as the oscillation rate. We believe, however, that any model with a decay ratio
(ratio of the height of the second peak to the height of the first peak) higher than 33 %
is unrealistic, and should be disregarded.
2. The difference in the free energy F between any two models: |∆F|. According to
[80], if |∆F| > 3 (3 is a conventional choice based on [81] and [80], refer to Section 2.4
for further detail) in Chapter 2), there is strong evidence that the model with the higher
value of the free energy is better. This rule is derived from a well known Bayes’ factor
which is a measure for comparing the evidences of two Bayesian models [80].
3.4 Results and Discussions
3.4.1 Model selection and parameter inference
All the distinguishable peaks with height more than 1.1 mmol/L starting between 6am
to midnight were selected, and all selected 132 time series comprising blood glucose
dynamics after food intake were fitted using the models M1, M2, M3 and ML. Note
that it is an event-based model so that each time series represents one food intake event.
Fig. 3.3 shows (typical) fitting for one postprandial peak. The procedure of model
selection is illustrated by considering this typical example. The most complex nonlinear
model M1 produced an unstable result with unrealistic periodic oscillations over time,
leading to a decay ratio close to one that does not satisfy the second criterion in Section
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3.3.3. Therefore, M1 was disregarded. M3 results in an unstable solution, leaving ML
and M2 for further consideration.
Figure 3.3: Typical outcome for one peak (the sixth peak in Fig. 3.2 (b)) fitting by
four models.
The selection between the models ML and M2 can be influenced by the choice of the
hyperpriors (a1 and b1) for the system noise. It is worth noting that the fitting results of
M1 and M3 can also be influenced by the choice of the hyperpriors. But in general, M1
and M3 tend to have less stable solutions compared with ML and M2, as high degree
polynomials may suffer from instability. The goal of this research is to find a generalised
model that can describe the glucose dynamics of food intake so that comparisons can
be made between different meals within the same subject, between different subjects
within the same group, and between different groups. Therefore, M1 and M3 will be
not be further discussed. As seen in the example presented in Section 2.8.2, different
settings of a1 and b1 cause large differences in the free energy value. Selecting the best
model based on the default prior of a1 = b1 = 10
−3 (which is asymptotically the Jeffreys
prior as shown in Section 2.5) may lead to a wrong choice of model. Table 3.3 and 3.4
present the values of the free energy using different hyperprior combinations for ML and
M2 respectively to fit the time series shown in Fig. 3.3.
Considering ML and M2 were competing models fitted to the same data, same hyperpri-
ors should be applied to them, i.e. using the values from the same location in Table 3.3
and 3.4. When hyperpriors a1 and b1 were both 10
−3, the free energy FML was higher
(the values instead of the absolute values are compared) than FM2 indicating that ML
is the better model; instead, when a1 was 10
−1 and b1 was 10−3, FM2 was larger than
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Table 3.3: Free energy of ML, denoted as FML , for different hyperprior settings of
the precision of system noise
FML b1 = 10−3 b1 = 10−2 b1 = 10−1 b1 = 100 b1 = 101
a1 = 10
−3 -93 -95 -767 -82 -248
a1 = 10
−2 -95 -71 -273 -72 -875
a1 = 10
−1 -64 -152 -806 -83 -318
a1 = 10
0 -106 -66 -991 -74 -239
a1 = 10
1 -68 -85 -76 -69 -214
Table 3.4: Free energy of M2, denoted as FM2 , for different hyperprior settings of the
precision of system noise
FM2 b1 = 10−3 b1 = 10−2 b1 = 10−1 b1 = 100 b1 = 101
a1 = 10
−3 -111 -78 -190 -57 -158
a1 = 10
−2 -39 -111 -86 -190 -118
a1 = 10
−1 15 -39 -111 -93 -196
a1 = 10
0 16 15 -45 -112 -116
a1 = 10
1 -40 -27 17 -88 -52
FML , indicating that M2 is the better model. Thus, the selection of the model is not
independent on the selection of hyperpriors. It is advisable to optimise the hyperpriors
to obtain the largest possible free energy value for each model (ML and M2) first before
choosing a model. As shown in Table 3.3 and 3.4, the largest three free energy values
obtained using different combinations of a1 and b1 for each model have been marked
bold in the table. Among them, only two of them shared the same location in both
tables, indicated by circles around the free energy values. Between them, a1 = 10
−1,
b1 = 10
−3 has higher free energy values in ML, and therefore were finally selected as the
optimised hyperpriors for both models.
The inference results with these selected hyperpriors for both models ML and M2 are
presented in Table 3.5. It is worth noticing that the mean values of the inferred system
noise intensity and measurement noise intensity are smaller in M2 compared with the
values in ML, and the standard deviations for both noise intensity are also smaller in M2.
Smaller noise intensity implies that the M2 fits the data better, which can be confirmed
by a larger free energy value of FM2 = 15 for M2 compared with the free energy value
FML = −64 for ML.
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Table 3.5: Inference results of the parameters for the example shown in Fig. 3.3
Mean ± SD Unit
ML θk (3.20 ± 0.06) ×10−3 [min−1]
θ1 (3.82 ± 0.11) ×10−5 [min−2]
x0 (-1.49 ± 0.03) [mmol/L]
x˙0 (8.40 ± 0.42) ×10−2 [min−1 mmol/L]
Iη (4.03 ± 0.30) ×10−5 [min−2 mmol2/L2]
Iε (0.26 ± 0.019) [mmol2/L2]
M2 θk0 (1.80 ± 0.75) ×10−2 [min−1]
θk1 (2.09 ± 0.34) ×10−2 [min−1 L/mmol]
θk2 (2.60 ± 0.33) ×10−3 [min−1 L2/mmol2]
θ1 (6.40 ± 1.12) ×10−5 [min−2]
x0 (-0.44 ± 0.14) [mmol/L]
x˙0 (6.1 ± 1.25) ×10−2 [min−1 mmol/L]
Iη (2.50 ± 0.19) ×10−5 [min−2 mmol2/L2]
Iε (6.3 ± 0.48) ×10−2 [mmol2/L2]
The same hyperpriors a1 = 10
−1, b1 = 10−3 for system noise were applied to fit all
the peaks in the cohort using ML and M2. Some more examples illustrating how the
choice between models ML and M2 was made are presented in Fig. 3.4. For the time
series presented in Fig. 3.4 (a), the free energy difference between ML and M2 is 277.9
(FM2 − FML = 111.3 − (−166.6) = 277.9) indicating a strong nonlinear character in
this peak. It is worth noting that the calculation of free energy does not take into
account the simulated data points beyond the data period, and the extended simulation
is to show the trend of the solution. The nonlinear model M2 is able to capture the
dynamics of this response better than the linear model ML, even though M2 still misses
the sub-peak which has been described in Section 3.2. Such double (and multiple) peaks
were commonly present in all the profiles. They can be explained by a biphasic gastric
emptying rate [151] which has a big influence over the absorption rate of glucose [152].
Additionally, the release of insulin from the pancreas is not continuous [153] and consists
of two stages, fast and slow, which may also cause the second rise in the postprandial
excursion. For the DM subjects the peaks are generally higher and occur over a longer
time period compared with those from the control group, and as such the effect of the
sub-peak dynamics is more distinctive and increases the need for a nonlinear model to
capture such features. For the time series presented in Fig. 3.4 (b), ML does not satisfy
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Figure 3.4: The fitting results are shown for: (a) a peak of a T2D profile; (b) a peak
of a T1D profile. The lines are simulated deterministic solutions using the inferred
parameters for ML and M2.
the first criterion: the decay ratio is 35%. This means that the oscillations are considered
to be unrealistic, and therefore M2 was chosen as the fitting model.
Among 132 peaks across all fifteen subjects, the linear model ML was selected for 56%
of the peaks (Table 3.6) and the nonlinear model M2 was selected for the rest of the
peaks (44%). For the control group, ML worked for 70% of the peaks; for the T1D and
T2D group, only 54% and 45% of the peaks could be described adequately by ML. More
nonlinear peaks in DM groups than in controls emphasises the nonlinear character of
response in people with DM. According to [154], the hyper- and hypo-glycaemic regions
show greater deviation from linear behaviour, explaining the improved nonlinear fitting
for the T2D group. ML and M2 are essentially the same model since ML is a particular
case of M2. They represent different levels of complexity. The reason that they have to
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be treated as two models in practice is because the VB method treat parameter values
as distributions, which means that even if the mean values of the two extra parameters
in M2 are inferred as zero, the VB methods calculates the free energy taking account
of the uncertainty of these two parameters, leading to a smaller value of free energy for
M2.
Table 3.6: Summary of peak fitting using ML and M2
Summary Total peaks Control T1D T2D
Total peaks 132 46 37 49
No.(%) fitted by ML 74 32 (70%) 20 (54%) 22 (45%)
No.(%) fitted by M2 58 14 (30%) 17 (46%) 27 (55%)
As mentioned in the last paragraph of Section 3.2, some subjects exhibit similar patterns
in the glucose excursion after certain meals (breakfast/lunch/dinner) everyday. The
pattern in breakfast is easier to identify due to the fact that breakfast is taken after an
overnight fasting period and many people eat similar food for breakfast everyday. To
investigate whether the breakfasts for the same patient can be described by the model
with the same level of complexity, three peaks, which correspond to the glucose response
of a T2D subject after breakfast for three consecutive days (see Fig. 3.5), have been fitted
by ML and M2 as demonstrated in Fig. 3.6 (a) – (c). Even though there are no striking
differences visually between the deterministic solutions of ML and M2 shown in Fig. 3.6
(b) – (c), the large differences in free energy values are caused by different uncertainties
of the inferred parameters, the states and the hyperparameters. Please refer to Section
2.3.4 for more detail.
For each of the three peaks, visually there is minimal difference between the deterministic
solutions from the inference results of the two models, but the free energies FM2 for M2
in all these cases are larger than the free energies FML for ML (as shown in Fig. 3.6 (a)
– (c)). In all cases, the decay ratio was below 33% for both models, thus satisfying the
first criterion in Section 3.3.3. Therefore, M2 was chosen for all three peaks based on
the second criterion in Section 3.3.3.
Out of the eleven subjects who ate breakfast regularly, either ML or M2 could be fitted
to all breakfast peaks for seven of the subjects; for the remaining four subjects, some
breakfast peaks selected ML and the rest of the breakfast peaks selected M2. For
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Figure 3.5: Glucose time series G of a T2D subject. The solid grey curves represent
the measured glucose values and the dots are the values used for modelling of single
postprandial peaks. The glucose time series corresponding to responses to food intake
during breakfasts are indicated by dark black crosses. The solid and dashed vertical
lines correspond to midnight (12 am) and 6 am respectively.
example, for the T2D subject shown in Fig. 3.2 (c), ML was chosen for all the breakfast
and dinner peaks (5 peaks), and M2 was chosen for all the lunch and snack peaks (4
peaks). The selection of model between ML and M2 was performed strictly based on
the criteria provided in Section 3.3.3. It is not surprising that different peaks belonging
to one person can be fit by two models (ML and M2). ML is a particular case of M2
when θk1 and θk2 equal to zero. Computationally, when the parameters θk1 and θk2
are close to zero, the free energy of M2 will be smaller than the free energy of ML due
to the penalisation for a larger degree of freedom in the parameter space. A different
preference of the models for different meals implies different mechanisms that control the
postprandial glucose excursions at different times of the day. The different mechanisms
may be caused by diurnal hormone fluctuation and/or different compositions of meals
at different times.
3.4.2 Structural identifiability and parameter sensitivity
A structural identifiability analysis has been performed for both models ML and M2. As
shown in the example with the system (2.68), it has already been proven that the linear
model ML is structurally identifiable. The nonlinear system M2, which is the example
shown in Section 2.6, has also been proven identifiable.
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Figure 3.6: The fitting results are shown for three peaks (represent breakfasts) of a
T2D profile (as in Fig. 3.5) in three consecutive days from (a) – (c). The free energy
value of ML is denoted as FML , and the free energy value of M2 is denoted as FM2 .
To check parameter sensitivity, the procedures explained in Section 2.7. The one-at-
a-time parameter sensitivity analysis has been performed for both models ML and M2
(see details in Section 2.7). To check how sensitive the output is to a small change in
each deterministic parameter, the following steps have been performed for each model:
1) Simulate the time series with no measurement or system noise and obtain the root
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mean square error (RMSE) between the noise free time series and the measurement
time series.
2) Take 1000 random samples (1000 samples are considered large enough to make sta-
tistical analysis) of θ
(j)
i (j = 1, 2, . . . , 1000) from a uniform distribution from 0.99θˆi
to 1.01θˆi, where θˆi is the posterior mean of θi.
3) Calculate the RMSE(j) values between the measurement values and each of the 1000
generated time series, using the sampled parameter θ
(j)
i and the posterior means
of the rest of the parameters.
4) Using (2.83), obtain the sensitivity index SI for parameter θi.
The same procedure can be performed for the inferred parameters of all of the time series.
Considering that the parameter values for the different time series fitted by ML or M2
are in the same neighbourhood, the sensitivity index SI for one typical time series as
shown in crosses in Fig. 3.3 is presented as an example here. For the linear model ML and
the nonlinear model M2, as shown in Table 3.7 and Table 3.8, one percentage change
in the parameter can cause the corresponding SI percentage change in RMSE. The
RMSE values between the measurements and the output, generated when the posterior
means of the parameters were used, is 0.98 mmol/L for ML and 0.42 mmol/L. With 1%
perturbation in each parameter shown in the first column of Table 3.7 and Table 3.8,
the range of RMSE(j) is shown in the third column. The RMSE values remains within a
small range; therefore, the models ML and M2 are robust around the inferred posterior
means of the parameters.
Table 3.7: Summary of the parameter sensitivities for ML and the range of RMSE
with 1% parameter perturbation
Parameter SI RMSE(j) range
θk 2.15 0.96 – 1.00 mmol/L
θ1 1.29 0.97 – 0.99 mmol/L
3.4.3 Parameter comparison between the groups
The deterministic part of ML is represented by two parameters θk and θ1, and of M2
by four parameters θk0 , θk1 , θk2 and θ1. The stochastic part is represented by Iη and Iε
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Table 3.8: Summary of the parameter sensitivities for M2 and the range of RMSE
with 1% parameter perturbation
Parameter SI RMSE(j) range
θk0 -3.77 0.40 – 0.43 mmol/L
θk1 5.61 0.41 – 0.49 mmol/L
θk2 -2.58 0.41 – 0.45 mmol/L
θ1 -0.18 0.416 – 0.423 mmol/L
in both models. Statistical analysis of the models’ parameters was performed by using
the Wilcoxon rank sum test. The null hypothesis of no difference between the groups of
interest was tested at the 5% level of significance, and this is presented by p-values.
3.4.3.1 Coefficients of function f0 and undamped frequency
The functions f0 have the same structure for both the linear ML and nonlinear M2
models (Table 3.2), and contain the coefficient θ1. The square root of this parameter
(
√
θ1) defines an undamped natural frequency in the system, at which a system would
oscillate in the absence of any driving or damping force. The values of
√
θ1 were com-
pared among the three groups (control, T1D and T2D) for models ML and M2 (Fig.
3.7 (a)). If there is a significant difference in the medians between any two groups, the
p-values are marked by a star. For the peaks that were fitted by ML, the median value
of
√
θ1 in the control group is significantly higher than the median values in both DM
groups, whereas there is no statistically significant difference between the T1D and T2D
groups. For the peaks fitted by M2, the same result is observed (Fig. 3.7 (b)):
√
θ1
differs significantly between the control group and both DM groups. Thus, by analysing
the undamped frequency of the models developed it is possible to distinguish between
the cases with and without DM.
3.4.3.2 Coefficients of function f1 and damping
The functions f1 characterise damping in the systems and are represented by polynomials
of different orders for ML and M2. The nonlinear model M2 contains a quadratic
nonlinear ‘damping’ function and is characterised by three parameters, whereas the linear
model ML contains one damping coefficient parameters. These inferred coefficients have
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Figure 3.7: Boxplots for parameter
√
θ1/2pi obtained from (a) ML and (b) M2. Note
that the denominator 2pi is to convert the units from [radian/min] to [min−1]
Figure 3.8: Boxplots for the damping coefficients ζ = θk
2×√θ1 obtained from ML.
also been compared across the control and both DM groups. For the linear model ML,
the damping coefficient ζ = θk/2
√
θ1 and a boxplot for the three groups is shown in Fig.
3.8. No significant differences are shown between the three groups.
A comparison of the coefficients of the function f1 between the three groups for both
models ML and M2 is presented in Fig. 3.9. For ML, the median value of θk of the control
group is significantly larger than in the T2D group. For M2, it is noticeable from Fig.
3.9 (b) – (d) that the values of θk0 , θk1 and θk2 for the control group have a wider spread
compared with the other two groups. The median value of θk0 for the control group is
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Figure 3.9: Boxplots for parameters: (a) θk in ML; (b) θk0 in M2; (c) θk1 in M2; (d)
θk2 in M2.
significantly larger than the median value for the T2D group. The median value of θk1
for the control group is significantly smaller compared with the median value of the T2D
group. However, there is no conclusive difference between the parameters θk2 , θk1 and
θk0 of M2 between the control group and both DM groups as the p-values are close to
the threshold value of 0.05.
It is important to note that the parameter θk0 of the function f1 defines the stability of
both models, ML and M2. In system theory, a system is in a steady state if the state
variables which define the behaviour of the system are unchanging in time. It is assumed
that the system would eventually reach a steady state with a constant value. Therefore,
the real parts of the eigenvalues λ1,2 of the linear system ML or the linearised system
M2 around the steady state [
F
θ1
, 0]ᵀ must be negative:
λ1,2 =

− θk02 ± 12
√
θ2k0 − 4θk1 if θ2k0 ≥ 4θk1
− θk02 ± i2
√
−θ2k0 + 4θk1 if θ2k0 < 4θk1
(3.4)
All the inferred parameters θk0 were positive as shown in Fig. 3.9 (b), making the real
part of the eigenvalues negative and confirming the stability of the developed models.
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Figure 3.10: Boxplots for intensities of system noise Iε in (a) ML and (c) M2, and of
measurement Iη noise in (b) ML and (d) M2
Note that when θ2k0 < 4θk1 , the eigenvalues are complex numbers, and the fixed point is
a spiral in the phase portrait.
3.4.3.3 Noise
The parameters of the stochastic terms, i.e the intensities of the system noise Iη and
measurement noise Iε in ML and M2, are shown in Fig. 3.10. The intensities of the
system noise are of the same order across all three groups for both models without
any statistically significant difference: p > 0.05. The source of the system noise is the
aggregated force accounting for other external factors such as physical activity, stress
etc. which are not part of the model (only the impact of food intake on blood glucose
dynamics is considered). The inclusion of system noise into the analysis provides more
flexibility in the model’s structure, but also accounts for its imperfections.
The measurement noise mainly comes from the inaccuracy of the readings from the
CGM devices. There are significant differences in Iε values between the control group
and both DM groups for ML. (Fig. 3.10 (b)). The higher intensities of measurement
noise are observed in T1D and T2D groups than in controls (p = 0.002 and p = 0.01
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correspondingly). This is well justified as the peak blood glucose levels are generally
higher in the DM groups than in the control group, and the CGM devices are less
accurate at the larger values. For M2, there is significant difference in measurement
noise intensities between T1D and the other two groups.
3.4.4 Impulsive force
As discussed before, food intake is simplified as a bolus injection of glucose at t = 0.
The value of F is an aggregated food impact, which is influenced by the quantity and
the constituents of the food intake. The interpretation of F is difficult. The absorption
of glucose is a slower process than an impulse function, and according to Dalla Man’s
maximal model [135], two compartments in the stomach and one in the intestine are
involved in the absorption of glucose. It is difficult to directly link the value of F
with either of the three compartments in the maximal model. Complex carbohydrates
including polysaccharides (found in wheat, rice, potatoes, maize) require digestion into
glucose prior to absorption into the blood stream, a process that takes significant time.
Food that contains more liquid or solid would have a different glucose absorption rate.
Glucose in liquid form is absorbed faster compared to the solid food, which may be
reflected by a higher value of F as an initial impulsive impact. The slower and two
different absorption rates for solid food, which could potentially be caused by a biphasic
gastric emptying rate, may cause a double peak as described in Fig. 3.4(a) and a lower
value of F . The delayed response in glucose uptake cannot be shown directly from the
value of F since the exact meal time is unknown, but a combined consideration of the
shape of the peak, the parameter values of the model together with the food impact can
provide useful information about the relationship between the consumed food and the
corresponding glucose response.
The comparison of the initial force parameter F among the groups is shown in Fig.
3.11. The median value of the food impact F is significantly larger in the T1D group
compared to the control group. The larger and wider range of F show inadequate glucose
regulation in the T1D group which may be caused by an inaccurate amount and time
of the insulin injection by the patient or by the insulin pump. The median value of the
food impact F for the T2D group is not significantly different from the control group,
showing a better glucose regulation compared with the T1D group, which may suggest
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Figure 3.11: Boxplots for the initial force parameters F compared between the three
groups.
that the medication taken by the T2D subjects was effective (refer to Table. 3.1 for
details of medication used). According to [108], the time of taking hypoglycaemic drugs
by a patient before the meal and the duration time of being on medication could also
have an influence on F .
To investigate the effect brought by the hypoglycaemic drugs, a comparison has been
made between five T2D subjects that take hypoglycaemic drugs regularly and a newly
diagnosed T2D subject (No. 15) with no medication. The values of F obtained from all
of the peaks of a single patient are grouped and represented by a box in a boxplot. All
six subjects in the T2D group are shown in Fig. 3.12 (b). The values of F for subject
No. 15 were compared with each other subject pairwise using the Wilcoxon rank sum
test. The median value of F for the newly diagnosed patient who had not taken any
medications (Fmedian = 0.30) was significantly higher (p = 0.002) than the median value
of F across all the other five T2D patients (Fall median = 0.12) as shown in Fig. 3.12 (a).
The lower F values in subjects who took regular medication imply that the suppression
of the impulsive food impact could be a long-term effect of the hypoglycaemic drugs.
Thus, the F value has the potential to be used as an indicator of how well the patient
is managing the disease.
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Figure 3.12: Boxplots for the food impact force F compared (a) between patient No.
15 and the rest of the T2D group; (b) among the subjects in the T2D groups.
3.4.5 Link between the data-driven model and physiological models.
The signs of pre-DM
As introduced in Section 3.1, physiologically based models are widely accepted in glucose
dynamics modelling. Among them, the compartmental maximal model (MM) suggested
by Dalla Man et al. [135] was designed to simulate the postprandial transient responses
to food intake for subjects with and without DM. Twelve differential equations and
thirty five parameters are included in the model MM . Different time series representing
different subjects can be simulated by changing the values of the 35 model parameters.
Three postprandial glucose responses characterising three non-DM subjects were simu-
lated using the Simulating the Glucose-Insulin Response script provided in SimBiology
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toolbox [155]. The standard parameter values suggested [135] were used: (i) without
any signs of DM, (ii) with low insulin sensitivity, and (iii) with impaired β cell function.
Cases (ii) and (iii) describe potential T2D patients with partially impaired pancreatic
function, and are considered as pre-DM cases. The impaired function is compensated by
either secreting more insulin or increasing tissue sensitivity, and thus keeping the blood
glucose levels still within the healthy range. Note that ML and M2 belong to a different
class of model compared to MM . As a physiologically based model, the glucose varia-
tion is only one of the variables that is generated by the MM using a set of population
based parameter values that describe a typical pre-diabetes subject.
Treating these three simulated peaks the same way as the measurement time series
in our cohort, the VB method was used to select between ML and M2 and infer the
corresponding parameters. The purpose of inferring simulated time series is threefold.
1) If either ML or M2 can be fitted well to the simulated time series, the ML and M2 are
proved to be consistent with the well-recognised compartmental MM . 2) The differences
in the inferred parameter values between three simulated subjects can reveal how the
parameter values change when a healthy person starts to develop T2D in theory. 3)
A simulated time series is free from the limitations brought about by using the CGM
devices, including a 3–12 minute delay from measurements and actual blood glucose
level, measurement noise, and a fixed sampling frequency of one data point every five
minutes.
Figure 3.13: The dotted line is the simulated time series from the maximal model for
a non-DM case without any signs of DM and the solid line is the deterministic solution
using the parameter values inferred from model ML.
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All three simulated time series can be fitted by the linear model ML, and an example
result of fitting for case (i) is shown in Fig. 3.13. Values of the inferred parameter
θMMk are as follows respectively: (i) 0.027, (ii) 0.023, (iii) 0.021 [min
−1], and the values
of θMM1 are (i) 0.4, (ii) 0.25, (iii) 0.16 [min
−2]. They have been compared with θk
and θ1 obtained for all measured peaks fitted by ML for our cohort of subjects. The
values of θk for all the peaks in the control group that modelled by ML are presented
as the left box in the boxplot shown in Fig. 3.14 (a), and the values of θk for all the
peaks in the T2D group modelled by ML is presented on the right box in Fig. 3.14
(b). The value of θMMk for the simulated non-DM subject locates in the interquartile
range of the box for the control group and in the top quartile of the box for the T2D
group. The values of θMMk for both pre-DM cases locate in the lower part of the box
for the control group, but within the top part of the interquartile of the box for T2D. A
qualitatively similar result is observed for parameter θMM1 (Fig. 3.14 (b)): the simulated
value for case (i) is within the interquartile of the control group distribution and beyond
the interquartile of T2D. Similarly, θMM1 for both pre-DM simulated subject locate
within the bottom quartile of the control group and within the interquartile of the T2D
range. This clearly shows that these two simulated pre-DM cases fall into the area
between the non-DM and T2D distributions. It is worth noting that this observation
is based on three simulated glucose variation time series, and it is too early to draw
any significant conclusions without further validation from glucose dynamic data of pre-
diabetes patients. This was an outcome that arose though the modelling performed.
However, a close observation of the trend of the parameters θk and θ1 might provide
crucial information for early diagnosis of DM, particularly if such trends identify early
abnormalities in glucose dynamics before the rise in the blood glucose concentration is
considered significant.
This result provides same evidence of the robustness of the model (3.1a–3.1b) and its
validation by comparison with an established phenomenological model [135]. The deter-
ministic solution of our model (3.1a) in Fig. 3.13 indicated by the solid line contains only
two parameters and matches the dynamics of the time series simulated using the MM
[135] with thirty-five parameters indicated by the dotted line in Fig. 3.13. Being data-
driven, our model takes full advantage of the CGM data, and, at the same time, reflects
the intrinsic characteristics of the glucose-insulin system without detailed knowledge of
the underlying physiological mechanisms.
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Figure 3.14: Boxplots for (a) θk0 and (b) θ1 for all measured peaks fitted by ML in
our cohort of participants. Horizontal lines mark θMMk0 and θ
MM
1 for no signs of DM
(upper dashed green line), low insulin sensitivity (middle solid line) and impaired β-cell
function (lower dashed pink line) cases.
3.5 Conclusions and limitations of the study
The VB method introduced in Chapter 2 was successfully applied to develop dynamical
models for transient glucose responses towards food intake and to infer model parameters
for a cohort of fifteen subjects with or without DM. The results demonstrated a univer-
sal nonlinear stochastic model that is capable of capturing the dynamics of postprandial
blood glucose excursions in a total of 132 peaks. The inferred deterministic parameters
belong to different ranges for people with and without DM, demonstrating the potential
for useful clinical applications including early diagnosis of DM. The parameter values
were compared with three simulated subjects, two with pre-DM and one without DM,
using the well-recognised MM , which allows useful physiological parameter interpreta-
tions. The significant difference in the food impact parameter values between a newly
diagnosed T2D subject (without medication) and the rest of the subjects in the T2D
group (with medication) implies that the food impact parameter may serve as an indi-
cator of the impact of various drugs on the stability of blood glucose responses as well
as control of DM.
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This study is limited by a relatively small number of subjects, but the statistics presented
are based on 132 peaks, and therefore is deemed sufficient to make conclusions. The
results confirmed previous findings [108] suggesting an ability to distinguish DM and
non-DM cases on the basis of model parameters, with promising interpretations for
clinical use. The relationships that have been uncovered between model parameters and
clinical group require further investigation to confirm these associations and elucidate
the underlying mechanisms.
It is hoped that the developed modelling framework would be useful for other researchers
to (i) successfully identify the parameters of their predictive models for blood glucose
control, (ii) account for nonlinearity and stochasticity of the underlying process, (iii)
consider the uncertainty in parameter estimations by using probabilistic parameter dis-
tributions rather than fixed values, and (iv) tackle the personalised needs of patients by
considering individual, not averaged, time series.
In future, this study will be continued by including other factors that influence blood
glucose variations, such as exercise, stress, etc. More subjects will be involved in the
research within a controlled environment where the time and the macro nutrients of the
food intake will be recorded in detail, which would potentially improve the model by de-
creasing the uncertainties in the delay between the food intake and the glucose response.
A different input, such as a train of delta-functions, will be considered to incorporate the
various gastric emptying rate into consideration. With all factors included in the model,
a more precise description of the data is expected and a predictive model accounting for
multiple external inputs could be developed.
Chapter 4
Post-transplant antibody
dynamics
Antibody dynamics after kidney transplantation are of great clinical interest as they are
considered to be associated with short and long term clinical outcomes [156]. However,
the limited data on post-transplant antibody dynamics and their diverse behaviours
have made the task of modelling difficult. There is no model available in the literature
to analyse personalised dynamic patterns based on real patient data. In this chapter,
a data-driven model has been developed for the first time to describe the evolution of
antibodies in the critical first several months after transplantation. The VB method
introduced in Chapter 2 has been applied to select the best model among the models
with different orders and infer their parameters on a subject by subject basis. This work
has been published by Zhang et al. in [157] and [158]. The structure of the chapter is
as follows: Section 4.1 gives a background introduction to kidney transplantation and
post-transplant antibody dynamics. Section 4.2 describes the data and presents visual
analysis of the variety of dynamic responses of antibodies to transplantation. Section
4.3 explains the method used for model selection and parameter estimation. Section
4.4 presents the chosen model and detailed analysis of the model parameters. Section
4.5 summarises the results, outlines the relevance of the model for kidney transplant
management, and justifies the need for further work.
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4.1 Introduction
Kidney transplantation has been proven to be the best treatment for renal failure. Suc-
cess of the transplantation is dependent on the reaction of the immune system primarily
against human leukocyte antigen (HLA) of the transplant [159]. HLAs are proteins that
help the immune system to distinguish between the body’s own antigens and non-self
antigens, and can be found on most cells in the body [160]. HLAs are encoded by a
group of HLA genes allocated on chromosome six. A position on the chromosome is
called a genetic locus. For humans, two alleles (an allele is a variant form of a gene) are
located at each genetic locus, with one allele inherited from each parent. Based on the
genetic loci, HLA genes are categorised into three groups: class I (HLA-A, -B, -C loci),
class II (HLA-DP, -DM, -DQ, -DR loci), and class III (not the main concern for this
study). The HLAs have more than 10,000 HLA Class I and over 3,600 HLA Class II
alleles identified [161], therefore it is unusual to find two unrelated individuals with the
same HLAs. Ideally, a recipient of the kidney transplantation must fully match the HLA
proteins with the donor so that the immune system of the recipient does not trigger a
harmful antibody response against the transplanted organ. In the early days of kidney
transplantation, strict HLA matching rules required a perfect match at the -A, -B and
-DR loci [162–164]. With the improvements in the graft rejection rate, the rules have
been relaxed over the years [165, 166]. In the UK, only a minority of the transplants in
the UK are fully matched for HLA [167] because of the shortage of fully matched organ
donors.
One of the biggest problems of HLA-mismatched transplantation is the immune response
of antibodies produced by B cells (a type of white blood cell) against the transplanted
organ. Antibodies can come in different varieties known as isotypes. Out of these iso-
types, Immunoglobulin G (IgG) is deemed to be the most detrimental to transplantation
outcome [168]. When directed at a donor’s HLA in the newly transplanted organ, IgG
is referred to as donor specific antibody (DSA). DSAs are usually caused by a patient’s
previous exposure to non-self antigens via blood transfusion, pregnancy, organ or tissue
transplant [169]. DSAs can form and persist for years after transplantation, and are fre-
quently found at the time of transplant failure (when the graft loses the filtering ability
to deal with the waste product from the blood) [170–172]. Post-transplant production
of anti-HLA DSAs is indicative of an active immune response, and therefore increases
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the risks of Antibody-Mediated Rejection (AMR) leading to a decline in renal function
[173]. AMR is clinically confirmed by a renal biopsy (indicators are peri-tubular capil-
laritis, glomerulitis, peri-tubular capillary C4d staining) [174]. AMR includes immediate
AMR (minutes after operation), acute AMR (within the first 30 days after operation,
our focus in this research), and chronic AMR (developed over years). Some acute AMR
can progress to a chronic phase resulting in eventual graft failure [175]. However, gen-
erally the long term consequences of the acute AMR, particularly episodes of lower
severity, on graft function are uncertain [176]. In recent years, a number of publications
[172, 177, 178] have confirmed that DSAs are the major cause of acute AMR and chronic
graft failure. However, the association between acute AMR or chronic graft failure and
high DSA levels can vary between patients. In the acute setting, transplantation across
very high DSA levels may result in 50% graft loss, but data based on the currently
used antibody detection assays cannot reliably predict the outcome [179]. Likewise, for
chronic AMR, the relationship between the occurrence of AMR and the detection of
circulating DSA is not clear [180, 181].
There are two type of DSAs: de novo DSAs and preformed DSAs. De novo DSAs do not
pre-exist but develop after transplantation against the foreign graft, usually years after
the transplantation [182]. They can cause a gradual damage to the organ that eventu-
ally results in organ failure [182–184]. Preformed DSAs, on the other hand, are present
before the transplantation and thorough measurements of preformed DSAs are carried
out to predict the likelihood of finding a compatible donor, and to avoid transplantation
from a donor presenting HLA antigens to which the patient is sensitised [173]. Even with
a low level of preformed DSA, graft outcome may be compromised [185]. Transplanta-
tion that is performed across an HLA barrier with preformed DSAs present is defined
as antibody incompatible transplantation (AiT) [175]. To allow AiT, there is a consensus
on removing DSAs before transplantation for patients with DSA levels above a pre-
determinined threshold, which has not been determined systematically [174]. Clinically,
it is difficult to eliminate preformed DSAs completely because the removal of anti-HLA
DSAs has generally been followed by re-synthesis of DSAs. Repeated treatments may
create a period of time during which the anti-HLA DSA levels drop to an acceptable
level, allowing for the transplantation to be undertaken. To remove preformed DSAs
immediately before transplantation, different methods, such as plasmapheresis, double
filtration, immunoabsorption, have been developed [156, 159, 174, 186, 187]. Since the
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incorporation of plasmapheresis, the acute AMR occurrence rate has dropped to about 5
– 7% of all kidney transplantation [188]. After the transplantation, because of immuno-
logical memory, an immune response can be triggered towards the graft by re-synthesis
of the anti-HLA DSAs that have been removed prior to the transplantation, resulting in
severe acute AMR and an increased risk of graft loss [174]. Therefore, safe transplan-
tation of potential recipients with high levels of circulating DSAs, i.e. highly sensitised
recipients, is an ongoing problem resulting in prolonged waiting times for transplanta-
tion [159]. Such a type of transplantation is defined as a high risk kidney transplantation
in clinical practice.
It has recently been recognised by the transplant community [156, 189] that post-
transplant screening for anti-HLA DSA could be an important tool for monitoring of
transplant recipients. Early DSA dynamics are likely to profoundly affect clinical out-
comes [156, 190, 191]. It is observed that the dynamic behaviour of post-transplant
DSAs varies from case to case, and even different DSAs in the same patient (targeting
different HLA) show diverse patterns. A strong mathematical approach to describe the
dynamics of the preformed DSA is in need. It can help clinicians, e.g. by suggesting
what laboratory assays can be developed to detect more detrimental DSAs, and the time
points at which laboratory assays should ideally be collected. Once appropriate assays
are available, the modelling may help in the interpretation of results of the assays at
different time points. This could be particularly important in relation to falls in DSA
levels, since this is a key clinical objective that is currently not achievable in clinical
practice. However, no such mathematical model exists.
Physiologically based models are not yet feasible to analyse the antibody dynamics due
to the complexity of the underlying immunological responses to transplants. The possi-
ble mechanisms underlying changes in DSA levels are complex. DSA levels may change
because of rises and falls in the rate of production which are controlled by multiple fac-
tors. Falls in the levels of DSA post-transplant are very interesting, as they may occur
much faster than the ‘natural’ rate of antibody clearance from the body — antibodies
are estimated to have a half life of about 20 – 30 days [192]. Mechanisms associated
with reductions in antibody levels could include the absorption of antibodies onto HLA
molecules on the graft [182]— it is known that the levels of HLA on a graft may in-
crease post-transplant, but this cannot yet be quantified. Some HLA is shed by the graft
so antibodies could be absorbed in the circulation. It is known that one physiological
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method used by the body to control antibody levels is to produce antibodies that block
other antibodies (idiotypic antibodies), and the production of idiotypic antibodies could
explain the falls in DSA post-transplant [193]. However, as with other potential regu-
latory mechanisms, it is currently hard to measure idiotypic antibodies accurately, and
therefore, such a regulatory mechanism hypothesis based on the production of idiotypic
antibodies cannot be proved experimentally under current techniques.
Data-driven models, on the other hand, require an accurate way of measuring the DSA in
human sera, which was not possible until very recently [194]. Due to the development of
Luminex technology based on single-antigen bead assays in recent years [156, 190, 195],
these highly sensitive and specific assays using HLA proteins meet the increasing need for
monitoring post-transplant DSA [196] and open up opportunities to develop data-driven
mathematical models for the evolution of antibodies after transplantation.
A unique dataset with detailed antibody measurements using the single-antigen beads
assays spanning three to six months has been obtained by our group [156]. A previous
analysis [156] of this data set revealed various patterns of antibody dynamics, both
with or without acute AMR. Some DSA time series show a rapid rise during the first
two weeks followed by a rapid fall to almost undetectable levels, which then remain
low. This finding is striking: in many of these patients, the DSAs had persisted for
many years before transplantation, and therapies used experimentally have been unable
to stop antibody production before transplantation. A better understanding of this
phenomenon could therefore have practical benefits.
The aim of this work is therefore to describe early antibody response within the first
six months of transplantation in mathematical terms by deriving appropriate dynamic
models and analysing the dynamic responses in relation to the occurrence of acute AMR.
As a key early outcome in AiT, acute AMR episodes are associated with the levels of
immunosuppression required in the post-transplant period, and are also associated with
short and long term graft survival [176]. This approach might enable a more intelli-
gent application of laboratory testing and suggest therapeutic approaches to selectively
control this antibody response and improve clinical transplant outcomes.
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4.2 Data description and visual analysis of dynamic pat-
terns
Data from twenty-three patients who underwent renal AiT at University Hospitals
Coventry and Warwickshire (UK) (UHCW) between 2003 and 2012 were analysed in
this study. The data comprised of time series of DSA evolutions over a period of about
ten days before and six months after transplantation. Serum samples for DSA analysis
were taken almost daily in the first three to four weeks, as most dynamic behaviour
occurs during that period, and sampling became more sparse later when the antibodies
tended to be more stable. Antibody levels were measured using the microbead assay
manufactured by One Lambda Inc (Canoga Park, CA, USA), analysed on the Luminex
platform (XMap 200, Austin, TX, USA). The assay measures the Mean Fluorescence
Intensity (MFI) which corresponds to antibody level although the relationship is lin-
ear only over a limited range. It is known that the inter-assay coefficient of variability
for DSA measurements is around 10-30% [197]. As described in [156], when the MFI
value is higher than 10,000 AU (Arbitrary Units) and below about 1,000 AU, the linear
correlation breaks.
Some of the patients had multiple DSAs targeting different HLA, so the total number
of post-transplant time series available for this analysis was thirty-nine. Twenty-seven
DSA time series belonging to fourteen patients that experienced episodes of acute AMR
in the first thirty days after transplantation (AMR group), and twelve DSA time series
belonging to the other nine patients who did not have an episode of AMR (no-AMR
group). Rejection episodes were diagnosed by renal biopsy or clinically if there was
rapid onset of oliguria with a rise in both serum creatinine and DSA levels [156]. In
patients receiving HLA antibody-incompatible grafts, the incidence of AMR was 30 –
40% [191]. Although AMR can be severe and can eventually result in graft failure, it
usually develops slowly over a period of several days. This gives an opportunity to detect
AMR at an early stage and treat it, resulting in better outcomes [156, 190].
Visual examination of the time series reveals diverse dynamic behaviour of DSAs. Fig.
4.1 and Fig. 4.2 show some examples of the patterns from the no-AMR group and the
AMR group respectively. As some patients had multiple DSAs, the case number in these
figures and in the corresponding text is followed by the DSA type. For example, in Fig.
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4.2, patient 36 had two anti-HLA DSAs, HLA-A24 and HLA-DR17, comprising two
different time series: case 36 HLA-A24 (case 36 A24 for short) and case 36 HLA-DR17
(case 36 DR17 for short). Pretransplant antibody removal (before day 0) can be seen
to reduce total DSA levels due to cycles of double filtration plasmapheresis. Typically,
between two and five alternate day sessions were performed.
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Figure 4.1: Measured time series illustrating individual DSA changes in the no-
AMR group. Markers correspond to each measurement point. MFI=mean fluorescent
intensity.
The initial drop is typically followed by a rapid rise in DSA which usually occurs with a
lag of a few days after transplantation (day 0) and is caused by two factors: plasmaphere-
sis stopping and an increased rate of DSA synthesis due to an immunological memory
response. After the peak levels a diversity of dynamic patterns is noticeable: antibody
levels do not follow a common route, varying from case to case, and even differing for
different DSAs in the same patient. In some cases there is a rapid fall in DSA to a
steady state, corresponding to a low (almost zero) level of DSA, and this is typically
reached within the first month after operation. Such patterns are observed in both the
no-AMR and AMR groups: case 34 (both B62 and B60) and case 28 in Fig. 4.1, and
case 36 DR 17 in Fig. 4.2. In other cases the dynamics of the fall after the peak are
followed by another rise, and antibodies do not settle at a low level within the first three
months after operation: case 59 in Fig. 4.1, case 36 A24 and cases 61 and 69 in Fig.
4.2. They either demonstrate a slow dynamic around a certain constant level (case 61
in Fig. 4.2) or change dramatically over the first three months (case 59 in Fig. 4.1 and
case 69 in Fig. 4.2). There is no obvious relationship between these dynamical patterns,
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steady state levels and the occurrence of AMR episodes. In some cases, as shown above,
low steady state levels are observed in the no-AMR group and higher levels or dramatic
changes are noticeable in the AMR group. There are also cases of the absence of AMR
despite high levels of DSA or presence of AMR despite low DSA levels. Finally, some
patients (e.g. case 36 in Fig. 4.2) rejected the kidney, but had multiple DSAs with one
type that rose after the initial fall post-transplant (A24) and another type that kept
falling to a low steady level (DR17). This visual analysis demonstrates that there is no
certain association between higher levels of post-transplant DSA and the occurrence of
the rejection episodes.
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Figure 4.2: Measured time series illustrating individual DSA changes in the AMR
group. Markers correspond to each measurement point. MFI=mean fluorescence in-
tensity.
The aim of this study was to analyse these dynamical patterns in order to propose a set
of characteristics capable of discriminating between the patients with and without the
incidence of AMR. In this study, we are particularly interested in the DSA dynamics
after the first peak value down to an almost zero level, i.e. focus is on the typical pattern
of a rapid fall that occurs in most of the patients with and without AMR episodes. Falls
in the serum levels of anti-HLA DSA after kidney transplantation are of great clinical
interest, as they are associated with resolution of rejection and good long term outcomes
in patients at high risk of graft loss [191].
Chapter 4. Post-transplant antibody dynamics 113
4.3 Models and methods
4.3.1 Data fitting and model selection
As seen from the preliminary observations of the dynamic patterns, the anti-HLA DSA
response to the transplanted kidney is a complex immunological process, nonlinear and
stochastic in general. Time series available for analysis are complex and one-dimensional:
only one variable as a function of time (MFI levels) is available representing a response
of the entire immune system to the external stimuli (a newly transplanted kidney). A
mathematical model can quantitatively describe the dynamics in the post-transplant
DSA time series and capture the main features that are shared between different DSA
time series. These diverse dynamic patterns pose a set of challenging questions with
respect to the form of the function, the order of the system and the number of parameters
to be used in the model. It is also unclear whether the system equation should be
linear or nonlinear, stochastic or deterministic, and what would be the most appropriate
modelling approach to identify system parameters in the situation where no preliminary
knowledge of the model is available. Although we only consider the falling part of MFI
level dynamics, all the above questions remain.
4.3.1.1 Exponential fitting
It can be noticed that the falling MFI dynamics of HLA DSA after the peak value is a
relaxation process, the simplest theoretical description of which is an exponential law.
Initially the curve fitting tool (Cftool) in Matlab [198] was used to fit each of the thirty-
nine DSAs. Some of the time series were described by this approach sufficiently well;
however, the use of superposition of exponential functions could not describe all the
cases with and without AMR in our cohort. As the next step, instead of exponential
functions, i.e. solutions of linear dynamic equations, dynamic mathematical models in
the form of differential equations were considered.
It is worth mentioning that there are other parameter estimation and system identifica-
tion methods, such as the least squares method, available, especially for linear systems.
However, the main purpose is to search for the best possible model that describes the
data regardless of the form of the model – linear or nonlinear, deterministic or stochastic.
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Therefore, the employed method needs to be able to compare between linear/nonlinear
and deterministic/stochastic models. Classical system identification methods such as the
least squares method would constrain the model choice within linear and deterministic
forms. In addition, most commercially available toolbox such as the system identifica-
tion toolboxes [199] in MATLAB cannot deal with data with highly irregular sampling
frequency, which is indeed the characteristic of the data as described in Section 4.2.
The DSA measurements 30 days after transplantation are highly irregular and sparse,
as seen in Fig. 4.1 and Fig. 4.2. Therefore, Variational Bayesian method fit the purpose
of the study perfectly and thus, it has been chosen as the prime method in this chapter,
similarly to the previous application discussed in Chapter 3.
4.3.1.2 Form of the model: linear/nonlinear and stochastic terms
The general form of an n-th order nonlinear Ordinary Differential Equation (ODE) with
coefficients in the form of a polynomial function, as proposed in Section 2.1, have been
considered. Initially two stochastic terms were included to represent noise in the system
equations. Measurement noise is added due to uncertainty in the measured data, and
the dynamic noise accounts for any other hidden properties not captured by the model.
Thus, DSA falls after the initial rise (to a peak level) in the early post-transplant period
can be described by the following model:
dn
dtn
xt +
n−1∑
i=0
fi+1,θi(xt)
di
dti
xt + f0(xt, θ0) = ηt (4.1a)
yt = xt + εt (4.1b)
Equation (4.1a) is an evolution equation of nth order, where xt is a function of t that
describes the MFI dynamics, and yt is the measured MFI time series. ηt is system
noise, and εt is measurement noise. Each noise was modelled as Gaussian-distributed
white noise with zero mean and intensity (variance) of Iη and Iε respectively. fi+1(xt)
(i = 0, 1, . . . , n − 1) are polynomial functions of xt. The derivative of order zero of xt
is defined to be xt itself. The order of the system equation n is to be decided together
with the unknown parameters θi (i = 0, 1, 2, ..., n− 1). n initial conditions are required
to obtain a closed form solution.
Chapter 4. Post-transplant antibody dynamics 115
Model Mn constituting (4.1a) – (4.1b) covers a variety of dynamic patterns depending
on the order of the system n. A more complex model may be able to explain a wider
range of system behaviour in the data at the risk of overfitting.
4.3.2 Model and parameter identification
As explained in Chapter 2, both the model and parameter identification were carried
out using the VB method. The freely available SPM9 toolbox [77] (referred to as the
VB toolbox) for MATLAB [198] allows accounting for both types of stochastic terms:
measurement noise and system noise.
Starting from the first order linear model M1 (n = 1 in (4.1a)) where the coefficients
fi+1(xt) are constants with constant parameters θi (i = 0, 1, . . . , n− 1), the order n was
increased until the model Mn fitted the data sufficiently well, i.e. satisfied the criteria
given in Section 4.3.3. Attention has to be paid to the features in the dataset that can
be explained by a model with a higher order, but cannot be explained by the model
with a lower order, and to decide if the features are general enough to make the final
decision on the order for all DSA time series under investigation.
For each model candidate M , free energy FM was maximised by iteratively optimising
the states of the system and model parameters to approach the model log-evidence
log (p(yt|M)), as introduced in Section 2.2.2. This procedure is embedded into the VB
algorithm as introduced in Chapter 2 Section 2.3. The maximised value of the free
energy, among other criteria (normalised root mean square error and the stability of the
immune response, both of which are discussed in the next section), defined how well the
model performs.
As explained in Section 2.5, the priors regarding the parameters are important. Such
information on possible parameter values was not available to us, and therefore the mean
values of the parameter priors were set to zero. To allow the algorithm to search in a
relatively wide region for the optimal parameters, all variances were set to be 104, i.e.
priors with wide distributions were considered. Both noise precisions αη and αε were
modelled by a gamma distribution with two hyperparameters (shape aη, aε and rate bη,
bε respectively). Weakly informative Jeffreys priors, as described in Section 2.5, were
chosen for the precisions of the noise, with both shape and rate parameters set to 1. The
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initial conditions were all modelled as Gaussian distributions. The prior means of the
initial conditions were defined from the measurement time series, and the prior variances
were set to 104.
4.3.3 Model selection criteria
The following four criteria were applied to identify the best model.
1. The free energy F has been maximised by tuning the system parameters in an
iterative manner for each model. Note that decision making based on the comparison of
the free energy of any two models with different orders could be problematic due to the
heavy penalisation of the model complexity embedded in the VB method (as explained
in Section 2.4). Increasing the order of the system by one would not only increase the
degrees of freedom in the parameter space, but also increase the dimension of the system
states. This leads to a dramatic decrease in the free energy, which could be an order
(or several orders) greater than the free energy difference between models of the same
order. Therefore, the free energy criterion was only used to compare models of the same
order. For models with different orders, criterion 2, as below, was utilised.
2. Normalised Root Mean Squared Error (NRMSE) was used to compare the models
with different orders for each individual time series. Inferred parameters θ were applied
back to the system equation to generate time series without stochastic terms, i.e. the de-
terministic solution. Note that because parameters were identified in the form of normal
distributions, the most probable (mean) values of the parameters were substituted into
the system equation. The root Mean Squared Error (RMSE) between the measurement
MFI time series yt and the inferred deterministic time series yˆt can be calculated as
follows:
RMSE =
√∑n
t=1(yˆt − yt)2
n
(4.2)
NRMSE accounts for the different heights of the peaks for each DSA time series and is
found by dividing the RMSE by the maximal MFI value for a given DSA time series.
The model with the lowest value of NRMSE describes the data most accurately. For
the model to be deemed satisfactory, NRMSE should not exceed the value of 0.15 (or 15
%) as it is known that the inter-assay coefficient of variability for DSA measurements is
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around 10-30% [197]. It could be argued that NRMSE only represents the goodness-of-
fit without considering the model complexity, whereas the AIC (as introduced in Section
2.4) accounts for the complexity of the model by subtracting the total number of the
model parameters from the logarithm of the mean squared error. In this analysis peak
heights vary between 1000 AU and 10,000 AU, so the RMSE value of each time series
needs to be normalised by its peak height before the normalized RMSE (NRMSE) values
are compared across all 39 time series. Therefore, the NRMSE was chosen over the AIC
in order to take different peak heights into consideration.
3. Generic form. As the entire aim was to find a model capable of capturing the common
patterns in all time series, a model that could only describe some of the DSA time series
was disregarded.
4. System stability. Due to the chosen dynamic pattern in the data where the antibody
level falls rapidly to an almost zero level and remains low, the model describing such data
has to have a unique stable steady state, which implies that the system’s response decays
with time. This has been checked via calculations of the real parts of the corresponding
eigenvalues which have to be negative for stability. Note, even though the steady state
of the immune homeostasis was disturbed by transplantation, the antibody levels settled
rapidly to a new steady state except for the extreme cases (example case 069 HLA-DR53
in Fig. 4.2), but consideration of such cases is outside the scope of this work.
4.4 Results and Discussions
4.4.1 Model selection
To choose the best model that is capable of describing all of the falling dynamics of the
DSA time series in the cohort, a series of choices needed to be made: 1) the order of
the system, 2) deterministic (measurement noise only) or stochastic model (both system
and measurement noise), 3) linear or nonlinear models. The results are presented in the
following sections.
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4.4.1.1 Comparison of linear models of different orders
Linear models with different system orders were considered first. The equation (4.1a)
in Section 4.3.1.2 transforms into a linear differential equation when the coefficients
fi+1(xt) are constants, with constant parameters θi (i = 0, 1, . . . , n− 1), where fn(xt) =
θn, . . . , f2(xt) = θ2, f1(xt) = θ1. f0(xt) is defined as −θ0 for convenience.
A first order linear model was considered first, and it did not show good performance.
Then linear models with higher system orders were investigated. In this section, we
present the methodology of system and parameter identification by comparing solutions
for linear first, second and third order dynamic equations only:
Model 1 (M1):
dxt
dt
+ θ1xt − θ0 = ηt (4.3)
Model 2 (M2):
d2xt
dt2
+ θ2
dxt
dt
+ θ1xt − θ0 = ηt (4.4)
Model 3 (M3):
d3xt
dt3
+ θ3
d2xt
dt2
+ θ2
dxt
dt
+ θ1xt − θ0 = ηt (4.5)
Note if the third order equation had not been successful, the procedure would have con-
tinued to account for nonlinearities (presented in Section 4.4.1.3) first and then increased
the order of the system until a suitable solution was found.
Initially not only the measurement noise εt (as in (4.1b)) but also the system noise ηt (as
in (4.1a)) was included in the models. It was found that for all DSA time series, models
without system noise have larger free energy compared with the counterpart mathe-
matical representations containing both types of stochasticity (an example is shown in
Section 4.4.1.2). The benefit - improved fitting - obtained by using the more complex
model with system noise does not exceed the penalty introduced by adding two degrees
of freedom in the parameter space. Therefore, we excluded the system noise from the
models and this is reflected in the zero right hand side of (4.3) – (4.5).
Typical fittings for four DSA time series, one from the no-AMR group and the other
three from the AMR group, by the three suggested models (4.3) – (4.5) are shown in
Fig. 4.3. The results for models M1 – M3 in Fig. 4.3 (a) and (c) show a winning model
candidate M3. Even though (a) is from a patient in the no-AMR group and (c) is from
a patient in the AMR group, both time series show oscillations after day 30. M1 failed
to describe the dynamics of both time series as indicated by large NRMSE values in
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Figure 4.3: Typical fitting results compared among the three models M1 – M3 for
(a) HLA-B60 (case 52) for a patient from the no-AMR group; (b) HLA-DRB3*01 for a
patient (case 14) from the AMR group; (c) HLA-A32 for a patient (case 16) from the
AMR group; (d) HLA-A2 for a patient (case 17) from the AMR group. The measured
values are indicated by circles.
Table 4.1: NRMSE= 0.272 and NRMSE= 0.090. M2 successfully described the initial
falls for both time series, but failed to capture the oscillations in DSA after day 30,
which is also confirmed by the large NRMSE value of 0.053 and 0.096 (Table 4.1). M3
captured successfully both the falling part and the later trend with smaller NRMSE
values of 0.014 and 0.053. Fig. 4.3 (b) exhibits different dynamics with a cluster of data
around day 20. This is a common feature observed in the majority of time series in
both AMR and no-AMR groups, and requires special attention. The temporary stall of
falling could not be expressed by using M1 or M2; however, M3 successfully depicted
the sudden changes in falling as shown in the magnified box 1 in Fig. 4.3 (b). Further,
the fittings by M1 and M2 were almost indistinguishable after day 70, and both models
underestimated the settling level of the DSAs. The fitting by M3 otherwise correctly
estimated the settled value and gave a better description of another clustered region
around day 30 (see the magnified box 2 in Fig. 4.3 (b)). Thus, M1 and M2 were ruled
out based on their incapability of describing the important features, and the higher order
model M3 was chosen.
From Table 4.1, it is noticeable that the free energy values of a model with a lower order
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Table 4.1: Summary of the free energy and the NRMSE values for three models of
different order corresponding to the four example datasets in Fig. 4.3.
Free Energy NRMSE
M1 M2 M3 M3S M1 M2 M3
(a) −99 −164 −233 −1036 0.272 0.053 0.014
(b) −182 −346 −507 −634 0.083 0.085 0.013
(c) −150 −268 −387 −1692 0.090 0.096 0.053
(d) −110 −204 −292 −463 0.088 0.071 0.073
are consistently larger than the free energy values of a model with a higher order. A
higher order model has a larger number of hidden states. For example, M2 has twice as
many hidden states as M1. Since the calculation of the free energy takes the inference of
hidden states into account, the uncertainty of the larger number of the hidden states in
the model with a higher order increases the K-L divergence, causing a lower free energy
value. Therefore, NRMSE is a better criterion, compared to the free energy value, for
model selection between models with different order.
The same approach was applied to all the other DSA time series. In 32 out of 39 cases,
the NRMSE value of M3 was the smallest among the three models. In the other 7 cases,
the NRMSE value of M2 was comparable with the NRMSE value of M3. An example
is shown in Fig. 4.3 (d) where the fittings by M2 and M3 were indistinguishable from
each other, with close NRMSE values as in Table 4.1. To compare the NRMSE values
between M2 and M3 across all 39 cases, the NRMSE value of M3 was subtracted from
the NRMSE of M2, and the differences for all time series are shown in the boxplot
Fig. 4.4. The differences in the NRMSE between the two models were tested by the
one-sample t-test at the significance level of 0.001, and the mean value was found to be
significantly larger than zero. Therefore, the deterministic model M3 was selected as
the best model across the cohort with the dynamic equation in the form:
d3xt
dt3
+ θ3
d2xt
dt2
+ θ2
dxt
dt
+ θ1xt − θ0 = 0 (4.6)
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Figure 4.4: Boxplot of the difference between the NRMSE of M2 and NRMSE of M3.
4.4.1.2 Deterministic versus stochastic
As stated in Section 4.4.1.1, there are two submodels for the model with the order of
three: M3 with measurement noise only, the other one with system noise and measure-
ment noise, referred to as M3S. A comparison example of the time series in Fig. 4.3 (b)
between the fittings obtained from M3 and M3S is shown in Fig. 4.5. It is visually clear
that M3 fit the data better than M3S, which can be confirmed by a higher free energy
value of M3 (FM3 = −507 as shown in Table 4.1) compared with the free energy value of
M3S (FM3S = −634). Intuitively, M3S is structurally more flexible to reflect the varia-
tions in the data by allowing large system noise intensity, i.e. with large enough system
noise, M3S can fit any data. Therefore the accuracy of the model improves, reflected by
the smaller measurement noise intensity of M3S (Iε(M3S) = 132 AU) compared with
the noise intensity of M3 (Iε(M3) = 259 AU). However, the deterministic fitting of M3S
is worse than M3D, because M3S loses important information carried by the data about
the system by categorising it as system noise. Without enough measurement data, such
miscategorisation is difficult to avoid. With two more degrees of freedom introduced in
describing the system noise (two hyperparameters of the system noise), the complexity
term of the free energy increases (as explained in Section 2.3.4), causing a smaller value
of free energy for M3S, in spite of a larger accuracy term. These results hold true for
all of the time series. The free energy comparison between M3S and M3 for the other
three examples shown in Fig. 4.3 can be found in Table 4.1.
Therefore, M3 is chosen over M3S for all of the time series in the cohort. However,
when the measurements are sparse and corrupted with noise, the data have limited
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constraining power over the parameters to support a more complicated model with
system noise. The falling dynamic of DSAs, as a result of the complex immune response
towards the newly transplanted organ, contains system noise. When more and better
data with less measurement error become available, the information about the system
noise may be extracted from the data.
Figure 4.5: Fitting comparison between M3S and M3 for the time series in Fig. 4.3
(b).
4.4.1.3 Nonlinear versus linear
Polynomial forms allow a description of a wide range of nonlinear solutions, and can
be adjusted to fit different dynamic features by increasing the number of components
and by varying their parameters. To keep a parsimonious form of the system equa-
tion, nonlinearity was introduced into the second order model (the lowest possible order
considering the first order does not provide good fitting), in the form of polynomial
nonlinear coefficients f1(xt) or f2(xt) in (4.1a). It was acknowledged that a linear de-
scription is preferable over nonlinear if this does not increase the number of unknown
parameters dramatically. Consequently, the maximal number of unknown parameters
in the second order nonlinear model was kept comparable with the number of parame-
ters of the third order linear equation, i.e. no more than 4. Under this condition, two
nonlinear models were considered: model NM1 with nonlinearity in the damping term
(f1(xt) = k1xt + θ1, f2(xt) = θ2) and model NM2 with nonlinearity in the xt term
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(f1(xt) = θ1, f2(xt) = k2xt + θ2). The corresponding system equations are as follows:
NM1:
d2xt
dt2
+ θ2
dxt
dt
+ (k1xt + θ1)xt − θ0 = 0 (4.7)
NM2:
d2xt
dt2
+ (k2xt + θ2)
dxt
dt
+ θ1xt − θ0 = 0 (4.8)
An example of the fittings of the time series from Fig. 4.3 (c) by the nonlinear models
NM1 and NM2 is shown in Fig. 4.6. Neither NM1 nor NM2 captured the dynamic
features of the time series. The free energy criterion can be applied here to compare
the models with the same order: the free energy of M2 as shown in Table 4.1) is the
largest among the three models (FNM1 = −270, FNM2 = −283 and FM2 = −268);
the oscillatory dynamic behaviour of the data is not captured by NM1 or NM2. The
NRMSE criterion was applied here for models of different order: both the NRMSE values
for the nonlinear models (NRMSENM1 = 0.080 for NM1 and NRMSENM2 = 0.067 for
NM2) are larger than NRMSE for M3 (NRMSEM3 = 0.053). Additionally it is clear
that the fitting using NM2 leads to an unstable solution. Therefore, the linear model M3
shown in (4.5) outperformed both NM1 and NM2, and was chosen as the final model.
This example is a typical (representative) fitting for all the other time series in the cohort.
There are a variety of nonlinear forms which could be considered for the functions fi
in (4.1a). However, with the sparse measurement time series available, a simple form is
preferred, and that is why nonlinearity is introduced to the second order model before
settling on the choice of the third order linear model M3. However, neither of the
chosen forms of the nonlinear models showed better performance than the linear model
M3. Therefore, M3 was finally chosen as the best model.
4.4.2 Model validation
So far, the third order linear model M3 has been chosen as the best model. An empirical
validation method has been applied to check that M3 did not overfit the data compared
with M2 by including one more extra degree of freedom in the parameter space. If a
model overfitted the data, the predictive ability of the model deteriorates. The validation
method, known as the leave-one-out cross validation technique, has been applied to
compare between the second order model M2 and the third order model M3 [200]. For
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Figure 4.6: Fitting results compared between the two nonlinear models NM1 and
NM2 and the linear model M3 for the time series shown in Fig. 4.3 (c). The measured
values are indicated by circles.
each time series in the cohort, we performed the following procedure for both models
M2 and M3:
1) Leave data point i out from the measurement time series, fit the model M (M = M2
or M3) based on the rest of the data points using the VB method, then after the
parameters are inferred, obtain an estimation for data point i by substituting the
inferred deterministic parameters, and compute the estimation error term (ei =
yi − yˆi, where yi is the measurement and yˆi is the estimation);
2) Repeat step one for i = 1, . . . , n
3) Compute the RMSE from e1, . . . , en for both models, and choose the model with the
smallest error.
The differences in the RMSE between M2 and M3 for each time series have been calcu-
lated and they are presented in the boxplot in Fig. 4.7. It is clear that in most cases M3
has less errors compared with M2 between the observations and the estimations. The
differences in the errors estimated by M2 and M3 are tested by a one sample t-test with
significant level of 0.05. The test results rejected the hypothesis that the mean of the
differences between M2 and M3 is zero, indicating that M3 is a better model compared
with M2.
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It is worth noticing that there are cases when M2 is the better model; however, the aim
is to identify a model that is capable of describing all of the time series and M2 is a
special case of M3. Therefore, the choice of M3 over M2 was validated.
Figure 4.7: NRMSE value of the errors between the observations and the estimated
values by M2 and M3
4.4.3 Structural identifiability and parameter sensitivity
A structural identifiability analysis as introduced in Section 2.6 has been performed for
M3. For the third order linear system
...
x t + θ3x¨t + θ2x˙t + θ1xt + θ0 = 0 (4.9)
with observations
yt = xt (4.10)
and initial conditions
x0 =

x0
x˙0
x¨0
 (4.11)
The Laplace transform of (4.9) is as follows:
(s3X − s2x0− sx˙0− x¨0) + θ3(s2X − sx0− x˙0) + θ2(sX − x0) + θ1X + θ0s−1 = 0 (4.12)
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Rearranging (4.12), the following form can be obtained:
X =
(x0 + x˙0 + x¨0)s
3 + (θ3x0 + x˙0)s
2 + (θ2x0 + θ3x˙0 + x¨0)s− θ0
s4 + θ3s3 + θ2s2 + θ1s
(4.13)
where θ3, θ2, θ1, x0 + x˙0 + x¨0, θ3x0 + x˙0, θ2x0 + θ3x˙0 + x¨0 and θ0 are assumed to be
known [93]. Therefore, θ3, θ2, θ1 and θ0 are uniquely identifiable.
To check parameter sensitivity, the procedures explained in Section 2.7 – the one-at-
a-time parameter sensitivity analysis – were performed for model M3 (see details in
Section 2.7). To check how sensitive the output is to a small change in each deterministic
parameter, the following steps have been performed for model M3:
1) Simulate the time series with no measurement or system noise and obtain the root
mean square error (RMSE) between the noise free time series and the measurement
time series.
2) Take 1000 random samples of θ
(j)
i (j = 1, 2, . . . , 1000) from a uniform distribution
from 0.99θˆi to 1.01θˆi, where θˆi is the posterior mean of θi.
3) Calculate the RMSE values between the measurement values and each of 1000 gen-
erated time series, denoted as RMSE(j), using the sampled parameter θ
(j)
i and the
posterior means of the rest of the parameters.
4) Using (2.83), obtain the sensitivity index SI for parameter θi.
The same procedure can be performed to the inferred parameters of all the time series.
Considering the parameter values for different time series fitted by M3 are in the same
neighbourhood, the sensitivity indices SI of θ1, θ2, θ3, and θ0 in M3 for one typical
time series as shown in Fig. 4.6 is presented as an example here. As shown in Table
4.2, 1% change in θ1 in M3 can cause 0.17% change in RMSE. The The RMSE values
between the measurements and the output, generated when the posterior means of the
parameters were used, is RMSE(j) = 239.0 AU. With 1% perturbation in θˆ1, RMSE
(j) is
between 239.3 AU to 240.2 AU. According to Table 4.2, the RMSE values remain within
a small range when each of the four parameters are perturbed within 1%, the model M3
is robust around the inferred posterior means of the parameters.
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Table 4.2: Summary of the parameter sensitivities for M3
Parameter SI RMSE(j) range
θ1 0.17 239.3 – 240.2 AU
θ2 0.11 239.4 – 240.1 AU
θ3 0.30 239.4 – 241.5 AU
θ0 -0.19 239.2 – 240.1 AU
4.4.4 Analysis of the inferred parameters
Statistical analysis of the model parameters was performed using the Wilcoxon rank
sum test. The null hypothesis of no difference between the groups of interest was tested
at the 5% significance level, and the results are presented as p-values.
4.4.4.1 Comparison of deterministic parameters
The inferred parameters (θ0, θ1, θ2 and θ3) of the selected model M3 have been compared
between the two groups (AMR and no-AMR) for meaningful differences. The results
are presented in Fig. 4.8 (a) – (d) in the form of boxplots. For all four parameters,
Figure 4.8: Boxplot for the inferred parameters θ0, θ1, θ2, θ3
the ranges of the parameter values are much wider in the AMR group compared with
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the no-AMR group, indicating more diverse dynamic behaviour of DSA in the AMR
group. The Wilcoxon rank sum test showed statistically significant differences in the
median values between the AMR and the no-AMR group for all four parameters, which
confirmed the results of our preliminary study [157] with fewer cases.
Even though the values of the parameters do not have direct clinical interpretations,
which is one of the main drawbacks of data-driven modelling in biomedical research, a
certain combination of the parameters indicates important features of the system under
investigation. The ratio θ0/θ1 from (4.5) defines the settling level of DSA, which is of
clinical interest. Kidney transplantation constitutes a major disturbance in the immune
system, and the system should settle down to a new homeostatic equilibrium after the
transient response to the transplanted organ. A successful transplantation is usually
characterised by a new stable steady state with low DSA levels (ideally zero, or below
the threshold of the detection assay). From the comparison between the AMR and no-
AMR groups shown in Fig. 4.9, the majority of the settling MFI values in both groups
are less than 1000 AU, indicating low DSA settling levels. The highest settling level in
the no-AMR group is 3862 AU, compared with the level of 5783 AU in the AMR group.
The lowest settling level in the no-AMR group is 22 AU, compared with the level of 27
AU in the AMR group. As shown in Fig. 4.9, there is no significant difference with a
Figure 4.9: Boxplot for the settling values compared between no-AMR and AMR
groups
p-value of 0.5 in the median value of θ0/θ1 between the groups (300 AU in the no-AMR
group, 425 AU in the AMR group), which means that a DSA time series from the AMR
group does not necessarily have a higher settling level. However, significant difference
in θ0 and θ1 separately between the groups shown in Fig. 4.8 implies that the dynamic
behaviour of DSA in the AMR group might be controlled by more complex and diverse
underlying mechanisms.
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Such a detailed analysis of the parameters of the models developed allows for enhanced
understanding of the clinical characteristics which are most important for successful out-
come in this high risk form of transplantation. Our findings may facilitate the formation
of an accurate pre-transplant risk profile which predicts AMR and allows the clinician to
intervene at a much earlier stage. Given that AMR in the early post-transplant period
has been shown to lead to worse long-term graft outcomes any strategy to prevent early
AMR will be of great benefit to the patients [191].
4.4.4.2 Comparison of stochastic parameters
Noise accounts for both measurement error due to inaccuracy in the MFI readings, and
the perpetual actions of many unaccounted for factors that influence the evolution of
the system. The noise intensities Iε were compared between the no-AMR and AMR
groups. In our preliminary analysis [157] of a limited number of time series (9 for the
no-AMR group and 12 for the AMR group), the no-AMR group had a smaller and more
compact range of the noise intensities compared with the AMR group (shown in Fig.
5 of [157]). Limited by the numbers of cases available, the Wilcoxon rank sum test
showed no significant difference in the median value between groups with a p-value of
0.08. This study, on a larger cohort with almost twice as many time series, confirmed
the previous observation with a smaller p-value of 0.01, indicating a significant difference
in the median values of the noise intensities between groups.
The square root of the noise intensity
√
Iε, which is an absolute error value, shares the
same unit as the MFI level. In the no-AMR group with an average MFI peak height of
5716 AU, the median (and range) for
√
Iε were 159 AU (5 AU – 353 AU). In the AMR
group with an average MFI peak height of 8502 AU, the median (and range) for
√
Iε
were 253 AU (34 AU – 1425 AU). A smaller noise intensity and more compact range of
values across the no-AMR group is noticeable. Even though the assay used to measure
the DSA level in both groups was the same, the relationship between MFI measurement
and the antibody level deviates from linearity as the antibody level approaches 10,000
AU. The higher antibody peak values in the AMR group can therefore introduce an
additional source of measurement error compared with the no-AMR group, explaining
the wider range and greater magnitude of the noise intensity seen in the AMR group.
Another explanation could be a different level of model imperfection between the two
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groups. The higher level of noise in the AMR group could be caused by more and/or
stronger unconsidered factors inM3. Also it is worth noticing that the priors for the noise
intensity applied in the inference method are chosen to be weakly informative. A more
informative prior may limit the flexibility of the model, but a carefully chosen informative
prior could improve the estimation of deterministic parameters and parameters related to
the noise description. The choice of the priors is not straightforward, and an appropriate
methodology of choosing the best priors will be further developed in the future carried
on by a new PhD project described in Chapter 5.
In single antigen bead measurements, another measure, termed the inter-assay coefficient
of variability (CV) is often used to indicate the measurement uncertainty. It is defined
as the ratio of the standard deviation and the mean value of several measurements
using separate assays. In [201], the inter-assay CV was larger than 20% when the
measurements from seven different labs were compared. In our model, considering the
median value of
√
Iε and the median value of MFI measurements, the median CV is
13% and 14% for the no-AMR and AMR groups respectively, which is less than the 20%
given in [201].
4.4.5 Eigenvalues
The evolution equation (4.5) can be transformed into the third order linear state space
model of the form 
x˙t
x¨t
...
x t
 =

0 1 0
0 0 1
−θ1 −θ2 −θ3


xt
x˙t
x¨t
+

0
0
θ0
 (4.14)
The solution of (4.14) is defined by the eigenvalues λ1, λ2, λ3 of the 3 × 3 matrix,
the corresponding eigenvectors and three initial conditions. The sum of the eigenvalues
defines the divergence of the vector field (phase volume V (t)) in the state space [202]:
V (t) = V0e
(λ1+λ2+λ3)t = V0e
Rt, (4.15)
where R can be interpreted as the dissipation rate of DSA. For all of the time series in
the cohort, the dissipation rate is less than zero, which means that the phase volume
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shrinks. Analytically, R equals the trace of this 3× 3 matrix:
R = −θ3 (4.16)
−400 −200
0 200
−100
0
100
0
5000
10000
x˙, [AU/day]x¨, [AU
2/day2]
x
,
[A
U
]
−2
0
2
−0.5
0
0.5
210
220
230
240
250
 
x˙, [AU/day]x¨, [AU2/day2]
 
x
,
[A
U
]
(a)
(b)
Figure 4.10: Phase portraits of the three dimensional system for two DSA time series,
(a) from a patient in the AMR group and (b) from a patient in the no-AMR group.
The time difference between two consecutive markers is one day.
The eigenvalues for every DSA time series were calculated using the inferred parameters
θ1, θ2 and θ3. Each DSA time series in the cohort is characterised by three eigenvalues,
one of which is real, λ1, and two of which are complex conjugate, λ2,3 = λr ± iλi.
Generally speaking, all of the eigenvalues can be real, but one real eigenvalue and two
complex eigenvalues are found for all the DSAs in the cohort. All eigenvalues λ1 and
the real parts of λ2 and λ3 were negative, confirming that the system generates stable
solutions for each DSA type, which satisfies criterion 4 in Section 4.3.3. The system
dynamics for each DSA demonstrate a decay with some oscillations, the frequency of
which is determined by λi. There was no significant difference (p > 0.05 as in Fig.
4.11 (a) (b)) in either the characteristic times, associated with the largest or smallest
real parts of the eigenvalues, for the AMR and no-AMR groups. The characteristic
dissipation rate R takes into account the overall decay along the path from the peak
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value down to the steady state. To visualise the dynamics of DSA, phase portraits have
been plotted for an AMR case (Fig. 4.10 (a)), and a no-AMR case (Fig. 4.10 (b)). The
trajectories start from the inferred initial states and evolve to the fixed points in a spiral
manner in the phase space. It can be seen that the dissipation rate in the AMR group
(Fig. 4.10 (a), R(a) = −0.81 days−1) is faster than the no-AMR group (Fig. 4.10 (b),
R(b) = −0.27 days−1).
The dissipation rates and frequencies of oscillations were compared between the AMR
and no-AMR groups for the 39 time series. In the no-AMR group, the median and range
(in brackets) for R were −0.42 (−0.66 — −0.25) days−1. In the AMR group, the median
and range (in brackets) for R were −0.79 (−3.88 — −0.15) days−1. The comparison
of the dissipation rates R between the groups for all of the time series confirmed a
significantly faster dissipation rate of DSA in the AMR group than in the no-AMR
group with a p-value of 0.04 (shown in Fig. 4.11 (c)).
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Figure 4.11: Boxplot for (a) the larger real part of the eigenvalues; (b) the smaller
real part of the eigenvalues; (c) the imaginary part of the eigenvalues λ2,3; (d) the
dissipation rate between the two groups.
The imaginary parts of the eigenvalues between the AMR and no-AMR groups also
showed significant differences with a p-value of 0.03 (shown in Fig. 4.11 (d)). In the no-
AMR group, the median and range (in brackets) for λi were 0.20 (0.01 — 0.34) days
−1.
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In the AMR group, the median and range (in brackets) for λi were 0.28 (0.05 — 0.80)
days−1. The larger values of the imaginary parts in the AMR group represent a higher
frequency of oscillation, which indicates a stronger regulation during the transient anti-
body response for the patients in the AMR group. One hypothesis for this regulation is
the possible production of a secondary antibody (such as anti-idiotype) which targets the
dramatically increased DSA, resulting in a battling force between the DSA production
and secondary antibody production [193].
Note that the previous study by Higgins et al. [156] investigated the change in absolute
MFI values and in the mean percentage falls in the AMR and no-AMR groups, and
suggested that the falls were greater in the AMR group compared with the no-AMR
group. Our results show that not only is the difference in the MFI level between peak
and steady state different between the two groups, but the rate of change of the fall is
faster in the AMR group, also implying a stronger regulation mechanism in this group.
4.5 Conclusions
With a unique dataset of DSA time series available, a mathematical model in the form of
differential equations has been developed for the first time to describe the dynamics of the
‘falls’ in DSA for patients with and without AMR episodes. A third order linear model
was selected as it successfully captured the common features of the falling dynamics in
DSA during the early post-transplant stage in the AMR and no-AMR groups. The model
has proved useful in classification between two clinically different groups. Even though
the settling level of the DSA, which can be observed from the clinical data, showed no
difference between the AMR and the no-AMR groups, all the parameters of the model
(both deterministic and stochastic) were found to be significantly different between the
two groups. This approach is found to be useful in capturing properties of antibody
evolution from their peak concentration to the final settling level and showed that the
dynamic responses are different in AMR and no-AMR groups. A higher frequency of
oscillations and a faster antibody dissipation rate for the AMR group has been observed
from the phase portraits depicting the trajectories of the system states, and a further
test confirmed significant differences between the groups.
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The findings have important implications for the development of laboratory assays
that might define the nature of the mechanisms responsible for the falls in DSA lev-
els post-transplant, since a fuller understanding of these mechanisms might allow for
pre-transplant manipulation of DSA levels and improved clinical outcomes. This is par-
ticularly important with respect to the oscillating nature of DSA levels, which may reflect
a system slowly reaching homeostasis, and may be reflected in laboratory measurements.
Further work might also include modelling in relation to more detailed characteristics
of the antibodies. For example, we have already shown that the subclasses of IgG are
associated with clinical outcomes, so that measuring the levels of these subclasses at
more time points might be valuable [203]. The clinical outcome measures might also be
extended. Since acute antibody-mediated rejection is often treatable and is not always
associated with a poor clinical outcome (especially when the settling level of DSA is very
low), longer term graft survival could also be considered as an important outcome level.
Day to day renal function does not always follow DSA levels [190] and our understanding
of how a graft responds to DSA levels and how AMR evolves is limited.
This study presents the results on data-driven model development for early post-transplant
antibody dynamics, focusing on one of the typical patterns of a rapid fall following a
rapid rise in DSA after kidney transplantation. Future work will involve classification
and modelling of the other patterns of the post-transplant DSA dynamics that have
been described in Section 4.2 and the development of a universal model that is capable
of describing such non-typical dynamic patterns in DSA evolution.
Chapter 5
Conclusions and future work
This thesis developed and presented data-driven model identification techniques, con-
sisting of selecting and developing models based on one-dimensional clinical dynamic
data in the field of biomedical engineering. The dynamic data contain essential informa-
tion about the evolution of the underlying physiological system; dealing with these data
is challenging due to the limited accessible measurements. Targeting at this practical
difficulty, a data-driven model development strategy has been devised to extract infor-
mation carried by a measurement time series of a single variable about the underlying
complex system. The original project aims and objectives have been fully met. The
developed models are chosen to be based on nonlinear stochastic differential equations,
which was selected due to the nonlinear, stochastic and continuous nature of the un-
derlying physiological system. Recognising the nonlinearity as one of the fundamental
system characteristics, we hypothesised and confirmed the form of the dynamic equa-
tions to express various degrees of nonlinearity by different orders of polynomials. To
incorporate stochasticity into the model framework, system noise and measurement noise
have been accounted for separately in the system equation and measurement equation.
Being data-driven, the complexity of the model is highly dependent on the quality and
availability of the measurements. The model development strategy allowed selection of
the best model with the appropriate degree of complexity based on the measurements
available.
With the principle of parsimony at its heart, the variational Bayesian method was ap-
plied to select the model structure with the appropriate level of complexity and to infer
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the model parameters. The VB method has been known since the 1990s, but its effi-
ciency in parameter estimation and model selection has not been fully recognised outside
of the area of neural-imaging for which it has been developed. It is hoped that this thesis
can bring an awareness of the VB method to the biomedical engineering community, by
stressing its advantages compared with other approaches, such as the maximal likelihood
method, maximum-a-posteriori method, etc. Compared with sampling methods such as
Markov Chain Monte Carlo and Sequential Monte Carlo methods, the VB method is
deterministic and therefore much more efficient for performing Bayesian inference. It has
been widely applied to various models in the literature, such as Hidden Markov Chain
models [204], mixed effect models [205] etc. The VB method maximises the value of free
energy by optimising the parameters and the states of the system. The free energy con-
tains an intrinsic penalisation for model complexity, and does not require an additional
penalty term to account for model complexity, unlike other model selection criteria such
as the AIC and the BIC. However, the heavy penalisation for model complexity by the
free energy can cause a bias towards choosing over-simplified models, especially when the
measurements are too sparse to support complex model structures. Sparse data are one
of the common problems in biomedical research, and all parameter inference approaches
including the VB method have difficulties. However, the successful application of the
VB approach in Chapter 4 showed its potential in dealing with sparse data. For the
task of model selection, other criteria, such as the stability of the model, minimisation
of the root mean square error, have been considered for each application, alongside the
free energy criterion, to determine the most suitable parsimonious model as shown in
Chapter 3 and Chapter 4.
In the first application (Chapter 3), a novel generalised model was successfully con-
structed to describe each of 132 postprandial glucose excursions from fifteen subjects
with and without DM. The postprandial glucose excursion usually lasts for several hours
before the glucose concentration settles to a steady state. Monitoring and controlling
the glucose variability during this period is important for people with DM to achieve
the goal of maintaining glycaemic stability in daily life. With the glucose measure-
ments taken by the CGM device every five minutes, the amount of data was sufficient
to support the complexity level of the second order nonlinear stochastic model. The
VB method was successfully applied to select the order of the polynomial coefficients
accounting for system nonlinearity. Based on the free energy criterion and the decay
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ratio criterion which was devised to keep the glucose oscillations realistic, a second or-
der nonlinear stochastic model with second order polynomials in the damping term was
selected as the generalised model. Structural identifiability and parameter sensitivity
analysis were applied to confirm the reliability of the model. A successful comparison
with a well known physiologically based ‘maximal model’ taken from literature was per-
formed. Three time series were generated by the maximal model with 35 parameters
for a control and two pre-DM subjects, and were successfully fitted by the developed
model with 2 deterministic parameters. It cannot be denied that the parameters in the
maximal model have direct physiological interpretation, however, the successful fitting
of the simulated time series using the maximal model by the developed model clearly
demonstrated the parsimony of the developed model.
Comparing between the control group and the DM group, most time series in the control
group (subjects without DM) could be described sufficiently well by a second order
linear model with a constant damping term, which is a particular case of the nonlinear
model. However, the nonlinear model with a second order polynomial damping term
was selected for most glucose excursions from the group of people with DM. As an initial
visual observation of the DM profiles can detect and suspect nonlinear dynamics in the
DM profiles, the developed nonlinear model confirmed such observations and successfully
adapted a parsimonious form to capture such nonlinearity. Such a difference in the model
selection between the groups can be explained from the physiological point of view: the
impaired glucose regulation for people with DM may drive the glucose variations to
exhibit more nonlinear behaviour, reflected by the preference of the nonlinear model for
the DM group.
Investigation of the clinical relevance of the developed model revealed some useful prop-
erties. The inferred parameter values can serve as classifiers for individual profiles of
the control group and the DM group, because the deterministic and the stochastic pa-
rameters for the control and the DM group were found to be in different ranges. The
simulated pre-DM subjects were fitted by the linear model, and the parameter values
corresponding to these pre-DM subjects were found to be located between the parameter
ranges of the controls and the DMs. This implies a clinical potential of the developed
model to diagnose pre-DMs through measurement of the dynamic blood glucose ex-
cursions after food intake. The food impact parameter values for a newly diagnosed
Chapter 5. Conclusions and future work 138
DM patient without any treatment were significantly larger than for the other DM pa-
tients who took regular medication. This might reflect the effectiveness of medication
intervention given to the DM patients.
The developed glucose dynamic model can be further extended by considering more
factors that were not included in the model. The developed model only takes a single
input — the food intake — into account. Other factors, such as physical exercise and
mental stress, are known to impact on the glucose regulation system, and can be included
as multiple inputs or additional dynamic variables in the model. In this work, food intake
was considered as an impulsive excitation force; however, glucose absorption into the
system does not happen instantaneously, and therefore a function of time can be explored
as the input function to reflect the real event. With respect to the stochastic terms, only
additive noise has been considered in this thesis. However, in the postprandial glucose
application, the CGM devices usually have a larger measurement noise when the readings
of the glucose concentration is high. Therefore, a different measurement equation with
multiplicative measurement noise could be considered.
In the second application (Chapter 4), a third order linear model was successfully de-
veloped for the first time to describe the ‘falling’ dynamic patterns exhibited by 39
post-transplant antibody time series from 23 patients who underwent a high risk anti-
body incompatible kidney transplantation (AiT). These measurements were taken by a
team of world-leading doctors and clinical researchers at University Hospitals Coventry
and Warwickshire (UHCW), which is the leading clinical centre in the UK for antibody
incompatible kidney transplantation. This clinical centre proposed a National Registry,
which is the first of its type in the world and has hosted more than one hundred complex
cases since 2003. The post-transplant antibody dynamics manifest a variety of patterns,
among which a pattern of a clear rise and fall is shared by 39 post-transplant antibody
time series that belong to two groups of patients with and without episodes of acute
AMR.
The VB method was successfully applied to select the best model and infer its parame-
ters. The choice between the stochastic model and the deterministic model, and between
the linear model and the nonlinear model was made by comparing the free energy values
for each time series. The normalised root mean square error criterion, accounting for
Chapter 5. Conclusions and future work 139
the peak height of the time series, was devised to select the order of the system. Over-
coming the difficulty with the sparseness of the data and the irregularity of the sampling
frequency, the third order linear model was selected and confirmed by the leave-one-out
cross validation technique. The VB method showed a robust performance of parameter
inference with limited numbers of measurement data points. The combined consider-
ation of the free energy criterion and the normalised root mean square error criterion
for model selection was proved to be a good strategy when data are sparse. Structural
identifiability and sensitivity analysis have also been applied to confirm the reliability
of the model. The developed model is structurally identifiable and is robust around the
inferred parameter values.
The ranges of the parameter values were found to be significantly different between the
AMR and no-AMR group. The post-transplant antibody dynamics was found to have
a significantly higher frequency of oscillations and a faster antibody dissipation rate for
the AMR group. These findings have important implications for the development of
laboratory assays that might define the nature of the mechanisms responsible for the
falls in the post-transplant antibody levels.
This work can be further extended by considering more varieties of dynamic patterns that
manifest in the post-transplant antibody time series. Only time series with a dramatic
rise and fall after transplantation have been modelled. Other dynamic features, such
as an unsettled oscillations and a slow rise after the fall, require further investigation.
Different forms of nonlinearity or different model orders might be considered to reflect
the diverse dynamic patterns. In addition, the measurement noise was modelled to
have a constant noise intensity regardless of the measured value. However, the linear
relationship between the antibody concentration and the MFI readings (measurements)
breaks when MFI < 1000 AU or > 10, 000 AU. This suggests that a non-additive noise
can be considered.
Overall, the nonlinear model identification techniques developed in this thesis are limited
to a polynomial form of nonlinearity. Such techniques can be extended to incorporate
other forms of nonlinearity, such as exponential, logarithmic, trigonometric functions,
into the model development process. However, in the context of biomedical system
identification, the dynamic patterns exhibited in the measured time series should direct
the incorporation of different nonlinear forms.
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This dissertation forms a solid foundation for future research to account for the factors
that have not been included into the models. Two Ph.D students have been recruited
to continue the research initiated by this Ph.D project and further develop and validate
the models. The two projects are:
1) Personalised predictive modelling and control of blood glucose dynamics.
2) Mathematical modelling for clinical outcome prediction in kidney transplantation.
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Appendix: Matlab code
As introduced in Chapter 2, a VB toolbox [77], initially developed for neuroimaging data,
was applied to perform the inference in this thesis. It can be accessed via http://mbb-
team.github.io/VBA-toolbox. The specific codes for the models that have been built in
Chapters 2, 3, and 4 are shown as follows:
1 %%Chapter 2 f_chp2 is the model for the example shown in Section 2.8
2 function [fx ,dF_dX ,dF_dTheta ,d2F_dXdTheta] = f_chp2(Xt,Theta ,ut,inF)
3 % function [f,J] = f_doubleWell(t,x,theta)
4 %
5 % This function computes the evolution function that comes from a .
6 % IN:
7 % - t: time index (not used here)
8 % - x: the current state of the system
9 % - theta: a 2x1 vector parameter (containing the position of the two
10 % wells.
11 % OUT:
12 % - f: the current value of the evolution function
13 % - J: the jacobbian of the system
14
15 deltat = inF.deltat;
16 k = Theta (1);
17 b = Theta (2);
18 a = Theta (3);
19 x1 = Xt(1);
20 x2 = Xt(2);
21
22 f = [ x2 ; -a-b*x1-k*x2 ];
23 J = [ 0 1
24 -b -k ];
25
26 fx = deltat .*f + Xt;
27 dF_dX = deltat .*J’ + eye (2);
28 dF_dTheta = deltat .*[ 0 -x2
29 0 -x1
30 0 -1];
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31 d2F_dXdTheta (:,:,1) = zeros (2,3);
32 d2F_dXdTheta (:,:,2) = deltat .*[ 0 -1 0
33 -1 0 0];
34
35
36 %% f_ML and f_M2 are the models ML and M2 described in Chapter 3
37 function [fx ,dF_dX ,dF_dTheta ,d2F_dXdTheta] = f_ML(Xt ,Theta ,ut ,inF)
38 deltat = inF.deltat;
39 k = Theta (1);
40 b = Theta (2);
41 x1 = Xt(1);
42 x2 = Xt(2);
43
44 f = [ x2 ; -b*x1-k*x2 ];
45 J = [ 0 1
46 -b -k ];
47
48 fx = deltat .* f + Xt;
49 dF_dX = deltat .*J’ + eye (2);
50 dF_dTheta = deltat .*[ 0 -x2
51 0 -x1];
52 d2F_dXdTheta (:,:,1) = zeros (2,2);
53 d2F_dXdTheta (:,:,2) = deltat .*[ 0 -1
54 -1 0];
55
56
57 function [fx ,dF_dX ,dF_dTheta ,d2F_dXdTheta] = f_M2(Xt ,Theta ,ut ,inF)
58 deltat = inF.deltat;
59 k0 = Theta (1);
60 k1 = Theta (2);
61 k2 = Theta (3);
62 b = Theta (4);
63 x1 = Xt(1);
64 x2 = Xt(2);
65
66 f = [ x2 ; -b*x1-k0*x2-k1*x1*x2-k2*x1^2*x2 ];
67 J = [ 0 1
68 -b-k1*x2 -2*k2*x1*x2 -k0 -k1*x1-k2*x1^2 ];
69
70 fx = deltat .* f + Xt;
71 dF_dX = deltat .*J’ + eye (2);
72 dF_dTheta = deltat .*[ 0 -x2
73 0 -x1*x2
74 0 -x1^2*x2
75 0 -x1];
76 d2F_dXdTheta (:,:,1) = zeros (2,4);
77 d2F_dXdTheta (:,:,2) = deltat .*[ 0 -x2 -2*x1*x2 -1
78 -1 -x1 -x1^2 0];
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79
80
81 %% f_chp4 is the model described in Chapter 4.3
82 function [fx ,dF_dX ,dF_dTheta ,d2F_dXdTheta] = f_chp4(Xt,Theta ,ut,inF)
83 deltat = inF.deltat;
84
85 a = Theta (1);
86 b = Theta (2);
87 c = Theta (3);
88 d = Theta (4);
89 x1 = Xt(1);
90 x2 = Xt(2);
91 x3 = Xt(3);
92
93 f = [ x2 ; x3; -a*x1-b*x2-c*x3-d ];
94 J = [ 0 1 0
95 0 0 1
96 -a -b -c ];
97
98 fx = deltat .*(f+ut *[0;1;0]) + Xt;
99 dF_dX = deltat .*J’ + eye (3);
100 dF_dTheta = deltat .*[ 0 0 -x1
101 0 0 -x2
102 0 0 -x3
103 0 0 -1];
104 d2F_dXdTheta (:,:,1) = zeros (3,4);
105 d2F_dXdTheta (:,:,2) = zeros (3,4);
106 d2F_dXdTheta (:,:,3) = deltat .*[ -1 0 0 0
107 0 -1 0 0
108 0 0 -1 0];
